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The quest to unravel the association between meat and cancer risk started in 1975, when 
Armstrong and Doll observed that international variation in meat consumption was 
strongly correlated with cancer incidence and mortality, particularly cancer of the colon [1].  
In addition, rapid changes in cancer rates were observed among populations migrating 
from low to high meat consumption countries [2]. This early ecological evidence generated 
a great deal of scientific interest to further examine the meat-cancer association using 
individual-level study designs. Since then, hundreds of epidemiological studies from many 
countries with diverse diets have reported on the relation between meat and cancer risk. 
However, despite these efforts, the effect of meat consumption on cancer risk remains a 
controversial issue. 
In order to further elucidate the role of meat consumption in the etiology of cancer it is 
important to examine the total range of meat consumption, including extreme intake 
levels. In addition, more insight on the association between meat consumption and cancer 
risk can be obtained when epidemiological analyses are conducted at the level of meat-
related dietary patterns, total meat intake, subtypes of meat, and individual meat 
carcinogens. By including molecular markers in epidemiologic studies, it is possible to shed 
more light on the biological pathways linking meat consumption to cancer risk.  When the 
results from such multiple lines of research are consistent, evidence on the association 
between meat and cancer risk is enhanced.  
For the abovementioned reasons, this thesis set out to investigate the association between 
meat consumption and cancer risk using a multi-dimensional epidemiological approach. 
The first chapters of this thesis focus on meat-related dietary patterns in relation to cancer 
risk (i.e. vegetarian and low meat diets), whereas specific mechanisms of meat-related 
carcinogenesis (i.e. dietary fat, heterocyclic amines (HCAs), polycyclic aromatic 
hydrocarbons (HCAs), nitrite/nitrate, and heme iron) are examined in the second part of 
this thesis. 
MEAT CONSUMPTION AND CANCER: THE EPIDEMIOLOGICAL EVIDENCE 
This section briefly summarizes the existing epidemiological evidence regarding the role of 
meat consumption in the etiology of cancer.  
Research indicates that the cancer promoting effect of meat differs both by meat subtype 
and cancer endpoint. The cancer site most consistently associated with meat intake is the 
colorectum. In 2007, a review and meta-analysis commissioned by the World Cancer 
Research Fund / American Institute for Cancer Research concluded that there was 
convincing evidence for a positive association between red meat and processed meat 
intake and colorectal cancer [3]. Based on their conclusions, the WCRF recommends people 
to consume less than 500 grams of red meat per week and to avoid the consumption of 
processed meat [3]. Although the conclusions of the WCRF report have been questioned by 
some [4, 5], the most recent meta-analysis including data from 26 prospective studies 
supports limiting the amount of red and processed meat consumption for colorectal cancer 
prevention [6]. Chan et al indicated that for every 50 g/day increase of fresh red meat or 
processed meat the risk of colorectal cancer increased by 17% and 18%, respectively [6]. 
INTRODUCTION 
 
11 
In contrast, evidence for an association between red and processed meat and other major 
cancers such as prostate [7], breast [8], lung [9] and pancreatic cancer [10] is less abundant 
and less consistent across studies. Some rarer type cancers like renal cell, endometrial, 
ovarian, esophageal, and stomach cancer have been hypothesized to be associated with 
red and processed meat intake, but confirmative evidence from prospective population 
based data are sparse [11-15]. However, definitions and consumption patterns of red and 
processed meat differ between populations and across studies. Conclusions and 
recommendations are therefore not as clear as they could be [3].  
In contrast to red and processed meat, white meat (i.e. poultry) has not been as extensively 
investigated in prospective epidemiologic studies [3]. Nonetheless, the available studies 
generally reported null or cancer preventive effects (e.g. ref 16-19). Moreover, although 
the nutrient composition of meat is strongly determined by a number of factors including 
the animal of origin, only a few studies examined cancer risk in relation to meat subtypes 
(e.g. beef, pork, lamb, or offal (i.e. organ meats)).   
A DIETARY PATTERN APPROACH  
Individuals who consume a diet void of all meat provide an interesting opportunity to 
further elucidate the relation between meat consumption and cancer risk. Studies of 
vegetarians can nicely complement the above mentioned epidemiological studies that are 
conducted at the food group level (i.e. meat (subtypes)). Although vegetarian diets are 
defined by the absence of all meats, fish and shellfish, several subtypes can be defined. For 
example, lacto-ovo vegetarians include both eggs and dairy products in their diet, lacto-
vegetarians consume dairy products but no eggs, and ovo-vegetarians consume eggs but no 
dairy products. In addition, pescetarians abstain from eating all meat with the exception of 
fish whereas vegans exclude all animal-derived products and ingredients from their diet. 
Thus, the choice of a specific vegetarian diet may determine the effect on the nutritional 
status and cancer risk. While the worldwide demand for meat is expected to grow 
considerably over the next decades, the total number of vegetarians is also rapidly 
increasing as a result of nutritional, ethical, and more recently, environmental concerns 
[20]. This transition is accompanied by an increase in the number of meat reducers [21]. 
However, while the health effects of vegetarian diets are receiving increasing scientific 
interest, little to no research has been conducted in the area of low meat consumers (in 
this thesis defined as individuals who consume meat for 1 day/week). 
Vegetarian and low meat diets 
A few prospective cohort studies specifically set out to study cancer incidence and 
mortality in vegetarians. A pooled estimate of mortality rates in five prospective cohort 
studies (including the Adventist Health Study I (AHS))[22], the Adventists Mortality Study 
[23], the Health Food Shoppers Study [24], the Heidelberg Study [25], and the Oxford 
Vegetarian Study [26]) reported no large differences in (total) cancer mortality between 
vegetarians and non-vegetarians [27].  More recent results from the AHS II also revealed no 
significant associations between vegetarianism and cancer mortality [28]. Fewer and more 
inconsistent data are available on the role of vegetarian diets in cancer incidence. In the 
United States, results from the AHS I suggest that vegetarians are at a reduced risk of 
developing colon cancer and prostate cancer compared to meat eaters [29]. Preliminary 
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analyses from AHS II report lower risks of cancer of the gastro-intestinal tract and 
respiratory tract among vegetarians, and suggest that vegans had lower risks of overall 
cancer and female specific cancers [30]. In the United Kingdom, the Oxford Vegetarian 
Study [31] revealed no large differences in colorectal cancer incidence between vegetarians 
and non-vegetarians, whereas results from the European Prospective Investigation into 
Cancer and Nutrition (EPIC)-Oxford cohort indicate that vegetarians were at an increased 
risk [32]. The latter strongly contrasts the finding that red and processed meat are 
convincing causes of colorectal cancer [6]. In addition, compared to non-vegetarians, 
vegetarians were at lower risk of stomach cancer, bladder cancer, and cancers of the 
lymphatic and hematopoietic tissues when data from EPIC-Oxford and the Oxford 
Vegetarian Study were pooled [33]. The UK Women’s Cohort study suggests that women 
who do not eat meat have a lower risk of breast cancer [34] than high meat consumers, but 
studies that compared vegetarians to non-vegetarians (including the UK Women Cohort 
study) reported no associations [29, 32, 33, 35]. Overall, too few data from large cohort 
studies are present to formulate more than general conclusions concerning the role of 
vegetarianism in the development of cancer [3].  
Some of the inconsistencies in previous findings may be due to differences in sampling 
strategies between studies; some studies stem from convenience samples that have likely 
also recruited more health-conscious non-vegetarians. Other inconsistencies may have 
resulted from differences in definition and operationalization of vegetarianism; only a few 
studies identified vegetarians based on extensive dietary data collection techniques [22, 
36], whereas others reported to have classified vegetarians by means of several broader 
questions relating to the overall consumption of animal products [25, 37, 38], or to have 
used self-reported vegetarianism [24] as inclusion criterion. However, there is substantial 
inconsistency in how people self-identify [39, 40], and the usefulness and reliability of self-
defined vegetarianism in etiological studies of cancer remains unclear. 
Appropriately planned vegetarian diets have shown to be consistent with the current 
dietary guidelines in all stages of the lifecycle [41]. Nonetheless, meat provides an 
important source of fat, protein, essential amino acids, and vitamins and minerals such as 
iron, zinc, and vitamin B12. Studies suggest that vegetarians have lower circulating 
concentrations of vitamin B12 compared to meat eaters depending on the level of animal 
product restriction in the diet [42]. Vegetarians have also inconsistently been reported to 
have lower serum levels of iron, vitamin D, omega-3 fatty acids, and zinc (summarized in ref 
43).  
Low meat diets may be less prone to such dietary deficiencies, and may consequently result 
in a similar or perhaps even lower cancer risk than vegetarian diets. However, within the 
existing studies of meat, vegetarianism and cancer risk, little to no attention has been paid 
to the lower end of the meat consumption spectrum. This may partly result from the 
relatively narrow intake distribution of meat intake in Western countries. In the 
Netherlands, less than 20% of the population consumes meat for ≤2 days per week for the 
hot meal [21].  This constrains our capacity to examine the cancer risk associated with 
(very) low intake levels.  Studying the meat cancer association in population based studies 
enriched with vegetarians and low meat consumers increases the heterogeneity of meat 
exposure which may increase the power to detect an effect.   
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Challenges associated with the dietary pattern approach 
Although vegetarian and low meat diets are only defined by the level of meat and/or fish 
consumption, they are likely to be interrelated with other dietary and lifestyle factors [38] 
that may have an independent effect on cancer occurrence. For example, vegetarians have 
higher levels of fruit and vegetable consumption, physical activity, and a lower prevalence 
of smoking and alcohol use [38]. In addition, a diet high in meat consumption may increase 
the risk of developing obesity [44, 45], which is an independent risk factor of many cancers. 
However, whether the health effects of no and low meat diets can be explained by factors 
other than meat consumption remains controversial. Most studies examining cancer 
incidence in vegetarians only adjusted for confounding variables outside the diet [29, 30, 
32, 33] and little is known about the potential explanatory role of these multiple connected 
factors. 
The vegetarian and low meat dietary patterns are likely to vary by sex, socioeconomic 
status, religion, ethnic group and culture. In addition, no and low meat consumers are likely 
to be health conscious. Because it has been postulated that these self-selection factors may 
confound any association with health outcomes [46], it is essential to replicate results in 
diverse populations. When similar cancer risk estimates are observed in different 
populations of vegetarians and low meat consumers, it is more likely that the results can be 
attributed to the diet as such rather than underlying selection processes because these will 
also differ between populations.  
An association with an overall dietary pattern does not enhance biological insight or 
mechanistic understanding. Studying dietary patterns should therefore be considered as a 
complementary approach to understand the relation between meat consumption and 
cancer risk that preferably would be combined with analysis at the levels of meat 
(subgroups) and meat carcinogens.  
A MECHANISTIC APPROACH  
The second part of this thesis focuses on mechanisms of meat-related carcinogenesis in an 
attempt to further elucidate the role of meat consumption in the etiology of cancer. If the 
primary cancer causing mechanism(s) of meat consumption can be established, it may be 
possible to change or intervene on the production processes that lead to carcinogen 
formation. In this section an overview of the most widely accepted and studied hypotheses 
is provided, but this list is not exhaustive. 
Dietary fat 
Dietary fat, particularly saturated fat, has long been suspected to be responsible for the 
meat-cancer association. Dietary fat increases bile acid secretion in the gut which acts as 
aggressive surfactants that may promote colorectal carcinogenesis [47]. Additionally, high 
intake of dietary fat is suggested to alter endogenous hormone levels, thereby possibly 
increasing the risk of hormone-related cancers such as breast, ovarian, endometrial, and 
prostate cancer. However, epidemiological studies have been inconsistent [3, 48] and 
intervention studies aimed at lowering total fat intake failed to confirm any association 
with cancer risk (e.g. ref 49-51) except for cancer of the ovaries [50].  
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Heterocyclic amines and polycyclic aromatic hydrocarbons 
More recent evidence suggests a role for meat-related specific mutagens. These include the 
formation of heterocyclic amines (HCAs) during high temperature cooking of meat when 
creatine or creatinine, amino acids, and sugar react to form a variety of HCAs [52]. This 
reaction is a function of both cooking temperature and cooking time. Over 20 HCA 
compounds have been identified, but the most abundant HCAs in cooked meat are 2-
amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-trimethylimi-
dazo[4,5-f]- quinoxaline (DiMeIQx) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine 
(PhIP). Polycyclic aromatic hydrocarbons (PAHs) are a second class of meat-related 
mutagens that are predominantly found in grilled, barbequed, and smoked meat. Preparing 
meat over a direct flame results in fat and meat juices dripping onto the hot fire causing 
PAH containing smoke to coat the surface of the meat. While more than 100 different types 
of HCAs have been identified, extensive information concerning meat carcinogenesis is only 
available for benzo[a]pyrene (B[a]P), which is considered a marker of total PAH exposure. 
Although there is ample evidence from in vitro and animal studies that HCAs and PAHs can 
damage DNA and cause tumors in multiple organs [53-57], evidence in humans remains 
inconsistent [3]. Over the past 10 years, an increasing number of epidemiological studies 
have included surrogates of HCA and PAH exposure in their dietary assessment (i.e. meat 
cooking technique, doneness level and surface browning of the meat) [58]. This 
information can be linked to databases containing the HCA and PAH content of numerous 
meats prepared by various cooking methods and doneness levels, to estimate intake levels 
[58]. Previous studies have reported that high exposure to meat-related HCAs and PAHs 
may be associated with the risk of cancers including colorectal, breast, prostate, pancreas, 
lung, stomach, and esophagus. A review published in 2009 suggests that the strongest and 
most consistent associations are observed for PhIP intake (see ref 59 and references 
therein). Associations between MeIQx, DiMeIQx and B[a]P were less consistent across 
studies and cancer endpoints [59], possibly due to their lower exposure concentrations. 
Dietary heme and N-nitroso compounds 
Dietary heme iron may also explain meat induced carcinogenesis. Heme is present at five-
fold higher concentrations in red than white meat [60] and could explain why white meat, 
in contrast to red meat, is not associated with cancer risk. Most epidemiologic research has 
examined heme iron in relation to colorectal cancer and a recent meta-analysis of five 
prospective studies indeed showed a consistent, though modest, increased risk of 18% 
comparing the highest to the lowest category of heme iron intake. Much less is known 
about the effect of heme on other cancer endpoints but some studies are indicative of an 
increased risk of e.g. esophageal [14, 61], gastric cancer [61], endometrial cancer [62], and 
lung cancer [63]. The hypothesis that heme iron may be associated with an increased 
cancer risk is strengthened by the observation that heme iron catalyzes the endogenous 
formation of N-nitroso compounds (NOCs) in humans [64]. In addition, NOCs may also be 
formed in processed meats when nitrite is added during the curing process [65]. NOCs are 
some of the most powerful chemical carcinogens, inducing tumors in multiple organ sites in 
numerous animal species [53]. Both heme iron and NOCs may also catalyze the formation 
of reactive oxygen species that can cause DNA damage [66, 67] and heme is also thought to 
promote colonic cytotoxicity and increased cell proliferation [68-70]. Nonetheless, 
mechanistic evidence on the role of heme iron in carcinogenesis from population based 
observational studies is lacking. 
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Molecular epidemiology to study meat-related carcinogenic pathways 
The previously described epidemiological studies of meat, meat carcinogens and cancer risk 
generally made use of traditional epidemiologic modes of data collection (e.g. using 
questionnaire data). Although this traditional approach has made pivotal contributions to 
specifying the association between meat and cancer risk, it often does not illuminate the 
exact biological mechanisms underlying the observed associations [71]. To open this “black-
box”, we need to move towards the field of molecular epidemiology and integrate 
biomarker data into our epidemiologic studies [72]. Biomarkers of exposure (e.g. circulation 
nutrient/carcinogen concentrations), susceptibility (e.g. genetic variation) and/or effect 
(e.g. molecular signatures in tumors) are currently being included in observational studies 
and may increase our understanding of the role of meat consumption in cancer risk.  
For example, the cancer risk posed by HCAs, PAHs, and NOCs depends on the extent to 
which they are metabolized: they undergo a series of chemical reactions in the human body 
during which they can be activated or detoxified by phase I and phase II xenobiotic 
metabolizing enzymes (XMEs)[73, 74]. Single nucleotide polymorphisms (SNPs) in the genes 
encoding these XMEs may modify the ability to activate or detoxify carcinogens. 
Associations between meat consumption and cancer risk may therefore be limited to 
genetically susceptible individuals. Nonetheless, studies examining interactions between 
XME polymorphisms, meat consumption and the risk of various cancer endpoints have 
reported mixed results (e.g. refs 75-81) but often had a small number of cases available or 
examined only a small set of SNPs from a limited number of candidate genes. Because the 
balance of activating and detoxifying enzymes is thought to influence carcinogen 
metabolism [82], comprehensive studies including numerous markers across multiple 
genes involved in xenobiotic metabolism are essential for studying this complex 
association. 
Next to the study of gene environment interactions, clarification of the association 
between meat carcinogens and the risk of cancer by molecular tumor subtype may also 
lead to a better understanding of the suggested pathways linking meat consumption to 
cancer. More specifically, such somatic (or acquired) genetic alterations in the tumor can 
be viewed as a signature of long term internal and external exposures and therefore also of 
meat-related carcinogens. Observational studies that are able to investigate these 
mechanisms using biomarker data in large populations are essential in providing further 
evidence for the meat cancer association. 
RATIONALE, AIM, AND OUTLINE OF THIS THESIS 
The overall aim of this thesis was to investigate the association between meat consumption 
and cancer risk in order to explain the heterogeneity observed in previous studies using a 
multi-dimensional epidemiological approach (see Figure 1).  
In the first part of this thesis, vegetarian and low meat dietary patterns were studied in 
relation to cancer risk. This section starts with two studies on meat consumption patterns 
and non-cancer health outcomes, since these may, in turn, affect the association between 
vegetarian and low meat diets and cancer risk. Because obesity is likely associated with a 
high meat dietary pattern but also an independent risk factor of many cancers, we were 
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first interested to examine whether meat consumption was associated with prospective 
weight gain (14 years) using the Netherlands Cohort Study on diet and cancer (NLCS) [83] 
(Chapter 2). Secondly, individuals following a vegetarian diet are likely at higher risk of 
developing nutrient deficiencies which is why we set out to study serum vitamin B12 status 
in vegetarian, vegan and meat eating men using data from the EPIC-Oxford cohort (Chapter 
3).  
Because low meat consumers (i.e. individuals who consume meat for 1 day/week) may be 
less prone to develop nutrient deficiencies, we hypothesized they might also have an 
additional beneficial cancer preventive effect over vegetarians when compared to high-
meat consumers. We therefore established an analytical cohort specifically designed to 
study the health effects of vegetarian and low meat diets focusing on cancer incidence and 
mortality. This population was extracted from the total NLCS and referred to as the NLCS-
Meat Investigation Cohort (NLCS-MIC). The NLCS aimed to over-represent vegetarians and 
low meat consumers at recruitment by intentionally contacting them through health food 
shops and magazines. In addition, the NCLS-MIC contains a considerable number of 
pescetarians. The NLCS used an extensive FFQ to assess dietary intake. This enabled us to 
classify vegetarians based on self-reporting (1 question) as well as on the more accurate 
and extensive FFQ data. Consequently, we could not only study vegetarianism and low 
meat consumption in relation to major cancer outcomes (colorectal, lung, female breast 
and prostate) but were also able to investigate the reliability of self-defined vegetarianism 
in relation to cancer risk estimates. As a result of the sampling strategy, this population has 
a large contrast in meat intake which should also aid the further specification of 
associations between subtypes of meat and cancer risk. Chapter 4 describes the 
composition and baseline characteristics of the NLCS-MIC cohort. In Chapter 5 and 6 
associations are described between vegetarianism, low meat consumption and the risk of 
colorectal and lung, female breast and prostate cancer, respectively, using data from NLCS-
MIC. 
In the second part of this thesis, we set out to study each of the proposed mechanisms of 
meat-related carcinogenicity in relation to the cancer endpoints most likely to be affected. 
Chapter 7 describes the association between meat and fat intake and the risk of ovarian 
cancer in the NLCS. In Chapter 8, we describe the combined effects of HCAs, PAHs and 
nitrite/nitrate intake and genetic variants in 18 phase I and phase II xenobiotic metabolizing 
enzymes genes in relation to advanced colorectal adenoma and colorectal cancer within 
the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. In Chapter 9 we 
studied heme iron in relation to the risk of colorectal cancer by specific molecular 
characteristics (i.e. mutation status of KRAS, APC and overexpression of P53) in the NLCS. 
Chapter 10 provides a discussion of the main findings in light of some important strengths 
and limitations, and recommendations for future research. 
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Figure 1: Schematic overview of the studies included in this thesis. 
NLCS (Netherlands Cohort Study), EPIC (European Prospective Investigation into Cancer and Nutrition), NLCS-MIC 
(NLCS- Meat Investigation Cohort), PLCO Screening Trial (Prostate, Lung, Colorectal and Ovarian) Screening Trial. 
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ABSTRACT 
Introduction: Hypotheses regarding the role of meat consumption in body weight 
modulation are contradictory. Prospective studies on an association between meat 
consumption and BMI change are limited.  
Methods: We assessed the association between meat consumption and change in BMI over 
time in 3902 men and women aged 55–69 y from the Netherlands Cohort Study. Dietary 
intake was estimated at baseline by a food-frequency questionnaire. BMI was ascertained 
through baseline self-reported height (1986) and weight (1986, 1992 and 2000). Analyses 
were based on sex-specific categories of daily total fresh meat, red meat, beef, pork, 
minced meat, chicken, processed meat and fish consumption at baseline. Linear mixed 
effect modelling adjusted for confounders was used to assess longitudinal associations.  
Results: Significant cross-sectional differences in BMI between quintiles of total meat 
intake were observed (P-trend<0.01; both sexes). No association between total fresh meat 
consumption and prospective BMI change was observed in men and women (∆BMI change 
highest vs lowest quintile after 14 y: men -0.06kg/m2, P=0.75; women 0.26kg/m2, P=0.20). 
Men with the highest intake of beef experienced a significantly lower increase in BMI after 
6 and 14 y than those with the lowest intake. After 14 y, a higher increase in BMI was 
associated with higher intakes of chicken in women and with pork in both sexes. Results 
remained similar when stratifying on median baseline BMI, and age-stratified analyses 
yielded mixed results.  
Discussion: Meat consumption, or factors directly related to meat intake, is not strongly 
associated with weight change during 14 year prospective follow-up in this elderly 
population. 
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INTRODUCTION 
Overweight and obesity have reached pandemic proportions resulting in a growing global 
burden of obesity related chronic disease [1, 2]. Hence, there is an increasing interest to 
identify modifiable factors in the diet that may be associated with maintaining a healthy 
body weight. In this respect, several plausible hypotheses underlie a potential role for meat 
consumption in the development of adiposity. 
Cross-sectional research has shown considerable lower obesity rates among vegetarians 
compared to meat-eaters in Western populations [3-7]. However, whether these 
differences in body weight can be explained by the abstinence of meat, the higher intake of 
beneficial dietary components such as fruit and vegetables, the overall lower energy intake, 
or the more favorable non dietary lifestyle factors of vegetarians has been debated. 
Nonetheless, cross-sectional studies examining the effect of meat consumption in 
particular on body weight have yielded ambiguous results [8-11], but are above all limited 
by their inability to distinguish between cause and effect.  
Until now, two longitudinal studies investigated the possible role of vegetarianism in 
preventing weight gain. Rosell et al. [12] observed only small differences in weight gain 
between meat eating and vegetarian men over a 5 year period, whereas a smaller study in 
Seventh-day Adventists [13] showed non-significant and mixed results. The few studies 
which prospectively examined the role of dietary meat consumption for weight 
maintenance yielded mixed results [14-21] and mostly reported only on the effects of total 
meat intake and not on different sources and types of meat products. 
In contrast, high protein diets have also been advocated for weight reduction and body 
weight regulation. Meat products are generally a rich source of high quality proteins which 
may increase satiety and up regulate thermogenesis [22]. Although well-designed long term 
studies are lacking, high protein diets have shown to positively affect weight maintenance 
on the short term [23]. In addition, studies on the weight reducing potential of the specific 
high protein, low carbohydrate Atkins diet [24], containing ad libitum amounts of meat, 
have been inconsistent [25-28].  
The Netherlands Cohort Study on diet and cancer (NLCS) acquired data from up to three 
consecutive weight measurements over a period of 14 years for 5,000 elderly individuals 
who were randomly selected from the total cohort. This study provides the unique 
opportunity to examine the association between the dietary intake of fresh meat, 
processed meat, poultry and fish and subsequent BMI change over time in the general 
elderly population. 
METHODS 
Subjects and study design 
The Netherlands Cohort Study was conceived in September 1986 with the enrolment of 
120,852 individuals in the Netherlands and with the purpose to investigate the associations 
between diet and the development of cancer. The cohort comprised 58279 men and 62573 
women aged 55-69 years at baseline who completed a self-administered questionnaire on 
dietary habits, lifestyle, medical history, and demographic information. Municipal registries 
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throughout the Netherlands were used to constitute an effective sampling frame of the 
population. Full details of the study design have been described elsewhere [29].  
The NLCS is a case-cohort design with a subcohort of 5000 individuals randomly selected 
from the larger cohort on recruitment into the study.  These individuals have been 
followed-up biennially from baseline in 1986 for migration and vital status to estimate 
person time at risk. Follow-up of the subcohort has also allowed for the additional 
accumulation of prospective data regarding a number of factors related to body weight and 
weight change. This subcohort was the study population used for the present study. 
For the current analyses, individuals who returned incomplete baseline dietary 
questionnaires, individuals with missing values for height or weight at baseline, and all 
prevalent cancer cases other than skin cancer at baseline were excluded. This resulted in an 
initial study population of 4280 individuals. Follow-up measurements regarding BMI were 
recorded in the years 1992 and 2000, and data were available for 3787 and 2091 
individuals, respectively, at these time points. The NLCS has been approved by the 
institutional review boards of the CIVO-TNO Research Institute (Zeist, the Netherlands) and 
Maastricht University (Maastricht, the Netherlands). The Institutional Review Board of 
Maastricht University approved the analyses reported herein. 
Dietary assessment 
Habitual meat intake at baseline was assessed using a self-administered semi-quantitative 
food-frequency questionnaire (FFQ) consisting of 150 food-items, estimating the average 
frequency of foods and beverages consumed over the previous 12 months. The 
questionnaire contained 14 items on the consumption of meat with the hot meal (mainly 
fresh meat, including chicken), 5 items on the consumption of meat products used as 
sandwich fillings, and 3 items on fish consumption. This dietary assessment was part of a 
larger questionnaire that included questions regarding several lifestyle factors.  
Fresh meat consisted of beef, pork, minced meat (including beef and pork), chicken, liver, 
and other meat (e.g. horsemeat, lamb). Fresh red meat consisted of the fresh meat items 
minus the chicken item. Coding of fresh meat items was based on raw weight to take into 
account the amount of fat originally present in the meat but eventually ending up in the 
gravy, which is usually consumed as well. Processed meat was defined as meat items that 
had undergone some form of preservation (mostly treatment with nitrate salt, some types 
smoked or fermented). The meat intake in each participant’s diet was calculated from the 
FFQ dietary data by summing the multiplied frequencies and serving sizes of the meat 
items. 
Ascertainment of BMI 
Subjects in the subcohort were followed up biennially since the time of the baseline 
questionnaire. At these time points, additional self-administered questionnaires were 
mailed to all individuals given they were still alive and reachable at the same address. If 
necessary, new addresses were obtained through the municipal population registries and 
individuals were contacted there. Height (cm) was reported on the baseline questionnaire. 
Body weight (kg) was reported on questionnaires on three different occasions: at baseline 
in 1986, in 1992 and 2000. In 1986 and 1992 the question was open-ended and phrased as 
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“how much do you weigh now (kg)?” In 2000, subjects were asked “have you weighed 
yourself recently (yes/no)?” If subjects answered “yes”, they were directed to an open-end 
question, “how much do you weigh (kg)?” At all three time points, the weight 
measurement was self-reported. BMI (kg/m2) was calculated for each time point by using 
the recorded weight at each time point divided by height squared at baseline. Moreover, 
the baseline questionnaire included the open-end question, “what was your weight at age 
20 (kg)?”, and a corresponding BMI was calculated using the recorded weight at age 20 
divided by height squared at baseline (age 55-69 y). An overview of the study design is 
presented in Supplemental Figure 1. 
Statistical analyses 
Data were analyzed using Stata (Intercooled STATA, version 11; Stata-Corp LP, College 
Station, TX). All analyses were conducted separately for different types of meat intake and 
were stratified by sex.. Total fresh meat consumption was quantified using two parameters; 
quintiles of intake (in g/d) and weekly frequency of meat intake (0-3d/wk, 4-5d/wk, 6-
7d/wk). Sex-specific intakes of total fresh meat, weekly meat consumption frequency, fresh 
red meat, beef, pork, minced meat, chicken, processed meat and fish were assessed. Mean 
total meat and individual meat product intake as well as other population characteristics 
were analyzed using data from the baseline questionnaire. Pearson’s correlation was 
applied to determine the association between continuous baseline characteristics and total 
fresh meat consumption. Cross sectional differences in baseline BMI values per quintile of 
total fresh meat consumption were examined by using a linear regression model adjusted 
for confounding variables selected for the longitudinal analyses as described below. 
Linear mixed effect (LME) modelling was applied to assess the change in BMI over time and 
the longitudinal relation between meat consumption intake at baseline and BMI at baseline 
(1986), in 1992 and in 2000. The mixed model consists of two parts: fixed effects and 
random effects. Fixed effects describe population slopes for a set of considered covariates, 
which include exposures and confounders. Random effects describe individual variability in 
outcome and in changes over time. We considered a model with individual random slopes 
for time. The model allowed us to examine the influence of covariates on the change in BMI 
over time [30]. This model also accounts for the correlation between repeated measures 
and accounts for missing values at different time points [31].  
For the LME model, a categorical time variable was created by using the values 0, 6 and 14 
reflecting the time points (in years) of the BMI measurement from baseline. Two dummy 
variables indicating the three time points and 4 meat intake dummy variables (reflecting 
quintiles or 5 categories of intake) were entered into the model. In case of chicken and fish 
consumption 3 dummy variables were entered, and for reported weekly frequency of meat 
intake 2 dummies were created, (reflecting the 4 or 3 categories of intake, respectively). 
Furthermore, interactions of the time dummies with the meat intake dummies (8, 6 or 4 
interaction terms, respectively) were included. A random slope for time at the individual 
level was obtained by using time as a continuous variable. Longitudinal information was 
derived by considering the regression coefficients of the time dummies and the regression 
coefficients of the meat-time interaction terms. The coefficients of the time dummies 
reflect the change in BMI over time (6 and 14 y, respectively) in the lowest 
quintile/category. The coefficient of an interaction term gives the difference between the 
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change in BMI in a quintile/category after 6 and 14 y and the change in BMI in the lowest 
quintile/category of meat intake as the reference category. All models were examined for 
evidence of an overall trend by statistically testing whether any of the time-by-quintile 
interaction-terms is equal to zero. This provides an overall assessment as to whether the 
increase in BMI over time is different between the quintiles/categories of intake; if 
significant; the direction of this trend should be quantified based on the individual 
coefficients of interaction.   
In addition to an unadjusted and age adjusted model, we created an LME model adjusted 
for age plus confounding variables. These confounding variables were identified as being 
associated with both BMI and meat intake from the previous literature or were variables 
that, when entered in our model, resulted in a >10% change in the regression coefficients. 
These include age (years), total energy intake (kcal), non-occupational physical activity 
(min/d), smoking status (never-, ex- and current smoker), education (low, medium, high), 
alcohol intake (g/d), grain and grain product consumption (e.g. rice, cereals, oats, noodles) 
(g/day), fruit consumption (g/d), and vegetable consumption (g/d). We additionally 
adjusted for special dieting habits (on doctor’s advice) in the 5 y preceding the baseline 
questionnaire (yes/no). To additionally examine the independent contribution of the 
individual meat categories (total fresh meat, fresh red meat, beef, pork, minced meat, 
chicken and liver), a fourth model was created in which the complementary meat items 
were also included in the respective multivariable models.  To enable comparison, the age 
and energy-adjusted analyses were restricted to subjects included in multivariable-adjusted 
analyses (e.g., with no missing values on confounding variables; n= 3902).  
Although LME models should be robust to missing values, we conducted the initial analysis 
excluding individuals with missing BMI at 1 or 2 time points (n=1855 remaining). To 
evaluate potential bias linked to diet modification (related to disease) during follow-up, we 
excluded individuals who developed cancer between 1986 and 2000 (n=2878 remaining). 
We investigated for all longitudinal analyses whether an association was present both in 
individuals with a high and low BMI at baseline by performing stratified analyses using 
median BMI at baseline (women: 24.49; men: 24.76) as cut-points. We also examined 
whether similar associations were found across the age spectrum of our subcohort by 
stratifying our initial analyses in three age categories (54-59, 60-64, and 65-70 y).  
In addition, we compared the prospective results to the association between meat 
consumption and change in BMI between age 20 and baseline, assuming that meat 
consumption at baseline reflects that during adulthood. This secondary analysis was 
performed using multiple linear regression, in which mean BMI change (age 20-baseline) 
(and 95%CI) were derived, adjusted for all confounders from the LME models and BMI at 
age 20. Trends were evaluated with the Wald test by assigning participants the median 
value for each level of the categorical exposure variables and this variable was entered as a 
continuous term in the regression model. All tests were two-tailed and differences were 
regarded as statistically significant at P<0.05 in all analyses.   
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RESULTS 
Baseline population characteristics are presented in Table 1. Meat consumption was higher 
in men than in women for all investigated meat categories with the exception of chicken 
intake which was similar among both sexes. Compared with women, men consumed more 
calories, drank more alcohol and had a higher proportion of former and current smokers. 
For both men and women, higher total fresh meat consumption was correlated with higher 
total energy intake, a younger age, a higher BMI and a higher consumption of alcohol. In 
contrast to men, body height was not correlated with total fresh meat consumption in 
women.  
Table 1: Baseline characteristics of the subcohort in the Netherlands Cohort Study 
   Men (N = 1991) Women (N = 1911)
    Correlation 
with total fresh 
meat intake1,2 
Correlation   
with total fresh 
meat intake1,2 
 
     
Characteristics    P 3 P 3 
Age, y 61.3 ± 4.2 4 -0.06 < 0.05 61.3 ± 4.3 -0.04 0.12 
Anthropometrics   
    Height, cm 176.6 ± 6.6 0.06 < 0.05 165.2 ± 6.1 -0.01 0.98 
    Weight, kg 77.7 ± 9.4 0.15 < 0.05 68.2 ± 10.0 0.18 < 0.05 
    BMI, kg/m2 24.9 ± 2.5 0.14 < 0.05 25.0 ± 3.5 0.19 < 0.05 
   
Dietary factors   
    Total energy intake, kcal/d 2170 ± 503 0.22 < 0.05 1690 ± 391 0.18 < 0.05 
    Types of meat and fish, g/d 
    Total fresh meat 5 106 ± 42.6 — — 92.8 ± 39.3 — — 
          Fresh red meat 6 93.2 ± 41.0 0.93 < 0.05 80.0 ± 37.8 0.92 < 0.05 
          Beef  27.6 ± 23.9 0.45 < 0.05 24.3 ± 21.6 0.41 < 0.05 
          Pork  40.9 ± 30.1 0.62 < 0.05 35.0 ± 28.1 0.65 < 0.05 
          Minced meat 7 19.9 ± 17.7 0.44 < 0.05 16.7 ± 15.0 0.40 < 0.05 
          Chicken  13.5 ± 14.5 0.30 < 0.05 13.6 ± 15.9 0.31 < 0.05 
    Processed meat 16.0 ± 17.0 0.13 < 0.05 10.4 ± 11.6 0.17 < 0.05 
    Fish  14.6 ± 16.8 0.01 0.72 11.7 ± 13.9 0.01 0.76 
   
Lifestyle behaviours   
    Cigarette smoking status, %  
       Never 12.9 — —   56.5 —  — 
       Former 51.8 — —   21.8 —  — 
       Current 35.4 — —   21.8 —  — 
    Alcohol Intake, g/day 15.1 ± 17.1 6.0 ± 9.7
    Physical Activity, %   
       <30 min/d 17.5 — —   22.8 —  — 
       30-60 min/d 31.1 — —   31.2 — — 
       60-90 min/d 19.4 — —   23.4 — — 
      >90 min/d 32.0 — —   22.6 — — 
1 Reported as pairwise Pearson correlation coefficients.
2 Including all types of meat (except processed meat) and poultry. 
3 P-values for pairwise correlation coefficients. 
4 Mean ± SD (all such values). 
5 Including all types of meat (except processed meat) and poultry. 
6 Including beef, pork, minced meat, liver and other meat. 
7 Including beef and pork. 
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Statistically significant cross sectional differences in BMI at baseline were observed 
between quintiles of total fresh meat consumption in men but most predominantly in 
women (Table 2). In both sexes, those with the highest meat intake also had the highest 
BMI at baseline. Although BMI did not change over time in men, BMI in women increased 
with 0.19 kg/m2 and 0.42 kg/m2 from baseline to 6 and 14 y of follow- up, respectively 
(P<0.05) (Table 3).   
Table 2: Baseline BMI per quintile of total fresh meat consumption in the subcohort of the Netherlands Cohort 
Study1 
 Men (N = 1991)2 Women (N = 1911)2
Quintile of total fresh meat 
consumption3 N 
BMI
(kg/m2) (95%CI) N 
BMI 
(kg/m2) (95%CI) 
1 395 24.5 (24.3-24.7) 389 24.1 (23.8-24.4) 
2 401 24.7 (24.6-24.9) 371 24.7 (24.5-24.8) 
3 406 24.9 (24.8-25.0) 387 25.0 (24.8-25.1) 
4 394 25.0 (24.9-25.2) 392 25.3 (25.1-25.4) 
5 395 25.4 (25.2-25.6) 372 26.0 (25.7-25.2) 
P -trend    <0.001 <0.001 
1 All values are mean ± 95%CI. Results derived from a linear regression model adjusted for mean values of age, 
baseline total energy intake (kcal),alcohol intake (g/d), vegetable consumption (g/d), fruit consumption (g/d), 
consumption of grains (g/d), physical activity level, smoking status, level of education, dieting habits in the past 5 y. 
2 Number of participants at baseline. 
3 Range of total meat consumption (g/d) men:  Q1, ≤ 74; Q2, 75-93; Q3, 94-108; Q4, 109-136; Q5, 137-296;  Range 
of total meat consumption (g/d) women: Q1, ≤ 62; Q2, 63-84; Q3, 85-101;   Q4, 102-122;  Q5,123-280. 
 
Table 3: BMI at baseline (1986), in 1992, and 2000 in subcohort members of the Netherlands Cohort Study1,2 
 Men Women
Year N   BMI (kg/m2) N BMI (kg/m2)
1986 1991 24.9 ± 0.06 1911 25.0 ± 0.08 
1992 1692 25.0 ± 0.06 1678 25.2 ± 0.08a 
2000 938 25.0 ± 0.08 958 25.4 ± 0.10a 
1 All values are mean ± SE. 
2 BMI derived from a linear mixed model including BMI and time. 
a Different from baseline, P < 0.05.  
 
The course of BMI change from baseline until 14 y of follow-up adjusted for confounding 
variables is depicted by quintiles of total fresh meat consumption (Figure 1) and frequency 
of meat consumption (Figure 2). The BMI of men increased only modestly after 14 y from 
baseline over all categories and quintiles of intake and no clear association between 
quintiles of intake and BMI change was observed. In women BMI increased in each quintile 
and frequency of intake over time, with a tendency for the highest increase in those with 
the highest meat consumption. Nonetheless, no statistically significant differences between 
quintiles and frequencies of intake or any significant trends were observed.  
The association between BMI change between baseline and 6 and 14 y of follow-up and 
specific subtypes of meat was examined by 4 different models (unadjusted, age-adjusted, 
confounders-adjusted, and adjusted for confounders and complementary meat items) 
which yielded comparable results. Table 4A and Table 4B present the findings for the 
confounder-adjusted model stratified for men and women respectively, according to 
quintiles and categories of intake and can be interpreted as the change in BMI in each 
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quintile/category at a given follow-up time compared to baseline. Men with the highest 
beef intake had a significantly lower increase in BMI than did men in the lowest quintile 
both after 6 and 14 y and a borderline significant trend was observed (P=0.06). Women in 
the highest quintile of pork consumption had a significantly higher increase in BMI than did 
women in the lowest quintile after 14 y (P=0.02). In addition, women and men with the 
highest chicken consumption had a significantly higher increase in BMI compared to those 
with the lowest intake after 14 y (men P=0.03; women P=0.05). 
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Figure 1: Change in BMI (kg/m2) over 14 y in each 
quintile of baseline total fresh meat intake in A) men 
(P-trend = 0.70) and B) women (P-trend = 0.46). 
Graphs derived from linear mixed models adjusted for 
age (y), total energy intake (kcal/d), physical activity 
level (<30, 30-60, 60-90, >90 min/d), smoking status 
(never, former and current smoker), alcohol 
consumption (g/d), level of education (low, medium, 
high), vegetable consumption (g/d), fruit consumption 
(g/d), consumption of grains (g/d) and special dieting 
habits (yes or no to being on a diet in the past 5 y). 
Total meat includes all types of meat (except 
processed meat) and poultry. P-trend tests for overall 
difference in BMI increase over time between groups 
of meat intake. Range of total meat consumption (g/d) 
in men: Q1, ≤ 74 (; Q2, 75-93; Q3, 94-108; Q4, 109-
136; Q5, 137-296; in women Q1, ≤ 62; Q2, 63-84; Q3, 
85-101; Q4, 102-122; Q5,123-280. 
Figure 2: Change in BMI (kg/m2) over 14 y in each 
category of self-reported frequency of meat 
consumption in A) men (P-trend = 0.17) and B) 
women (P-trend = 0.40). Graphs derived  from linear 
mixed models adjusted for age (y), total energy intake 
(kcal/d), physical activity level (<30, 30-60, 60-90, >90 
min/d), smoking status (never, former and current 
smoker), alcohol consumption (g/d), level of 
education (low, medium, high), vegetable 
consumption (g/d), fruit consumption (g/d), 
consumption of grains (g/d) and special dieting habits 
(yes or no to being on a diet in the past  5 y). Total 
meat includes all types of meat (except processed 
meat) and poultry. P-trend tests for overall difference 
in BMI increase over time between groups of meat 
intake. 
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Table 4A: Change in BMI from baseline (1986) over time associated with specific dietary meat intakes by quintile (Q) 
or categories (C ) of meat intake for male subcohort members  (n=1991) of the Netherlands Cohort Study1 
  Quintile or category of meat intake2  
  1 2 3 4 5 P-
trend3 
Fresh red meat 4, g/d       
 1992 0.15 ± 0.08 0.12 ± 0.13 -0.03 ± 0.12 0.04 ± 0.12 0.01 ± 0.12  
 2000 0.23 ± 0.13 0.13 ± 0.11 0.06 ± 0.11 0.08 ± 0.11 -0.11 ± 0.11 0.59 
Beef, g/d      
 1992 0.18 ± 0.08 0.11 ± 0.12 0.09 ± 0.13 -0.21 ± 0.12 -0.09 ± 0.13 a  
 2000 0.33 ± 0.13 0.12 ± 0.11 0.19 ± 0.11 -0.01 ± 0.11 -0.27 ± 0.11 a 0.06 
Pork, g/d      
 1992 0.15 ± 0.08 0.03 ± 0.12 0.06 ± 0.13 0.08 ± 0.12 -0.06 ± 0.12  
 2000 -0.04 ± 0.13 -0.01 ± 0.11 0.14 ± 0.11 0.12 ± 0.11 0.11 ± 0.11 0.39 
Minced meat 5, g/d       
  1992 0.03 ± 0.08 0.01 ± 0.13 -0.07 ± 0.12 0.07 ± 0.12 0.22 ± 0.21  
 2000 0.18 ± 0.13 0.06 ± 0.11 -0.08 ± 0.11 0.24 ± 0.11 -0.02 ± 0.11 0.05 
Processed meat, g/d       
 1992 0.15 ± 0.08 0.07 ± 0.13 -0.05 ± 0.12 0.01 ± 0.12 0.07 ± 0.12  
 2000 0.07 ± 0.13 0,00 ± 0.11 0.19 ± 0.11 0.07 ± 0.11 0.02 ± 0.11 0.41 
Chicken, g/d      
 1992 0.02 ± 0.07 -0.02 ± 0.11 0.05 ± 0.11 0.13 ± 0.10 —   
 2000 -0.17 ± 0.12 -0.09 ± 0.10 0.29 ± 0.10 b 0.19 ± 0.09 b —  0.04 
Fish, g/d      
 1992 -0.03 ± 0.07 -0.01 ± 0.12 0.09 ± 0.10 0.14 ± 0.12 —   
 2000 -0.03 ± 0.11 -0.06 ± 0.10 0.12 ± 0.09 0.28 ± 0.11 —  0.39 
1 All values are mean ± SE. Results derived form a linear mixed model adjusted for age, baseline total energy intake 
(kcal), physical activity level (<30,30-60,60-90, > 90 min/d), smoking status (never, former and current smoker), 
alcohol intake (g/d), level of education (low, medium, high), vegetable consumption (g/d), fruit consumption (g/d), 
consumption of grains (g/d) and dieting habits (yes or no to being on a diet in the past 5 y). 
2 Range of total fresh meat consumption (g/d): Q1, ≤ 75; Q2, 745-94; Q3, 94-108; Q4, 108-137; Q5, 137-296.  
3 Test for overall difference in BMI increase over time between groups of meat intake. 
4 Including beef, pork, minced meat, liver and other meat. 
5 Including beef and pork. 
a Significantly lower BMI increase than in the lowest quintile of intake, as derived from the quintile-by-time 
interaction (P<0.05). 
b Significantly higher BMI increase than in the lowest quintile of intake, as derived from the quintile-by-time 
interaction (P<0.05). 
 
When stratifying our data on median BMI at baseline, we observed virtually similar 
associations between (subtypes) of meat intake and changes in BMI (results not shown). 
Our age stratified (54-59, 60-64, 65-70 y) analyses yielded mixed results for several 
subtypes of meat, possibly due to smaller numbers in the age categories (results not 
shown). 
When excluding subjects with missing BMI measurements at 1 or 2 time points, results 
attenuated slightly for beef, pork and chicken, although the observed pattern across 
quintiles remained similar. Other results did not change noticeably. Our findings did not 
change when individuals who developed cancer after 1986 were excluded (data not 
shown).   
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Table 4B: Change in BMI from baseline (1986) over time associated with specific dietary meat intakes by quintile (Q) 
or categories (C ) of meat intake for female subcohort members (n=1911)  of the Netherlands Cohort Study1 
  Quintile or category of meat intake2  
  1 2 3 4 5 P-
trend3 
Fresh red meat 4, g/d      
 1992 0.18 ± 0.09 -0.25 ± 0.14 0.22 ± 0.14 0.09 ± 0.14 0.23 ± 0.14  
 2000 0.26 ± 0.14 0.42 ± 0.12 0.50 ± 0.12 0.37 ± 0.12 0.55 ± 0.12 0.79 
Beef,  g/d       
 1992 0.13 ± 0.09 0.33 ± 0.14 0.33 ± 0.14 0.06 ± 0.14 0.10 ± 0.14  
 2000 0.39 ± 0.15 0.44 ± 0.12 0.58 ± 0.12 0.41 ± 0.12 0.24 ± 0.13 0.16 
Pork, g/d       
 1992 0.21 ± 0.09 0.22 ± 0.15 0.22 ± 0.14 0.09 ± 0.14 0.23 ± 0.14  
 2000 0.13 ± 0.14 0.52 ± 0.13 0.46 ± 0.12 0.39 ± 0.12 0.60 ± 0.13 b 0.29 
Minced meat 5, g/d       
 1992 0.14 ± 0.09 0.12 ± 0.14 0.19 ± 0.14 0.30 ± 0.14 0.21 ± 0.15  
 2000 0.43 ± 0.15 0.44 ± 0.12 0.36 ± 0.12 0.46 ± 0.12 0.41 ± 0.13 0.88 
Processed meat, g/d       
 1992 0.13 ± 0.09 0.13 ± 0.14 0.27 ± 0.15 0.34 ± 0.14 0.10 ± 0.14  
 2000 0.28 ± 0.14 0.44 ± 0.12 0.46 ± 0.13 0.61 ± 0.12 0.29 ± 0.12 0.51 
Chicken, g/d       
 1992 0.04 ± 0.08 0.28 ± 0.12 b 0.16 ± 0.13 0.26 ± 0.12 —   
 2000 0.17 ± 0.14 0.47 ± 0.10 0.47 ± 0.11 0.53 ± 0.11 b —  0.28 
Fish, g/d       
 1992 0.16 ± 0.07 0.17 ± 0.13 0.28 ± 0.12 0.13 ± 0.16 —   
 2000 0.30 ± 0.12 0.54 ± 0.11 0.54 ± 0.1 0.23 ± 0.14 —  0.43 
1 All values are mean ± SE. Results derived form a linear mixed model adjusted for age, baseline total energy intake 
(kcal), physical activity level (<30,30-60,60-90, > 90 min/d), smoking status (never, former and current smoker), 
alcohol intake (g/d), level of education (low, medium, high), vegetable consumption (g/d), fruit consumption (g/d), 
consumption of grains (g/d) and dieting habits (yes or no to being on a diet in the past 5 y). 
2 Range of total fresh meat consumption (g/d): Q1, ≤ 63; Q2, 63-84; Q3, 84-101; Q4, 101-123; Q5, 123-280. 
3 Test for overall difference in BMI increase over time between groups of meat intake. 
4 Including beef, pork, minced meat, liver and other meat. 
5 Including beef and pork. 
b Significantly higher BMI increase than in the lowest quintile of intake, as derived from the quintile-by-time 
interaction (P<0.05). 
 
When retrospectively examining the association between meat consumption reported at 
baseline and weight change from age 20 (reported at baseline) until baseline (age 55-69 y), 
we observed a positive linear trend across all quintiles of total meat consumption in both 
men and women (P-trend<0.001) (Table 5). Similar associations were observed for nearly 
all subtypes of meat, although consumption of processed meat was not associated with this 
long term weight change in men (P-trend=0.73).  
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Table 5: Change in BMI (kg/m2) from age 20 y to baseline and corresponding 95% CI according to quintiles/ 
categories of intake of fresh meat, types of fresh meat, processed meat and fish, measured at baseline in the 
Netherlands Cohort Study.  
 Men  
N=1598 
Women 
N=1736 
Food item Change in BMI (95%CI)1 Change in BMI (95%CI)1 
Total fresh meat , g/d2 
     1 3 2.82 (2.62-3.02) 2.75 (2.50-3.00) 
     2 3.10 (2.97-3.23) 3.30 (3.13-3.46) 
     3 3.24 (3.13-3.36) 3.60 (3.46-3.75) 
     4 3.40 (3.27-3.52) 3.88 (3.72-4.04) 
     5 3.79 (3.57-4.01) 4.55 (3.29-4.82) 
     P-trend <0.001 <0.001
Fresh red meat, 
g/d4 
     1 3 2.83 (2.63-3.02) 2.86 (2.61-3.10) 
     2 3.09 (2.95-3.22) 3.31 (3.14-3.47) 
     3 3.24 (3.12-3.35) 3.58 (3.45-2.73) 
     4 3.40 (3.28-3.53) 3.84 (3.69-4.00) 
     5 3.78 (3.57-4.01) 4.47 (3.21-4.74) 
     P-trend <0.001 <0.001
Beef, g/d 
     1 3 3.11 (2.94-3.28) 3.44 (3.23-3.66) 
     2 3.18 (3.03-3.32) 3.51 (3.33-3.68) 
     3 3.24 (3.12-3.36) 3.57 (3.42-3.72) 
     4 3.32 (3.19-3.44) 3.67 (3.51-3.82) 
     5 3.52 (3.30-3.74) 3.88 (3.60-4.15) 
     P-trend 0.07 0.07
Pork, g/d 
     1 3 3.08 (2.90-3.27) 3.13 (2.90-3.36) 
     2 3.17 (3.03-3.31) 3.35 (3.17-3.52) 
     3 3.24 (3.13-3.37) 3.55 (3.40-3.70) 
     4 3.32 (3.20-3.45) 3.77 (3.62-3.93) 
     5 3.53 (3.30-3.75) 4.29 (4.01-4.56) 
     P-trend 0.06 <0.001
Minced meat, g/d5
     1 3 3.05 (2.88-3.22) 4.45 (3.24-3.67) 
     2 3.14 (3.00-3.28) 3.52 (3.35-3.69) 
     3 3.23 (3.11-3.35) 3.58 (3.43-3.73) 
     4 3.33 (3.21-3.46) 3.67 (3.51-3.82) 
     5 3.60 (3.39-3.81) 3.87 (3.59-4.16) 
     P-trend 0.03 0.01
Chicken, g/d 6 
     1 3 3.23 (3.07-3.40) 3.40 (3.20-3.60) 
     2 3.25 (3.11-3.39) 3.49 (3.32-3.66) 
     3 3.28 (3.16-3.39) 3.62 (3.47-3.77) 
     4 3.33 (3.14-3.51) 3.91 (3.68-4.15) 
     P-trend 0.06 0.01
Processed meat, 
g/d 
     1 3 3.15 (2.99-3.33) 3.41 (3.21-3.61) 
     2 3.20 (3.05-3.34) 3.47 (3.29-3.65) 
     3 3.24 (3.12-3.36) 3.55 (3.39-3.70) 
     4 3.29 (3.18-3.42) 3.67 (3.62-3.82) 
     5 3.47 (3.24-3.70) 3.98 (3.70-4.27) 
     P-trend 0.73 <0.001
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 Men  
N=1598 
Women 
N=1736 
Food item Change in BMI (95%CI)1 Change in BMI (95%CI)1 
Fish, g/d 6  
     1 3 3.21 (3.05-3.37) 3.40 (3.21-3.60) 
     2 3.24 (3.10-3.37) 3.50 (3.33-3.66) 
     3 3.28 (3.16-3.40) 3.68 (3.53-3.84) 
     4 3.38 (3.17-3.59) 4.02 (3.73-4.30) 
     P-trend 0.02 0.01
1 All values are mean ± 95%CI. Results derived from a linear regression model adjusted for mean values of age, 
baseline total energy intake (kcal), alcohol intake (g/d), vegetable consumption (g/d), fruit consumption (g/d), 
consumption of grains (g/d), physical activity level, smoking status, level of education, dieting habits in the past 5 y 
and BMI at age 20 y. 
2 Including all types of meat (except processed meat) and poultry. 
3 Reference category. 
4 Including beef, pork, minced meat, liver and other meat. 
5 Including beef and pork. 
6 Categorical cut points are for chicken: 0, 0-13.2, 13.2 - 22.8, ≥ 22.8 g/day; fish: 0, 0-10, 10-20,  ≥20 g/day. 
DISCUSSION 
This large scale observational study among 55-69 y old men and women showed no 
evidence of a prospective association between total meat consumption and subsequent 
changes in BMI over 14 y of follow-up.  
Although the global rates of overweight and obesity are steadily increasing, we observed 
only a small overall increase in BMI during the 14 y of follow-up. This is consistent with 
previous studies showing that men and women predominantly gain weight until middle age 
[32, 33]. Furthermore, we did not find any evidence for an association between total (fresh) 
meat consumption and subsequent change in BMI in this population. This would suggest 
that the largest weight modifying effect of meat intake, if present, might have taken place 
earlier in adulthood. However, our age stratified (54-59, 60-64, 65-70 y) analyses were not 
indicative of a clear interaction-effect with age. Recent results from the EPIC-PANACEA 
study on the association between various meat products and 5 year weight change 
including subjects from a wider age range (25-70 y) showed the strongest association 
between weight and red meat intake in subjects aged <35 y or >65 y and with poultry 
consumption in subjects aged >45 y  [21]. The few other observational studies on the 
association between total meat consumption and prospective weight gain report an overall 
tendency for a positive association [14-17, 21]. Two studies investigated the possible role of 
vegetarianism in relation to weight change but observed only small [12] or non-significant 
mixed results [13]. Yet, the length of follow-up (2-10 y) in these studies was relatively short 
and the quality of meat consumption assessment differed considerable between these 
studies, varying from comprehensive food frequency questionnaires [14, 15, 21] to food-
category based assessments [16, 17]. 
Our study is the first to further distinguish between the different components of red meat 
consumption and reports an inverse association between beef consumption and 
prospective changes in BMI in men. However, this beneficial effect on body weight was 
only present in subjects with very high intakes and attenuates below a consumption level of 
40g/day, thereby likely reflecting a dietary pattern in the extremes. Although beef 
consumption was positively correlated with a dietary pattern high in cooked leafy 
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vegetables, cabbages, legumes and carrots (r=0.20, P<0.001) and inversely correlated with 
a pattern high in pork, processed meat and potatoes (r=-0.16, P<0.001), adjustment for 
these patterns did not change the results noticeably (results not shown). In contrast, in 
women, the highest quintile of pork consumption was associated with a 0.60kg/m2 higher 
increase in BMI compared to the lowest intake, after 14 y of follow-up. The differences in 
nutritional content between beef and pork (e.g. the fat/protein ratio) may have resulted in 
these different weight inducing effects. Previous longitudinal studies examining changes in 
body weight [21] or waist circumference [19, 34] in relation to red meat consumption in 
general, showed contrasting results, but none of the reports specified the relative intakes 
of the individual components of red meat. 
Our data suggest that men and women with the highest chicken consumption (>22.8g/d) 
had a 0.19 and 0.53kg/m2 higher increase in BMI after 14 y of follow-up, respectively, 
compared to those who consumed no chicken at all. This is in line with recent results from 
a Danish study showing that high consumption of chicken was associated with greater 
weight gain at the waist after 5 y of follow-up in women, but not in men [19]. The EPIC-
PANACEA study recently reported a strong positive association between prospective weight 
change and chicken consumption but this was mainly driven by subjects with previous 
illness or weight loss attempts that resulted in changes in diet [21]. However, when we 
adjusted our analyses for special dieting habits (on doctor’s advice) in the 5 y preceding the 
baseline questionnaire or excluded subjects who developed cancer during follow-up, the 
results did not change appreciably.  
The discrepancy between our cross-sectional and prospective results raises the question 
during which age period the differences in BMI across the meat consumption spectrum 
develop. This prompted us to retrospective examine the association between meat 
consumption at baseline and change in body weight between age 20 and baseline (55-69 
y). It should however be noted that we 1) only have baseline data on meat intake and 2) 
use long term recall of early adulthood weight. Although earlier studies indicate that the 
remote recall of weight by elderly subjects is overall accurate and independent of current 
weight status [35, 36], and that, in addition, there is no reason to assume differential recall 
bias with respect to meat consumption at baseline, we cannot empirically test these 
assumptions at present. However, in case these assumptions do hold our results suggest 
that meat consumption, or factors directly related to meat consumption, are positively 
associated with weight change over the first 40 y of adult life. Studies specifically designed 
to examine long term prospective weight change, that combine multiple dietary- and 
anthropometric assessments are needed to verify these results.  
We must be careful when drawing strong causal inferences from both our prospective and 
retrospective findings given that BMI is influenced by multiple connected dietary and non-
dietary factors of which meat consumption is only one. However, our large scale study does 
provide relevant clues for further research and public health practice as regards to 
identifying modifiable dietary determinants of obesity. The dietary pattern of our 
subcohort and the types of meat consumed are likely population- and time-specific and 
consumption of subtypes of meat are likely to be less stable over time than total meat 
intake. We cannot completely exclude the possibility that individuals with the lowest total 
meat intake may have had an overall healthier lifestyle than did those with the highest 
MEAT CONSUMPTION AND CHANGES IN BMI 
 
37 
intake, resulting in less of a BMI increase over time. Nevertheless, when we attempted to 
control for further potential confounding in our model by accounting for intake of 
vegetables, fruit, grain content of the diet and dieting habits our observations did not 
change appreciably. We made use of a food frequency questionnaire to determine meat 
consumption, which was found to correlate well with a measurement using dietary records 
[37] but is nonetheless susceptible for measurement error [38]. We were not able to 
account for changes in physical activity or dietary intake which is likely to occur with 
ageing. However, the validity of the FFQ has been tested and shown to be representative 
for dietary habits over a period of at least 5 y [39]. Self-reported height and weight 
measurements recorded in the questionnaire were not validated within the NLCS, but 
previous studies provide sufficient evidence to presume that these are reliable and valid 
tools to ascertain body weight and height in large scale prospective studies [40-42]. 
Nevertheless, the prevalence of overweight might have been underestimated especially 
since body height is known to decrease and body composition is likely to change at older 
age [43]. Because we only have BMI measurements we cannot distinguish between 
changes in lean tissue or fat mass; a shortcoming of many observational studies which is 
currently debated in literature [44, 45]. However, several studies reported similar findings 
when comparing changes in BMI to changes in waist circumference, a proxy of abdominal 
adiposity. Generalization of our results to younger populations may be hampered since 
ageing is accompanied by specific changes in body composition and metabolic function that 
could have affected our findings. Body weight is likely to fluctuate over time resulting in 
successive periods of weight loss and gain [46, 47]. Our long follow-up including three 
consecutive self-reports reduces the influence of such weight cycling on the study results. 
Because of the older age group of our population at baseline many subcohort members 
only had one or two prospective measurements available for analysis. Although it is likely 
that those who remained alive until the last follow-up point tend to be healthier than the 
entire subcohort, there was no indication that survivorship bias distorted our results.  
Our data suggest that meat consumption, or factors directly related to meat intake, is not 
strongly associated with weight change during the 14-year prospective follow-up in this 
elderly population. However, more observational and intervention research is needed to 1) 
verify our prospective and retrospective observations and 2) to further elucidate the role of 
(subtypes of) meat in weight management and its implications for public health practice.   
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ABSTRACT 
Background: Vegans and to a lesser extent vegetarians have low average circulating 
concentrations of vitamin B12; however, the relation between factors such as age or time 
on these diets and vitamin B12 concentrations is not clear. The objectives were to 
investigate differences in serum vitamin B12 and folate concentrations between 
omnivores, vegetarians and vegans and to ascertain whether vitamin B12 concentrations 
differed by age and time on the diet.  
Methods: A cross-sectional analysis involving 689 men (226 omnivores, 231 vegetarians 
and 232 vegans) from the European Prospective Investigation into Cancer and Nutrition 
Oxford cohort.  
Results: Mean serum vitamin B12 was highest among omnivores (281, 95% CI: 271-291 
pmol/l), intermediate in vegetarians (182, 95% CI: 175-189 pmol/l), and lowest in vegans 
(122, 95% CI: 117-127 pmol/l). Fifty-two percent of vegans, 7% of vegetarians and one 
omnivore were classified as vitamin B12 deficient (defined as serum vitamin B12 <118 
pmol/l). Among non-supplement users, there was no significant association between age or 
duration of adherence to a vegetarian or a vegan diet and vitamin B12. In contrast, folate 
concentrations were highest among vegans, intermediate in vegetarians, and lowest in 
omnivores, but only two men (both omnivores) were categorized as folate deficient 
(defined as serum folate <6.3 nmol/l).  
Conclusion: Vegans have lower vitamin B12 concentrations, but higher folate 
concentrations, than vegetarians and omnivores. Nearly half of the vegans were 
categorized as vitamin B12 deficient and would be expected to have a higher risk of 
developing clinical symptoms related to vitamin B12 deficiency. 
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INTRODUCTION 
Although individuals who consume a vegetarian and vegan diets may have benefits that 
include a lower risk of cardiovascular disease [1, 2], there may also be a greater risk of 
developing deficiencies, because of the exclusion of meat and fish from the diet in 
vegetarians,  and of all animal products in vegans. Vitamin B12 is naturally present only in 
foods of animal origin, and vegans who do not consume sufficient quantities of foods 
fortified with vitamin B12 such as some breakfast cereals, plant-based milks, soy products 
and yeast extract, or regularly take a vitamin B12 supplement, will have an increased risk of 
developing vitamin B12 deficiency.  
Results from previous studies have shown that vegans have lower average serum 
concentrations of vitamin B12 in comparison to omnivores and vegetarians  [3-5], with 
evidence from some [4-8], but not all [3, 9, 10] studies suggesting that serum vitamin B12 
concentrations are also lower in vegetarians compared to omnivores. Several reports also 
indicate that a considerable proportion vegans [10, 11] and vegetarians [5, 12] have 
circulating concentrations of vitamin B12 indicative of depleted stores (serum vitamin B12 
<150 pmol/l). Previous research in populations consuming a mixed diet suggests that serum 
vitamin B12 decreases with age [13]; however, few studies have assessed this in older 
vegetarians and vegans. Moreover, it is not clear to what extent factors such the length of 
adherence to a vegan or vegetarian diet is associated with serum concentrations of vitamin 
B12. 
The objective of the present study was to report the serum vitamin B12 and folate 
concentrations and dietary intake of these micronutrients in British men consuming an 
omnivorous, vegetarian or vegan diet and to assess the associations of age and duration of 
adherence to a vegetarian or vegan diet with serum concentrations of vitamin B12.  
METHODS 
Study population 
The European Prospective Investigation into Cancer and Nutrition (EPIC)-Oxford cohort 
study recruited more than 65 000 participants between 1993 and 1999. Full details of the 
recruitment methods and the study participants have been described elsewhere [14]. The 
protocol for the EPIC-Oxford study was approved by the Royal College of General 
Practitioners’ Clinical Research Ethics Committee, the Central Oxford Research Ethics 
Committee and local research ethics committees, and all participants gave written 
informed consent. 
This study population sample consists of 689 men who provided a blood sample at 
recruitment to the EPIC-Oxford cohort between 1994 and 1997 and who had no history of 
cancer. To maximize the heterogeneity of dietary exposure, approximately equal numbers 
of men with different dietary habits were selected with no matching criteria:  omnivores 
who reported three or more servings of meat per week; lacto-ovo vegetarians who 
reported consuming soya-milk and/or soya products, and vegans. There were 226 
omnivores, 231 vegetarians, and 232 vegans included in these analyses. The ethnicity of 
96% of the study sample was white and the other 4% were Bangladeshi or Chinese. 
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Omnivores were defined as people reporting meat consumption. Vegetarians were defined 
as people who reported consuming dairy products (including milk, cheese, butter, and 
yogurt) and eggs (including eggs in cakes and other baked foods) but no meat or fish. The 
majority of vegetarians were lacto-ovo vegetarians (88%), consuming both dairy products 
and eggs, with smaller proportions avoiding eggs (8%) or dairy products (4%). Vegans were 
defined on the basis that they did not to consume any foods of animal origin (meat, fish, 
dairy products or eggs). The duration of adherence to a vegetarian and vegan diet was 
calculated as the age at recruitment minus the age at which the respondent last ate meat 
or fish, or any of meat, fish, dairy products or eggs, respectively.  
Assessment of dietary and lifestyle variables 
All participants completed a validated semi-quantitative 130-item food frequency 
questionnaire (FFQ) at baseline [15, 16]. Regular use of a vitamins supplement over the 
past 12 months was assessed in the FFQ and participants were categorized on the basis of 
whether they regularly used a vitamin B12 supplement or folate supplement. The daily 
intakes of vitamin B12 and folate obtained from supplements were also calculated. The 12 
men who did not provide any information on the use of supplements were categorized as 
non-users for each of these variables. Participants self-reported their height and weight, 
and Quetelet’s body mass index (BMI; weight (kg)/height (m2)) was calculated. Participants 
were further characterized by their smoking status (“never”, “former”, “current”) and level 
of education (“some secondary school”; “higher secondary school”, “university degree or 
equivalent”).  
Laboratory methods 
Following recruitment, blood was collected at local general practice surgeries into 10-mL 
Safety-Monovettes (Sarstedt, Nümbrecht, Germany). The samples were sent by post in 
sealed containers at ambient temperature to the EPIC laboratories in Norfolk where they 
were centrifuged and aliquots were stored in liquid nitrogen (-196˚C) until analysis. 
Concentrations of vitamin B12 and folate in serum were measured with the use of a 
Quantaphase II B12/Folate Radioassay (Bio-Rad, CA) at the Department of Clinical 
Biochemistry, King’s College Hospital, London. The inter-batch coefficients of variation (CV) 
were 7.9% for vitamin B12 and 7.7% for folate. Serum concentrations of vitamin B12 less 
than 118 pmol/L and serum folate concentrations less than 6.3 nmol/L were used as cut-
points to categorize deficiency as used in United Kingdom National Diet and Nutrition 
Survey [17]. 
Follow-up data 
In 2001, the vegan men who had a serum vitamin B12 measurement were contacted and 
asked to provide another blood sample. Out of the 227 surviving vegan men contacted, 
another blood sample was collected from 65 (29%) of them. Full-blood counts were made 
using a Sysmex cell counter (Sysmex, Milton Keynes, UK); serum vitamin B12, serum 
holotranscobalamin (holoTC), plasma methylmalonic acid (MMA), and plasma total 
homocysteine (tHcy) were measured as described in detail elsewhere [18]. 
Statistical Analyses 
All analyses were performed using Stata Statistical Software (release 9; Stata-Corp LP, 
College Station, TX). Where necessary, dietary variables and serum vitamin B12 and folate 
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concentrations were log-transformed to approximate a normal distribution. To assess the 
effect of duration of adherence to a vegetarian or vegan diet on serum vitamin B12 
concentrations, vegetarians and vegans were divided into four categories (≤5, 6-10, 11-15, 
≥16 y) according to the time they had been on these diets. The geometric mean and 95% CI 
for serum B12 were calculated for nine diet-duration groups (omnivores, 4 groups of 
vegetarians and 4 groups of vegans) by using multiple linear regression. Categories of BMI 
(<22.5, 22.5-24.9, ≥ 25 kg/m2), use of a vitamin B12 supplement, smoking status, level of 
education, number of days the blood sample spent in the post (1, 2 or ≥3 days) and alcohol 
consumption (quartiles) were included as covariates, but only BMI, education, and 
supplement use were included in the final model. Similar analyses were performed to 
investigate the associations of age and education with serum vitamin B12 concentrations. P 
values for trend for the association between time of adherence to the diet and age with 
serum concentrations of vitamin B12 were assessed separately for each diet group by 
treating age and duration on the diet as continuous variables in the regression models. All 
tests were two-tailed and differences were regarded as statistically significant at P< 0.05.  
RESULTS 
The mean age of the participants was 47 y; omnivores were on average 7 y older than 
vegetarians and 10 y older than vegans (Table 1). 
Table 1 : Characteristics of the EPIC-Oxford men by diet group  
 Omnivores Vegetarians Vegans  
 n = 226 n = 231 n = 232 P1 
Age (y) (mean (s.d.)) 52.8 (10.7) 46.2 (11.7) 42.8 (13.1) < 0.001 
BMI (kg/m2) (mean (s.d.)) 26.1 (3.7) 23.4 (3.0) 22.7 (3.1) < 0.001 
Age category  
20-39   15 (7) 75 (32) 104 (45)
 < 0.001 40-49  85 (38) 79 (34) 64 (28)50-59  55 (24) 40 (17) 31 (13)
60-78  71 (31) 37 (16) 33 (14)
BMI category  
< 22.5 37 (16) 93 (40) 125 (54)  
22.5-24·9   58 (26) 87 (38) 70 (30)  < 0.001 
≥ 25·0 131 (58) 51 (22) 37 (16)  
Education  
Some secondary school 54 (24) 35 (15) 32 (14)  
Higher secondary school 71 (31) 69 (30) 82 (35) 0.023 
University degree or equivalent 101 (45) 127 (55) 118 (51)  
Smoking 
Never  109 (48) 121 (52) 139 (60)  
Former  80 (35) 90 (39) 70 (30) 0.015 
Current   37 (16) 20 (9) 23 (10)  
Vitamin B12 supplement users  
Yes 10 (4) 45 (19) 43 (19) < 0.001 No 216 (96) 186 (81) 189 (81)
Time on vegetarian or vegan diet (y) 
≤ 5 y – 54 (23) 89 (38)  
6-10 y  – 56 (24) 69 (30)  
11-15 y  – 44 (19) 44 (19)  
≥ 16 y – 74 (32) 29 (13)  
Values are n (%), except where indicated otherwise. 
1 P-values derived from ANOVA or χ2 test. 
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Vegans had the lowest mean BMI (P<0.001) and a greater proportion of omnivores had an 
education below secondary level compared to vegetarians and vegans. The median time 
that vegetarian men had adhered to their diet was 11 y and for vegan men it was 7 y. 
Among the omnivores, 4% regularly took a supplement containing vitamin B12 compared 
to 19% of both vegetarians and vegans.  
The mean intake of dietary vitamin B12 was 8.8 µg among omnivores, which was almost 
five times greater than the mean intake in vegetarians (P<0.001) and 36 times higher than 
the mean intake in vegans (P<0.001, Table 2). Only 3% of the vegan men not taking a 
vitamin B12 supplement reported a dietary intake of vitamin B12 above the UK RNI of 1.5 
µg/day compared to 31% of the vegetarians and all omnivores. Among vitamin B12 
supplement users, 89% of the vegetarians and 63% of vegans met the RNI for vitamin B12 
intake. Vegans not taking a folate acid supplement had a significantly higher intake of folate 
than both vegetarians (P=0.001) and omnivores (P<0.001) and the mean intake of folate in 
the vegetarians was higher than that in the omnivores (P=0.014).  Dietary intake of folate 
was above the RNI (200 µg/day) in 96% of the omnivores, 99% of the vegetarians and 98% 
of the vegans. All supplement users had an intake of folate (from diet and supplements) 
that was above the RNI. 
Table 2: Estimated daily intake among omnivores, vegetarians and vegans
 Omnivores Vegetarians Vegans 
 (n = 226) (n = 231) (n = 232) 
Vitamin B12 intake (μg/day) [mean (95% CI)]
Non-supplement users 8.76 (7.93 - 9.68)1a 1.92 (1.72 - 2.13)b 0.24 (0.21 - 0.26)c 
Supplement users2 11.06 (6.21 - 19.67)a 3.39 (2.58 - 4.45)b 3.17 (2.40 - 4.19)b 
 
Folate intake (μg/day) [mean (95% CI)] 
Non-supplement users 342 (329 - 357)a 369 (353 - 386)b 420 (402 - 438)c 
Supplement users2 595 (513 - 690) 610 (566 - 658) 611 (564 - 663) 
 
Total energy intake (MJ) 10.6 (2.7) 9.2 (2.5) 8.5 (2.6) 
Carbohydrate (% total energy) 43.6 (5.9) 51.5 (6.4) 53.4 (7.8) 
Fat (% total energy) 34.0 (5.3) 31.0 (5.7) 29.9 (7.4) 
Protein (% total energy) 16.5 (2.7) 13.2 (2.0) 12.7 (1.9) 
Values are mean (s.d.) except where indicated otherwise.
1Differences in the means between the diet groups were tested for by using ANOVA. 
2 Includes intake from diet and supplements. 
a,b,c Different superscript letters indicate statistically significant differences, P < 0.05. 
 
 
The mean serum vitamin B12 in vegans was 33% lower than in vegetarians and 57% lower 
than in omnivores, and was 35% lower in vegetarians compared to omnivores (Table 3). In 
all, 52% of vegans and 7% of vegetarians had vitamin B12 concentrations below the cut-
point for biochemical deficiency (<118 pmol/l). A further 21, 17 and 1% of vegans, 
vegetarians and omnivores, respectively, had a serum vitamin B12 indicative of depletion 
(118 to 150 pmol/l). There was no significant difference in mean serum concentration of 
vitamin B12 between men who reported taking a vitamin B12 supplement compared to 
non-users of supplements in any of the diet groups (results not shown).  
The mean concentration of serum folate in vegans was 34% higher than in vegetarians and 
88% higher than in omnivores (Table 3). Very few men (< 1% of omnivores) were 
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categorized with biochemical folate deficiency (< 6.3 nmol/l). Vegetarians who reported 
taking a folate supplement had significantly higher mean serum folate concentrations 
compared to non-supplement users (P=0.015), but mean serum folate concentrations 
between supplement and non-supplement users did not differ for omnivores (P=0.738) and 
vegans (P=0.072, results not shown).  
Table 3: Serum concentrations of vitamin B12 and folate according to diet group
 Omnivores Vegetarians Vegans 
 (n = 226) (n = 231) (n = 232) 
Serum Vitamin B12  
(pmol/L) [mean (95% CI)] 
281 (270 - 292)1a 182 (175 - 189)b 122 (117 - 127)c 
 
“Deficient” < 118 pmol/L 1 (0) 16 (7) 121 (52) 
“Depleted” 118 to 149 pmol/L 3 (1) 40 (17) 48 (21) 
“Sufficient” ≥ 150 pmol/L 222 (98) 175 (76) 63 (27) 
 
Serum Folate  
(nmol/L) [mean (95% CI)] 
20·0  (19·1 - 21·0)a 28·0 (26·7 - 29·4)b 37·5 (35·8 - 39·3)c 
 
“Deficient” < 6·3 nmol/L  2 (1) 0 0
“Sufficient” ≥ 6.3 nmol/L 224 (99) 231 (100) 232 (100) 
Values are n (%), except where indicated otherwise.
1Differences in the means between the diet groups were tested for by using ANOVA with Bonferroni’s adjustment. 
a,b,c Different superscript letters indicate statistically significant differences, P < 0.001. 
 
Among participants not taking a supplement, dietary intake of vitamin B12 was significantly 
correlated with serum vitamin B12 concentrations (Spearman’s ρ=0.72, P<0.001). The 
correlation between dietary folate intake and serum concentrations of folate was weaker 
but statistically significant (ρ=0.12, P=0.002). 
The adjusted mean concentrations of serum vitamin B12 by time of adherence to a 
vegetarian or vegan diet and by age for non-supplement users are shown in Figure 1. There 
was no significant association between the length of adherence to a vegetarian or vegan 
diet and serum vitamin B12 concentrations. Neither was there a significant association 
between age or education and serum concentrations of vitamin B12 in any diet group 
(results for education not shown). All results were similar when restricted to nonusers of 
vitamin B12 supplements (results not shown).  
Of the 65 vegan men with repeated measures of serum vitamin B12 taken approximately 6 
years later, 34% were considered as biochemically vitamin B12 (serum vitamin B12 < 118 
pmol/l) and 8% were categorized as depleted (118 to 150 pmol/l) (Table 4). There was a 
strong positive association between serum vitamin B12 concentration and 
holotranscobalamin (holoTC) (r=0.77, P<0.001) and an inverse association with 
methylmalonic acid and total homocysteine (r=-0.74 and r=-0.73, respectively; P<0.0001 for 
both). Among the 22 men who had serum vitamin B12 concentrations below 118 pmol/l, 
82% had concentrations of holoTC that would indicate vitamin B12 deficiency (< 35 pmol/l), 
but only 32% had a combination of a methylmalonic acid greater than 0.75 μmol/l and total 
homocysteine greater than 15 μmol/l that would identify men who were likely to have a 
vitamin B12 deficiency. 
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Figure 1. Mean serum concentrations of vitamin B12 in omnivores (n = 226), vegetarians (n = 231) and vegans (n = 
232) by duration of adherence to a vegetarian or a vegan diet (top panel) and age (bottom panel). The results in the 
figure show the geometric mean and 95% CI adjusted for level of education and use of a dietary supplement, by diet 
group (○, omnivores; ●, vegetarians; and Δ, vegans). P values for trend by duration of adherence to a vegetarian or 
vegan diet and age within each diet group were obtained by treating the number of years since becoming 
vegetarian or vegan and age as continuous variables in the regression analyses, respectively. 
  
 
Table 4: Geometric mean (95% CI) concentrations of selected biochemical measurements according to categories of 
serum vitamin B12 concentrations in 65 vegan men with follow-up data.  
 < 118 pmol/L 118-149 pmol/L ≥ 150 pmol/L  
 n = 22 n = 5 n = 38 P1 
Serum vitamin B12 (pmol/L) 51 (40 - 64) 131 (81 - 213) 302 (253 - 360)  
   
HoloTCII (pmol/L) 26 (20 - 33) 29 (20 - 41) 77 (65 - 92) < 0.001 
HoloTCII < 35 pmol/L (%) 82 60 13  
   
MMA (μmol/L) 0.68 (0.52 - 0.89) 0.45 (0.26 - 0.79) 0.18 (0.15 - 0.22) < 0.001 
tHcy (μmol/L) 26.0 (21.2 - 31.8) 15.9 (10.4 - 24.2) 10.8 (9.3 - 12.6) < 0.001 
MMA > 0.75 μmol/L and tHcy > 15 
μmol/L (%) 
32 40 3  
Abbreviations: HoloTCII, holotranscobalamin II; MMA, methylmalonic acid; tHcy, total homocysteine 
1Differences in the means between the categories of serum vitamin B12 were tested for by using ANOVA 
 
< 5 5-8 9-15 > 16
Time on diet
Serum 
vitamin B12 
(pmol/L) 
Ptrend = 0.761
Ptrend = 0.599
20-39 40-49 50-59 60-78
Age (y)
Serum 
vitamin B12 
(pmol/L) 
Ptrend = 0.323
Ptrend = 0.660
Ptrend = 0.269
Omnivores
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DISCUSSION 
The results from this study show that mean serum concentrations of vitamin B12 reflected 
the level of intake of meat and animal products; omnivores had the highest concentrations 
of serum vitamin B12 and vegans the lowest. In addition, over half of the men consuming a 
vegan diet and 7% of men consuming a vegetarian diet were categorized – according to 
their serum vitamin B12 concentrations – as being vitamin B12 deficient. Very few men 
were categorized as being folate deficient (only two omnivores).  
The finding that vegans have lower serum concentrations of vitamin B12 and a greater 
prevalence of biochemical vitamin B12 deficiency than both omnivores and vegetarians is 
in agreement with results from several other studies [3, 4, 19]. However, the results from 
some but not all studies have shown that vegetarians have lower vitamin B12 
concentrations compared to omnivores and a greater proportion of vegetarians had serum 
vitamin B12 concentrations indicative of deficient or depleted levels [3-10]. The results 
from this study do not support the idea that vegetarians, because they consume some 
animal products, are not at risk of developing a vitamin B12 deficiency [20].  
These results showed no evidence that serum vitamin B12 concentrations decreased with 
increasing duration on a vegetarian or vegan diet, which is in agreement with results from 
one other small study [21], but not with another, in which an inverse correlation between 
serum vitamin B12 concentrations and time on a vegan diet (r=-0.18, P=0.047) was 
reported[11]. Evidence from an intervention study suggests that when the intake of vitamin 
B12 is restricted, serum concentrations of vitamin B12 may decline much more rapidly 
when than previously believed. In 13 lacto-ovo vegetarians, mean serum vitamin B12 
concentrations were reduced from 345 pmol/l to 226 pmol/l within two months of 
consuming a vegan diet [22]. Only two men in this study had recently started consuming a 
vegan diet (<1 year) and therefore, the effect on vitamin B12 concentrations of a short 
term dietary change could not be assessed. It is possible that once vitamin B12 stores 
decline to a certain level, serum concentrations are maintained despite a very low intake 
over a prolonged period via a number of mechanisms that might include an increased 
absorption of vitamin B12 in the gut, reduced vitamin B12 excretion, and an increased 
capacity to absorb recycled vitamin B12 from the bile via the enterohepatic circulation [20]. 
Another group at risk of becoming vitamin B12 deficient is the elderly because of a greater 
prevalence of gastric atrophy and hypochlorhydria, both of which lead to an insufficient 
absorption of food bound vitamin B12 [13]. Indeed, others have reported a decrease in 
average serum vitamin B12 concentrations with advancing age in elderly populations (>65 
years) [23-27]. There was no evidence of an age-related decline in serum concentrations of 
vitamin B12 among any of the diet groups in this study, which is similar to that reported in 
the United Kingdom National Diet and Nutrition Survey [17] ; this may be because these 
studies did not include many elderly participants.  
The finding that over 95% of vegans and 31% of vegetarians who were not using 
supplements failed to meet the RNI for daily vitamin B12 intake (1.5 µg/day from foods) 
was similar to that reported by others [12, 28]. Furthermore, even though vegetarian and 
vegan men who reported taking a vitamin B12 supplement had a higher intake of vitamin 
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B12, serum concentrations of vitamin B12 were not affected. It is possible that supplement 
use was not accurately reported, some of the vitamin B12 supplements taken contained a 
type of inactive plant based vitamin B12 [29] or that a proportion of men taking a vitamin 
B12 supplement had been recently diagnosed with a vitamin B12 deficiency. There appears 
to be a degree of awareness among these participants of the need to supplement vegan 
and vegetarian diets, inasmuch as 20% of vegans and vegetarians reported taking 
supplements regularly. However, because there was little difference in serum vitamin B12 
between supplement and non-supplement users, it may be necessary to improve the 
understanding of the need to regularly consume supplements containing adequate 
amounts of the active form of vitamin B12.   
Subclinical abnormalities are thought to emerge when serum concentrations of vitamin B12 
fall below 111 pmol/l [20]. Over half of the vegans had serum vitamin B12 concentrations 
below 118 nmol/L and thus, these men may have a higher risk of developing clinical 
symptoms related to vitamin B12 deficiency. Evidence of severe neurological damage as 
result of chronic vitamin B12 deficiency in vegans and vegetarians is rare; however, several 
case reports have shown neurological impairment that includes irreversible degeneration 
of the spinal cord, as well as difficulty in walking and handling utensils [30, 31]. There are 
very few studies that have looked for milder neurological symptoms among vegetarians 
and vegans who are vitamin B12 deficient.   
In this study, serum concentration of vitamin B12 was used as a biomarker of vitamin B12 
status, although recent evidence suggests that serum holoTC may be a more sensitive and 
specific biomarker of vitamin B12 status [32]. HoloTC is the fraction of vitamin B12 bound 
to transcobalamin that delivers vitamin B12 to cells that synthesize DNA and is thus 
considered the physiologically active component of vitamin B12[33]. The concentration of 
holoTC, MMA and tHcy were measured in a subgroup of the study participants; 
approximately 80% of men with serum vitamin B12 concentrations below the cut-point of 
118 pmol/l had values for holoTC indicative of vitamin B12 deficiency. On the other hand, 
only a third of these men had values for both MMA and tHcy above the cut-points 
considered as biochemically vitamin B12 deficient. Moreover, although the cut-off points 
used in this study to identify those at risk of vitmanin B12 deficiency have been used 
elsewhere[17], others have used a higher cutoff point (250 pmol,l) to define vitamin B12 
deficiency [34]. Therefore it is possible therefore that the true proportion of individuals 
with a vitamin B12 deficiency reported herein has been underestimated.  
In conclusion, the results from this study show that vegetarians and vegans have much 
lower concentrations of serum vitamin B12, but higher concentrations of folate in 
comparison to omnivores. Mean serum vitamin B12 was not associated with the duration 
of adherence to a vegetarian or vegan diet, which may indicate that mechanisms that 
maintain circulating concentrations of vitamin B12 are up-regulated in vegetarians and 
vegans. Further research into the health effects of vitamin B12 deficiency and depletion in 
vegans and vegetarians is warranted, and vegetarians and vegans should ensure a regular 
intake of sufficient vitamin B12 from fortified foods and/or supplements.  
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ABSTRACT 
Background: Vegetarian diets have been associated with lower risk of chronic disease, but 
little is known about the health effects of low meat diets and the reliability of self-reported 
vegetarian status. We aimed to establish an analytical cohort over-represented with 
vegetarians, pescetarians and 1 day/week meat consumers, and to describe their lifestyle 
and dietary characteristics. In addition, we were able to compare self-reported vegetarians 
with vegetarians whose status has been confirmed by their response on the extensive food 
frequency questionnaire (FFQ).  
Methods: Embedded within the Netherlands Cohort Study (n=120852; including 1150 self-
reported vegetarians), the NLCS-Meat Investigation Cohort (NLCS-MIC) was defined by 
combining all FFQ-confirmed-vegetarians (n=702), pescetarians (n=394), and 1 day/week 
meat consumers (n=1396) from the total cohort with a random sample of 2-5 days/week- 
and 6-7 days/week meat consumers (n=2965 and 5648, respectively).  
Results: Vegetarians, pescetarians, and 1 day/week meat consumers had more favorable 
dietary intakes (e.g. higher fiber/vegetables) and lifestyle characteristics (e.g. lower 
smoking rates) compared to regular meat consumers in both sexes. Vegetarians adhered to 
their diet longer than pescetarians and 1 day/week meat consumers. 75% of vegetarians 
with a prevalent cancer at baseline had changed to this diet after diagnosis. 50% of self-
reported vegetarians reported meat or fish consumption on the FFQ.  Although the 
misclassification that occurred in terms of diet and lifestyle when merely relying on self-
reporting was relatively small, the impact on associations with disease risk remains to be 
studied.  
Conclusion: We established an analytical cohort over-represented with persons at the 
lower end of the meat consumption spectrum which should facilitate prospective studies of 
major cancers and causes of death using ≥20.3 years of follow-up. 
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INTRODUCTION 
The popularity of (semi-)vegetarianism is rapidly increasing in the western world as a result 
of nutritional, ethical, and more recently, environmental concerns [1]. At the same time, 
the world-wide per capita meat consumption is also expected to increase considerably over 
the next decades [2], especially in developing countries [3, 4].  
Although this transition has been accompanied by an increasing scientific interest in the 
health effects of vegetarian diets, only a small number of large prospective cohort studies 
specifically set out to study these by including a large proportion of vegetarians [5-10]. Thus 
far, these studies provided convincing evidence that vegetarians have a lower risk of 
coronary heart disease [11], a possibly lower risk of diabetes [12], metabolic syndrome 
[13], and some types of cancer[14], and a greater life expectancy [11] compared to meat 
eaters. These observed health benefits may largely be explained by a more favorable 
distribution of chronic disease risk factors such as overweight [15, 16], blood lipids [17], 
and blood pressure [18] among the vegetarians.  
Despite these scientific advancements, no universally accepted definition for the term 
vegetarian exists and there is substantial inconsistency in how people self-identify being 
vegetarian [19, 20]. This ambiguity may hinder the comparability of previous studies. Only a 
few studies identified vegetarians based on extensive dietary data collection techniques [5, 
6] whereas others reported to have classified vegetarians by means of several broader 
questions relating to the overall consumption of animal products [7-9], or to have used self-
reported vegetarianism [10] as inclusion criterion. Even though it has been shown that self-
reported vegetarians are generally health conscious, several studies suggest that this group 
still includes a considerable number of occasional meat consumers [19, 20] which may have 
biased epidemiological study results. Therefore, the usefulness and reliability of self-
reported vegetarian status in observational studies needs to be further evaluated. 
Moreover, further work is needed in studies with a large number of vegetarians and low 
meat eaters to address whether complete abstinence of meat might have an additional 
beneficial health effect over low meat consumption, or vice versa. 
Therefore, we have defined an analytical cohort specifically designed to study the health 
effects of vegetarian and low meat diets focusing on cancer incidence and mortality, 
embedded within a large ongoing prospective cohort that used an extensive FFQ to assess 
dietary intake. In the current paper we present the description of the baseline 
characteristics of this analytical cohort that is overrepresented with low and no meat 
consumers. We performed a cross-sectional comparison of lifestyle factors, dietary intake, 
and prevalent cancer status across the various meat consumption categories. In addition, 
we performed a cross comparison of self-reported vegetarians and vegetarians whose 
status has been confirmed by their response on the FFQ. 
METHODS 
The prospective Netherlands Cohort Study on diet and cancer (NLCS) was initiated in 1986 
with the purpose of investigating the association between diet and cancer. The details of 
the study have been described elsewhere [21]. The study population originated largely 
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from 204 municipal population registries throughout the country. In addition, vegetarians 
were overrepresented by intentionally contacting them through health food shops and 
magazines. This method of recruitment resulted in the inclusion of 685 vegetarians and low 
meat consumers. A total of 58279 men and 62573 women between the ages of 55 and 69 
years completed a mailed, self-administered questionnaire on dietary habits and other risk 
factors for cancer, at baseline. The NLCS has been approved by the institutional review 
boards of the TNO Quality of Life Research Institute (Zeist, the Netherlands) and Maastricht 
University (Maastricht, the Netherlands). Because the NLCS traditionally uses a case-cohort 
approach for reasons of efficiency in questionnaire processing, the baseline questionnaires 
were only entered for all failures (i.e. incident cancer cases) and a random subcohort of 
5000 individuals that was chosen immediately after baseline. The first page of the 
questionnaire was entered and processed for all 120852 participants. 
NLCS-MIC 
We defined an analytical cohort, embedded within the NLCS, that is specifically designed to 
study the health effects of vegetarian and low meat diets; the NLCS ‘Meat Investigation 
Cohort’ (NLCS-MIC). The NLCS-MIC was created by expanding the random subcohort of the 
NLCS from 5000 to 10000 individuals (to increase power) and combining these with all the 
(self-reported) vegetarians and individuals who consumed meat 1 day/week from the NLCS. 
The latter groups were identified based on two items on the first page of the questionnaire 
relating to specific dietary regimens: “how many days on average per week do you eat 
meat?”, and “Do you have any special eating habits?” The remainder of the questionnaire, 
including the 150 item semi-quantitative food frequency questionnaire (FFQ), was also 
entered and processed for this group of vegetarians and low meat consumers. The detailed 
dietary data was used to further categorize NLCS-MIC into five meat consumption 
categories (non-meat consumers based on FFQ (divided into vegetarians and pescetarians), 
1 day/week-, 2-5 days/week-, and 6-7 days/week meat consumers), as described below.  
Meat consumption questions 
The NLCS-FFQ that was used to categorize NLCS-MIC, contained 14 items on the 
consumption of meat with the hot meal (mainly fresh meat, including chicken), 5 items on 
the consumption of meat products used as sandwich fillings, and 3 items on fish 
consumption. A validation study conducted in a subgroup of the cohort two years after the 
baseline measurement indicated that the Spearman correlation coefficients for meat, meat 
products and fish, as assessed by the questionnaire, and those estimated from the 9-day 
dietary record were 0.46, 0.54 and 0.53 respectively. The number of vegetarians and 
individuals consuming meat 1 day/week was too low in this validation sample to assess the 
above correlations in these selected groups [22]. In addition, the questionnaire also 
assessed the time since the start of any special eating habits and weekly frequency of meat 
consumption (for 0-1 day/week meat consumers), in years prior to baseline (1986).  
Classification of NLCS-MIC  
NLCS-MIC was classified based on the FFQ as depicted in Supplemental Figure 1.  
Classification of non-vegetarians 
Individuals who reported to eat ≥1 type of meat with the hot meal (14 items on FFQ) were 
categorized based on their self-reported weekly meat consumption frequency as indicated 
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in the question (“how many days on average per week do you eat meat?”) into 1 day/week, 
2-5 days/week, and 6-7 days/week meat consumers.  
Classification of “FFQ confirmed vegetarians and pescetarians”  
We defined ‘FFQ confirmed vegetarians’ (later referred to as ‘confirmed-vegetarians’) as 
individuals who reported to consume a diet void of meat and fish on the extensive FFQ 
(including vegans, lactoovo-, lacto-, and ovo-vegetarians). In order to be classified as non-
meat consumers individuals had to fulfill the following three criteria simultaneously: 1) not 
eating any meat items for the hot meal (14 items FFQ), 2) abstaining from meat as 
sandwich fillings (5 items FFQ), and 3) consuming meat for 0 days/week as indicated in the 
question (“how many days on average per week do you eat meat?”). In addition, individuals 
adhering to criteria 1 and 2 with a missing on criterion 3 who indicated to adhere to a non-
meat dietary regimen (i.e. vegetarian/vegan), were also considered to be non-meat 
consumers. All non-meat consumers were subsequently categorized to be either vegetarian 
or pescetarian (fish eater) based on the 3 items relating to fish consumption. 
Classification of self-reported vegetarians 
Because we wanted to examine the reliability of self-reported vegetarianism as compared 
to a vegetarian status confirmed by the FFQ, we additionally identified all self-reported 
vegetarians based on the question: “Do you have any special eating habits?” Individuals 
who reported to adhere to a vegetarian, vegan, or Seventh Day Adventist diet were 
classified as self-reported vegetarians. 
Due to the case-cohort design of the original NLCS cohort, NLCS-MIC consists of a random 
sample of 10000 individuals (with random meat consumption), and all the vegetarians and 
low meat consumers from the total cohort. As a result, all self-reported vegetarians who 
reported eating meat >1 day/week and who were not part of the randomly selected 
subcohort (n=119), were only included in analyses when comparing self-reported 
vegetarians to the complementary group of non-(self-reported) vegetarians, and not for all 
other contrasts  
Incomplete and inconsistent dietary data 
Within the NLCS, participants with incomplete and inconsistent dietary data are excluded 
from analyses [22]. These exclusion criteria were based on the number of blank and 
marked items, but not designed for use in non-meat eating populations. As vegetarians left 
meat-related items blank, they automatically meet these exclusion criteria more easily than 
those who consumed meat in their diet. Therefore, new cut-off values for non-meat 
consumers, using the same underlying principles as for the total NLCS cohort, were 
established.  For all non-meat consumers, the cut-off criteria for incomplete questionnaires 
were set at >90 blank- and <22 consumed items, whereas meat eaters were scored 
according to the original NLCS values (>60 items and <35, respectively). Out of the 135 non-
meat eaters with incomplete questionnaires, 39 were no longer considered to be 
incomplete after implementing these new scores. The proportion of incomplete 
questionnaires was 6% among the random sample of 10,000 and 7% among the non-meat 
eaters. Finally, NLCS-MIC consists of 11,867 cohort members, including 1,227 non meat 
consumers (785 vegetarians and 442 pescetarians) and 1,499 participants who consume 
meat for only 1 day/week.   
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Statistical Analyses 
Dietary and lifestyle characteristics were described for the five meat consumption 
categories (confirmed-vegetarians and -pescetarians, and individuals consuming meat1 
day/week, 2-5 days/week, and 6-7 days/week). We also examined differences in dietary 
and lifestyle characteristics between the classifications of vegetarian status, i.e.  between 
self-reported and FFQ based vegetarians.  
Because of the relatively high number of cancer survivors among the vegetarians, 
pescetarians and individuals consuming meat 1day/week, all prevalent cancer cases at 
baseline were excluded from the main analyses and described as a separate group. All 
analyses were conducted for men and women separately. All nutrient intake variables were 
adjusted for energy intake by the residual method [23]. Differences between the five meat 
consumption categories were assessed using chi-square tests for categorical variables, and 
one-way analyses of variance (ANOVA) for continuous variables.  
Due to a skewed distribution of some dietary intake variables we transformed these 
variables prior to performing analyses of variance, using the log normal transformation. 
Non-parametric tests were also applied to not normally distributed data (untransformed) 
(Kruskal-Wallis test), and because these results were comparable to those from ANOVA, 
the latter was applied to all items for consistency.  
All analyses were performed with STATA Statistical Software (Intercooled version 11; 
StataCorp LP, College Station, TX). All tests were 2-tailed, and differences were regarded as 
statistically significant at P<0.05.  
RESULTS 
Table 1: Self-reported vegetarian status at baseline of members of the NLCS-Meat Investigation Cohort (NLCS-MIC) by 
meat consumption statusa.    
    All confirmed vegetarians and low 
meat consumers from the total  NLCS 
cohort 
Random sample of meat 
consumers from the 
total  NLCS cohortb 
  
Vegetarians Pescetarians 1 day/wk 2-5
day/wk 
6-7 
day/wk 
Remainderc Total 
Men     
 Self-reported 
vegetarians  
194 (47%)d 96 (23%) 71(17%) 5 (1%) 1 (0.3%) 49 (12%) 416 
 Non self-reported 
vegetarians 
23 (0.5%) 56 (1%) 411 (9%) 1321 (28%) 2972(62%) N/A  
 Total  217 152 482 1326 2973 49  
       
Women Self-reported 
vegetarians  
380 (52%) 151 (21%) 132 (18%) 7 (1%) 4 (0.6%) 60 (8%) 734 
 Non self-reported 
vegetarians 
105 (2%) 91 (2%) 782 (15%) 1632 (31%) 2672(51%) N/A  
 Total 485 242 914 1639 2676 60  
      
Total   702 394 1396 2965 5649 109   
a Excluding prevalent cancer cases at baseline. 
b Sampling rate is 8.3%. 
c Self-reported vegetarians eating meat >1 day/wk and outside random sample (see also step 6 supplemental Figure 1). 
.d Percentage of self-reported vegetarians, all such values. 
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The NLCS-MIC 
After excluding prevalent cancer cases at baseline, the NLCS-MIC includes 1150 self-
reported vegetarians, of whom 50% were also classified as vegetarian according to the 
information on the FFQ (n=574; 194 men and 380 women); the remaining 50% of self-
reported vegetarians reported to eat meat and/or fish on the FFQ. Moreover, an additional 
23 males and 104 females were classified as vegetarians according to the FFQ but did not 
define themselves as being vegetarian, resulting in a total of 702 confirmed-vegetarians 
(Table 1). In addition, the NLCS-MIC also includes 394 pescetarians, 1,396 individuals 
consuming meat only 1 day/week, 2,965 individuals eating meat 2-5 days/week and 5,649 
individuals who consume meat six or seven days/week (Supplemental Figure 1).  
Comparison of the five diet groups based on the FFQ 
Data on lifestyle and reproductive characteristics by meat consumption category are 
presented in Table 2. No difference in age was observed between the diet groups. 
Vegetarians and pescetarians were more often female. Mean BMI was lowest amongst 
pescetarians and vegetarians and increased with increasing meat intake. In both men and 
women, those who reported not to consume meat had, on average, a higher level of 
education, and were least likely to be married or current smokers. Age at menarche was 
lowest in the vegetarian women. On average, vegetarians had the lowest number of 
children (data only available for women). Among men, those who reported not to consume 
meat had more frequent bowel movements compared to meat eaters (P<0.001), while fish 
eaters had the lowest rates of constipation (P<0.001) (data only available for men) (Table 
3). Among women, vegetarians and pescetarians more often considered their own health 
status to be excellent (20%) compared to all the meat eating groups (~14%).  
Detailed data on intake (in g/day) of major food groups, selected foods and macronutrients 
in the five meat consumption groups are shown in Table 4; intake of all items was 
significantly different across the groups (P<0.001) in both men and women. In short, total 
energy intake was lowest in those who reported to consume meat 1 day/week, followed by 
vegetarians, pescetarians, and highest in individuals consuming meat more than 2 
days/week. The vegetarians and pescetarians consumed the largest amounts of fruits, 
vegetables, pulses, grains, nuts and seeds, soy products, dairy and cheese; consumption of 
these products was lowest among 2-5 and 6-7 days/week meat eaters, while individuals 
who reported to consume meat 1 day/week had intakes at in-between levels. Mean fish 
intake decreased from the low to high meat intake groups and was highest amongst the 
pescetarians. Individuals in the highest meat eating group (6-7 days/week) consumed 
alcohol at levels almost three times as high as the vegetarians.  
Data on daily intake of vitamins and minerals in the five meat consumption groups are 
shown in Table 5. Intake of all these micronutrients was significantly different across the 
diet groups (P<0.001). Intake of vitamins A, B2, C, E, carotene, calcium, folate, phosphorus, 
and dietary fiber was highest among the vegetarians and decreased with increasing intake 
of meat. The opposite pattern was observed for intake of vitamin B6 and cholesterol in the 
diet which was highest among those consuming meat 6-7 days/week. The amount of salt 
added to the meal during cooking increased considerably with increasing meat intake; 
individuals consuming meat 6-7 days/week added nearly three times the amount of salt 
compared to vegetarians. 
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Time on diet 
The time of adherence to diet was significantly different between vegetarians, pescetarians 
and those consuming meat 1 day/week (P<0.001) (Table 6). Both vegetarian men and 
women were more often on a dietary regimen for a longer period of time (>15y) than 
pescetarians and low meat consumers.  
Table 6: Time on diet by meat consumption statusa
 Men Women
 All confirmed vegetarians, 
pescetarians and low meat 
consumers from the total cohort
Self-
reported 
vegetarians
All confirmed vegetarians, 
pescetarians and low meat 
consumers from the total cohort 
 Self-
reported 
vegetarians 
 Vegetarian Pescetarian 1 
day/wk
VegetarianPescetarian 1 
day/wk 
  
 n = 217 n = 152 n = 482 Pb n = 416 n = 485 n = 242 n = 914 Pb n = 734 
Time of adherence to 
special eating habit (%) 
    
    ≤ 5 y 9%c 28% 27% <0.001 18% 16% 33% 27% <0.001 21% 
    6-10 y 23% 27% 22% 23% 25% 27% 26%  25% 
    11-15 y 18% 13% 14% 16% 16% 16% 14%  16% 
    ≥16 y 44% 25% 23% 34% 37% 17% 19%  30% 
    No data   7% 7% 14% 9% 6% 7% 14%  9% 
a Excluding prevalent cancer cases at baseline.
b P values are derived from a chi2 tests comparing vegetarian, pescetarian, 1 day/wk meat consumers. 
c % of total vegetarians, all such values. 
Prevalent cancer cases (results not shown) 
The proportion of prevalent cancer cases was highest among the vegetarian and 
pescetarians (both 11%) and significantly decreased with increasing meat intake (1 
day/week (7%), 2-5 days/week (5%), and 6-7 days/week (4%) (P<0.001) (Supplemental 
Figure 1). Vegetarians who had been diagnosed with cancer before baseline (prevalent 
cancer cases) were more often female and showed a more favorable distribution of lifestyle 
factors compared to vegetarians without a cancer diagnosis; they were more physically 
active and less likely to be current smokers. As could be expected, prevalent cancer cases 
scored their general health status considerably lower, and spent more hours per day 
sleeping. Vegetarians with a prevalent cancer were more extreme in their dietary intakes 
compared to those without a cancer diagnosis; they ate substantially more fruits, 
vegetables, pulses, grains, nuts and seeds, dairy cheese, eggs, proteins and carbohydrates, 
but less fat and alcohol. Moreover, only 65% of vegetarians with a prevalent cancer 
reported using a nutritional supplement compared to 58% in the cancer free vegetarians. 
Three quarters of the vegetarians and 1 day/week meat consumers with a cancer diagnosis 
at baseline had started their dietary regimen in the same year or the year following their 
cancer diagnosis. This was also reflected in their shorter time of adherence to their special 
eating habits compared to cancer free individuals.  
Cross-comparison of self-reported vegetarian status and FFQ data 
We observed that 50% of all self-reported vegetarians reported meat consumption on the 
FFQ. However, self-reported vegetarians who reported meat of fish consumption on the 
FFQ did not differ much with respect to lifestyle and dietary characteristics compared to 
self-reported vegetarians who abstained from all meat and fish products. Moreover, the 
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self-reported vegetarians who reported meat consumption on the FFQ ate very little meat 
at rates comparable to the 1 day/week meat consumers (results not shown). Among 
women, compared to self-reported vegetarians who reported meat or fish consumption on 
the FFQ, confirmed vegetarians were significantly less often current smokers (15% and 6%, 
respectively (P<0.001), results not shown). Although confirmed self-reported vegetarians 
had a higher level of education (P<0.001) compared to the self-reported vegetarians who 
reported meat or fish consumption on the FFQ, this latter group still had a higher education 
level than any of the meat consumption groups (results not shown). Meat eating self-
reported vegetarians had higher intakes of vitamin B3, B6, cholesterol and a lower intake of 
dietary fiber, and added more salt to their meal during cooking compared to confirmed 
self-reported vegetarians  (P<0.001) (results not shown). 
DISCUSSION 
We defined an analytical cohort with a wide range of dietary intake by over-representing 
our study population with persons at the lower end of the meat consumption spectrum.  
The dietary intake patterns and lifestyle characteristics of vegetarians, pescetarians and 
those consuming meat 1 day/week were diverse and distinct from individuals consuming 
meat on a regular basis. A cross-comparison between self-reported vegetarians and 
vegetarians whose status was confirmed based on extensive FFQ data, did not show large 
differences between both groups in terms of diet and lifestyle characteristics.  
To date, no universally accepted definition for the term vegetarian exists and the only 
constant component in a vegetarian diet across all previous empirical studies has been the 
absence of meat. As previously outlined by Fraser, the problem of defining a dietary 
regimen on just one food group is that it results in a lack of control on intake of all other 
food groups that make up a vegetarian diet [24]. Consequently, all individuals who refrain 
from meat, but have otherwise quite distinct dietary intakes, are grouped together under 
one label of vegetarianism. We included a large number of individuals consuming meat only 
once a week with the purpose to address whether low meat consumption might have a 
beneficial health effect over complete abstinence of meat, or vice versa. Despite an 
increase in the number of low meat consumers and meat reducers in the Western world 
[25, 26], little to no research has been conducted in this area. However, we showed no 
large differences in terms of nutrient intake between these groups, though we had no data 
on vitamin B12 intake [27].  
Interestingly, we showed that the perceived general health of vegetarians is considerably 
better than that of non-vegetarians. This is in line with our finding that vegetarianism is not 
merely characterized by a diet void of all flesh foods, but rather extends into a complete 
healthy lifestyle. In our population, we found evidence for a higher level of health 
consciousness among the vegetarians, pescetarians and to a lesser extent low meat 
consumers, as indicated by a more favorable distribution of dietary and lifestyle factors. 
Although the diet groups were statistical significantly different with respect to most of the 
dietary variables, this may have resulted from our large sample size. Interestingly, the 
amount of salt added to the food during cooking increased with increasing animal product 
intake in a dose-response relation. Pescetarians had higher intakes of soy products, nuts 
and seeds, grains, cheese and eggs than vegetarians, which would suggest that they more 
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actively seek to replace the meat in the diet with plant based protein-rich foods to balance 
their diets.  
Appropriately planned vegetarian diets have shown to be consistent with the current 
dietary guidelines in all stages of the lifecycle [28]. The mean nutrient intakes (not from 
supplements) in all diet groups were generally well above the recommended daily 
allowances (RDA) of the European Commission [29],  except for iron for which the intakes 
were below the RDA of 14mg/day in the meat eating men and all women. The estimated 
iron intake was highest among pescetarians and vegetarians. However, these groups 
consume predominantly inorganic iron which has a low bioavailability compared to the 
heme-bound iron that is found in meat products [30].  More than 55% of the vegetarians 
and pescetarians reported to take a nutritional supplement over the last year compared to 
26% of individuals in the highest meat consumption group (6-7 days/week). This suggests 
that there appears to be a certain degree of awareness among these individuals of the 
need to supplement their diets to prevent dietary deficiencies.   
Although literature suggests that long-term adherence to a vegetarian diet appears more 
strongly associated with health outcomes than short term adherence [11, 31], very few 
prospective studies in vegetarian populations have specific data available on time since 
adopting the diet. On average, vegetarians adhered to their diet considerably longer than 
pescetarians and individuals consuming meat 1 day/week. As much as 75% of all 
confirmed-vegetarians who had been diagnosed with cancer before baseline changed to 
this dietary regimen after diagnosis. In addition, the proportion of prevalent cancer cases 
decreased with increasing meat intake. Previous research indicates that cancer survivors 
are highly motivated to make dietary changes towards a more plant-based diet after 
diagnosis with the intention to improve their health and well-being [32]. However, 
although nutrition has shown to affect cancer progression [33], it remains to be elucidated 
whether adopting a vegetarian lifestyle may influence the course of cancer prognosis or 
cancer recurrence.  
Nearly half of those who called themselves vegetarian reported to consume fish, meat or 
poultry on the extensive FFQ (ĸ=0.59). Similar findings have been reported previously [19, 
20] and indicate that the complete avoidance of meat cannot be assumed among self-
reported vegetarians. This suggests that self-identification is not a good measure for 
estimating the prevalence of vegetarianism. However, our findings suggest that the level of 
misclassification that occurs when merely relying on self-reported vegetarian status was 
small: the overall group of self-reported vegetarians did not differ considerably from 
individuals whose vegetarian status has been confirmed based on FFQ data in terms of diet 
and lifestyle. The FFQ assessed the diet in the past 12 months whereas self-definition was 
based on vegetarian status at the time of the questionnaire. Nonetheless, only 10% of the 
observed disagreement could be explained by this difference in time-frame. It would be 
interesting to examine the difference in risk ratios between both groups of vegetarians in 
future etiological studies of chronic diseases. After 20.3y of follow-up, a total of 1559 
incident cancer cases (165 among vegetarians and 346 among 1 day/week meat 
consumers) were identified in NLCS-MIC through record linkage with the Netherlands 
Cancer Registry. 
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An important methodological issue when comparing previous studies on the health effects 
of vegetarian diets relates to between-study sampling differences. Only a few reports on 
vegetarian diets, including ours, are from population-based studies while the majority stem 
from convenience samples that have likely also recruited more health-conscious non-
vegetarians [5-8, 10, 34]. The latter technique is particularly appropriate to recruit non 
vegetarians who only differ from vegetarians with respect to their meat and fish intake and 
is a suitable design for studies into diet and health in vegetarian populations that are 
mainly concerned with the adverse effects of meat. However, interest has shifted towards 
the health effects of the complete vegetarian lifestyle. For this, convenience sampling may 
be less appropriate since it likely decreases diet and lifestyle differences between 
vegetarians and non-vegetarians, and could bias results towards the null. Our population 
has a wide distribution of nutrient intakes and lifestyle characteristics, which should 
facilitate the identification of associations between vegetarianism, meat consumption and 
disease risk in future etiologic studies.  The ratio of low meat consumers to high meat 
consumers (meat consumption ≤1 day/week versus 6-7 days/week) was 1:23 in the total 
NLCS cohort and 1:2.2 in NLCS-MIC. 
The NLCS aimed to overrepresent vegetarians by intentionally contacting them through 
health food shops and magazines. Therefore, vegetarian dietary patterns were taken into 
consideration when designing the FFQ by including line items on meat substitutes that 
were commonly used by the vegetarian population at that time. Vegetarians and low meat 
consumers more often took the opportunity to report and give details of foods and 
beverages that were frequently eaten but that were not contained in the FFQ. Moreover, 
vegetarian status was taken into account for nutrient calculation of composite recipes. 
Previous studies indicate that vegetarians are able to recall their diet with higher reliability 
[35] but at the same time may be more tempted to report the intake of certain food items 
that they consider to be healthy as a result of social desirability bias [20]. The FFQ used in 
the NLCS was not designed for assessing the usefulness of self-reported vegetarianism as a 
classification tool. Interestingly, some 18% of individual who were classified as vegetarians 
based on their responses on the FFQ did not report to have any special eating habits. This 
phenomenon has previously been reported [20] and may result from lack of knowledge of 
the concept of vegetarianism by the general public at the time the measurement was 
conducted (1986).  
With NLCS-MIC we successfully established an analytical cohort comprising a considerable 
number of vegetarians, pescetarians, and 1 day/week meat consumers. The wide 
distribution of dietary and lifestyle characteristics within the cohort should facilitate the 
identification of associations between vegetarianism, meat consumption and the risk of 
major types of cancer and cause-specific mortality using ≥20.3 y of follow-up in future 
etiologic studies.  
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ABSTRACT 
Background: To study how a vegetarian or low meat diet influences the risk of colorectal 
cancer compared to a more common high meat diet, and to assess the explanatory role of 
(non-) dietary factors associated with these diets.  
Methods:  In the Netherlands Cohort Study – Meat Investigation Cohort (NLCS-MIC) 
(analytical cohort of 11082 individuals including 1040 self-defined vegetarians), subjects 
completed a baseline questionnaire on dietary habits and other risk factors for cancer in 
1986, based on which they were further classified into vegetarians (n=691), pescetarians 
(n=389), 1 day/week- (n=1388), 2-5 day/week- (n=2965), and 6-7 day/week meat 
consumers (n=5649). After 20.3 years of follow-up, 437 colorectal cancer cases (307 colon, 
92 rectal) were available for analyses.  
Results:  A non-significantly decreased risk of CRC for vegetarians, pescetarians, and 1 
day/week meat eaters compared to 6-7 day/week meat consumers was observed (age/sex 
adjusted Hazard Ratios (HR): 0.73(0.47-1.13), 0.80(0.47-1.39), and 0.72(0.52-1.00), 
respectively). Most of the differences in HR between these meat consumption groups could 
be explained by intake of dietary fiber. Other (non-)dietary factors characteristic for a 
vegetarian or low meat diet had negligible individual effects, but attenuated the HRs 
towards the null when combined. No statistically significant differences in CRC risk between 
vegetarians and non-vegetarians was observed, but the association was stronger using 
confirmed vegetarian status over self-defined status (age/sex adjusted HR: 0.78(0.51-1.20), 
and 0.91(0.66-1.25) respectively).  
Conclusion:  Vegetarians, pescetarians, and 1 day/week meat eaters showed a non-
significantly decreased risk of colorectal cancer compared to 6-7 day/week meat 
consumers, mainly due to differences in dietary pattern other than meat intake. 
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INTRODUCTION 
Only a few prospective cohort studies specifically set out to study colorectal cancer 
incidence in vegetarians. The Oxford Vegetarian study, the EPIC-Oxford study, and the 
Adventists Health Study I and II, intentionally included a large proportion of vegetarians, 
but yielded inconsistent and mixed results [1-5].  
Some of the inconsistency in findings may be owing to differences in sampling strategies 
between studies: some studies stem from convenience samples [1, 2, 5] that have likely 
also recruited more health-conscious non-vegetarians. Other inconsistencies may arise as a 
result of differences in definition and operationalization of vegetarianism, and the 
usefulness and reliability of self-defined vegetarianism in etiological studies of cancer 
remains unclear. Several additional questions concerning the effect of vegetarian diets on 
colorectal cancer stay unanswered and require further investigation. Although it is 
speculated that risk factors for colon and rectal cancer may vary [6, 7], anatomic subsite-
specific effects of vegetarian diets have not been reported. Moreover, it is unclear whether 
the association between vegetarianism and colorectal cancer risk differs by time of 
adherence to the dietary regimen.  
Within the existing studies of meat, vegetarianism and colorectal cancer risk, little to no 
attention has been paid to the lower end of the meat consumption spectrum. It would be 
interesting to address whether complete abstinence of meat is associated with a lower 
colorectal cancer risk than very low meat consumption, or vice versa. Moreover, it is likely 
that possible beneficial effects of vegetarianism and low meat consumption can, apart from 
the (near) abstinence of meat, also be attributed to other dietary and lifestyle factors that 
characterize these diets [8, 9]. Yet, little is known about the potential explanatory role of 
these multiple connected factors in the associations of vegetarian and low meat diets with 
colorectal cancer risk.  
We investigated the association between vegetarianism, (low) meat consumption and 
colorectal cancer risk with special focus on colorectal sub-locations, the time of adherence 
to the dietary regimen, the reliability of self-defined vegetarianism, and the contribution of 
individual dietary and lifestyle factors within the “Netherlands Cohort Study-Meat 
Investigation Cohort” (NLCS-MIC). This population based cohort includes a considerable 
number of vegetarians, pescetarians and low meat consumers resulting in a wide 
distribution of dietary and lifestyle characteristics that should facilitate the identification of 
associations with colorectal cancer risk. 
METHODS 
Study population and cancer follow-up 
The NLCS ‘Meat Investigation Cohort’ (NLCS-MIC) is an analytical cohort embedded within 
the ongoing prospective Netherlands Cohort Study (NLCS). The total NLCS study was 
initiated in September 1986 and includes 120852 men and women aged 55-69 years at 
baseline, largely originating from 204 municipalities with computerized population 
registries. In addition, to increase contrast within the cohort, vegetarians were 
overrepresented by recruitment through health food shops and magazines. At the start of 
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the study, participants completed a self-administered questionnaire on dietary habits, 
lifestyle characteristics, medical history, and other potential risk factors for cancer [10]. 
NLCS-MIC is specifically established within the NLCS to study the health effects of 
vegetarian and low meat diets. Because the total NLCS-cohort traditionally uses the case-
cohort approach for analyses, data was only entered for a random subcohort of 10000 
subjects and all enumerating cancer cases. As a result, NLCS-MIC had to be established by 
combining the random subcohort with all (self-reported) vegetarians and all individuals 
that consumed meat only 1 day/week from the total NLCS cohort for whom the data was 
also entered. All vegetarians and those consuming meat 1 day/week were initially 
identified based on two items relating to specific dietary regimens that are stated on the 
first page of the questionnaire that was processed for all 120,852 cohort members: “Do you 
have any special eating habits?”,  and “how many days on average per week do you eat 
meat?”. The 150 item semi-quantitative food frequency questionnaire (FFQ) was used to 
accurately categorize NLCS-MIC (n=11082) with complete and consistent FFQs into five 
meat consumption categories: confirmed vegetarians (n=691) and pescetarians (n=389), 1 
day/week- (n=1,388), 2-5 days/week- (n=2965), and 6-7 days/week meat consumers 
(n=5649). We defined vegetarians as individuals who consume a diet void of meat 
(including vegans, lactoovo-, lacto-, and ovo-vegetarians). Pescetarians do not eat meat but 
do eat fish.  As a consequence of the procedure followed, NLCS-MIC also includes 1133 self-
reported vegetarians of whom 109 reported to consume meat but were not part of the 
randomly selected subcohort. As a result, these latter individuals are only included in 
analyses when comparing all self-reported vegetarians (either confirmed or not) to the 
complementary group of non-(self-reported) vegetarians, and not for all other contrasts. 
Full details of the study design have been described elsewhere [8].  
The full-cohort approach is used for analyses of NLCS-MIC. NLCS-MIC is being monitored for 
cancer occurrence by repeated record linkage to the Netherlands Cancer Registry, the 
Dutch Pathology Registry, and the cause of death registry (Statistics Netherlands), together 
providing a near 100% coverage [11]. Follow-up for vital status was established by record 
linkage to the automated municipal population registries and the Central Bureau for 
Genealogy. Less than 1% of the cohort members were lost to follow-up. After 20.3 years of 
follow-up and exclusion of prevalent cancer cases at baseline (other than skin cancer), 477 
colorectal cancer cases (336 colon (ICD-O codes: 153.0-153.7) (184 proximal colon; 142 
distal colon and 10 unspecified) and 99 rectum (ICD-O code: 154.1)) remained eligible for 
analyses. Recto sigmoid cancer cases (ICD-O code: 154.0) were not evaluated separately 
because of the small number of cases (n=42) and the higher risk of misclassification [12]. 
The NLCS has been approved by the institutional review boards of the TNO Quality of Life 
Research Institute (Zeist, the Netherlands) and Maastricht University (Maastricht, the 
Netherlands).  
Questionnaire 
All participants completed a 150 item semi-quantitative FFQ at baseline, estimating the 
average frequency and amount of foods and beverages consumed over the previous 12 
months. Next to the questions relating to special eating habits and weekly meat 
consumption frequency that were used for the identification of vegetarians and 1 
day/week meat consumers,  the questionnaire also assessed the time since the start of any 
special eating habits and weekly frequency of meat consumption (for 0-1 day/week meat 
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consumers), in years until baseline (1986). In addition, the FFQ contained 14 items on the 
consumption of meat with the hot meal (mainly fresh meat, including chicken), 5 items on 
the consumption of meat products used as sandwich fillings, and 3 items on fish 
consumption (with the hot meal, for lunch, as a snack in between meals). Coding of fresh 
meat items was based on raw weight to take into account the amount of fat originally 
present in the meat but eventually ending up in the gravy, which is usually consumed as 
well. Processed meat was defined as meat items that had undergone some form of 
preservation (mostly cured (i.e. treated with nitrite/nitrate salt, sometimes smoked and/or 
fermented)).  
A validation study conducted in a subgroup of the cohort two years after the baseline 
measurement indicated that the Spearman correlation coefficients for meat, meat products 
and fish as assessed by the questionnaire and those estimated from the 9-day record were 
0.46, 0.54 and 0.53 respectively. The number of vegetarians and 1 day/week meat 
consumers was too low in this validation sample to assess a correlation in these extremes 
[13].  
Statistical analyses 
We estimated the association between meat consumption group (confirmed vegetarian, 
pescetarian, 1 day/week-, 2-5 days/week-, and 6-7 days/week meat consumers (reference 
group)) and the risk of colorectal cancer. In addition, the association with self-reported 
vegetarian status (self-reported versus complementary group of non-self-reported-
vegetarians) and confirmed vegetarian status (confirmed vegetarian versus complementary 
group of non-vegetarians) was examined. To increase power, vegetarians and fish eaters 
were combined in an overlapping category of non-meat consumers to examine whether 
their risk of colorectal cancer differed from the complementary group of individuals who do 
consume meat. To assess to what extent these associations can (partially) be explained by 
other dietary and lifestyle variables (e.g. smoking, physical activity, BMI and level of 
education), we calculated the difference in risk estimate, firstly adjusting for age and sex, 
then further adjusting for energy and each food group, or lifestyle factor in turn. Moreover, 
the association with meat consumption group and confirmed vegetarians status was 
stratified by duration of adherence to the specific diet (≤10 years, >10 years). 
Individuals adhering to a no or low meat diet often replace the meat in their diet with other 
protein-rich food groups. Using nutrient density substitution models and meat protein as a 
proxy for meat intake, we examined the effect of replacing one protein subtype for another 
by including nutrient density variables for all but one protein subtype in a multivariable 
model along with total protein intake and total energy intake [14].  
The following food groups and foods were also selected for analyses (in g/day): fresh meat 
(beef, pork, minced meat, chicken, liver), processed meat, fish, fresh red meat (fresh meat 
without chicken) and beef, pork, minced meat, chicken, and liver as separate types. For the 
individual meat types, subjects were classified into non-consumers, and tertiles of 
consumers (highest tertile as reference group), and as continuous variables. The latter were 
reported in 50 g/day increase for all fresh meat types except liver, and 25 g/day for 
processed meat and liver intake. For some variables, categories were used instead of 
quintiles. For liver intake, there was a non-user and a user group (>0 g/day). For both 
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chicken and fish a non-user and 3 user categories (0, 0-<6.6, ≥6.6-<22.8 and ≥ 22.8 g/day 
for chicken; 0, 0-<10, ≥10-<20 and ≥ 20 g/day for fish) were defined. 
For all the above described contrasts, age and sex adjusted and multi-variable adjusted 
hazard rate ratios (HRs) and their corresponding 95% confidence intervals (95% CI) were 
estimated using Cox proportional hazards models. The proportional hazards assumption 
was tested using the scaled Schoenfeld residuals. To evaluate whether early symptoms of 
colorectal cancer before diagnosis could have influenced the results, early cases (diagnosed 
within 2 years after baseline) were excluded in additional analyses. The covariates included 
in the multivariate analyses were either a priori selected risk factors of colorectal cancer, or 
variables that changed the risk estimates for meat consumption group, vegetarian status or 
total fresh meat intake by 10% or more. The latter criterion was not met for any other than 
the predefined covariates resulting in a final model including age(years), sex, total energy 
intake(kcal/day), cigarette smoking (never, ever, current), alcohol consumption (g/day), 
BMI (kg/m2), non-occupational physical activity (≤30,>30-≤60,>60-≤90,>90 minutes/day), 
and level of education (lower vocational, secondary-/medium-vocational, university and 
higher vocational). The independent contribution of the individual meat categories was 
examined by constructing addition models that summed to total meat. 
To enable comparison, the age and sex-adjusted analyses were restricted to subjects 
included in multivariable-adjusted, leaving 10,210 cohort members, including 437 
colorectal cancer cases (307 colon (129 proximal colon; 169 distal colon and 9 unspecified) 
and 92 rectal) for analyses. Moreover, when analyzing the contrast between self-reported 
vegetarians and non-vegetarians, an additional 90 self-reported vegetarians that reported 
to consume meat but were not part of the randomly selected subcohort were also included 
in analyses (including 7 colorectal cancer cases). Linear trends were evaluated with the 
Wald test by entering the categorical exposure variables as a continuous term in the Cox 
regression model. 
To test for heterogeneity between the colon and the rectum, and the anatomic subsites of 
colon cancer (proximal/distal), the competing risks procedure in Stata was used. However, 
the standard error for the difference of the log-HRs from this procedure assumes 
independence of both estimated HRs which would overestimate the standard error and 
thus overestimate the P values for their difference. Therefore, these P values and the 
associated confidence intervals were estimated based on a bootstrapping method. Each 
bootstrap analysis was based on 1,000 replications.  
All tests were two-tailed and differences were regarded as statistically significant at P<0.05.  
All analyses were performed using STATA Statistical Software (Intercooled STATA, version 
12; Stata-Corp LP, College Station, TX). 
RESULTS 
The distribution of demographic and (non-) dietary characteristics according to meat 
consumption group has been described previously [8, Chapter 4]. The percentage of men 
and supplement users was higher in rectal cancer cases than in non-cases (P<0.05) (Table 
1). 
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Table 1: Baseline characteristics (means or percent) and dietary intakes of exposures of interest of colorectal cancer 
cases and non-cases in NLCS-MIC, 1986-2006. 
Non 
cases 
Colorectal cancer 
cases  
Colon cancer
cases a 
Rectal cancer 
cases a Characteristics 
N 9773 437 307 92 
Diet Group (%) 
   Vegetarian  6% 5% 6% 1% 
   Pescetarian  4% 3% 4% 2% 
   1 day/wk meat  12% 9% 10% 11% 
   2-5 days/wk meat 26% 27% 27% 25% 
   6-7 days/wk meat 51% 56% 53% 61% 
    
Sex (% men) 47% 53% * 50% 64% * 
Age (y) 61.3 ± 4.2b 61.4 ± 4.0 61.5 ± 4.1 61.2 ± 3.8 
Current smokers (%) 26% 23% 21% 33% 
BMI mean 24.7 ± 3.2 25.0 ± 3.2 24.9 ± 3.2 25.1 ± 3.1 
Physical activity (non-occupational) (%) 
    <30 min/day 21% 19% 19% 15% 
    30-60 min/day 30% 33% 35% 30% 
    60-90 min/day 23% 19% 21% 16% 
    >90 min/day 26% 28% 25% 38% 
Level of education (%) 
    Low 46% 47% 45% 51% 
    Medium 37% 37% 38% 37% 
    High 17% 16% 17% 12% 
Supplement use (% users) 34% 31% 36% 22% * 
    
Energy (kcal) 1888 ± 519 1919 ± 512 1888 ± 515 2032 ± 503 * 
Fiber (g) 28.2 ± 7.6 27.8 ± 7.2 27.8 ± 7.3 27.9 ± 6.5 
Alcohol (g) 9.3 ± 13.8 11.8 ± 16.4 * 11.9 ± 16.7 * 12.3 ± 17.2 * 
Total fresh meat (g) c 81.1 ± 52.8 83.6 ± 48.1 80.9 ± 48.6 88.2 ± 48.4 
    Fresh red meat (g) d 70.6 ± 49.2 73.1 ± 45.5 70.7 ± 46.0 76.5 ± 44.3 
    Beef (g) 21.6 ± 23.9 22.1 ± 21.3 22.4 ± 21.9 19.5 ± 19.0 
    Pork (g) 30.5 ± 29.8 32.4 ± 29.0 29.9 ± 27.6 36.7 ± 28.6 * 
    Minced meat (g) 14.9 ± 16.3 15.3 ± 15.0 15.1 ± 14.8 16.7 ± 16.7 
    Liver (g) 1.6  ± 4.0 1.6 ± 3.7 1.5 ± 3.6 1.9 ± 4.1 
    Chicken (g) 11.3 ± 14.8 11.2 ± 14.1 10.9 ± 12.3 12.3 ± 15.1 
Processed meat (g) 11.0 ± 14.3 12.3 ± 14.4 11.4 ± 13.6 16.3 ± 17.8 * 
Fish (g) 13.1 ± 18.1 12.6 ± 14.9 13.3 ± 15.8 13.3 ± 12.9 
Vegetables (g) 199 ± 89 200 ± 85 200 ± 88 204 ± 81 
Fruits (g) 184 ± 128 175 ± 115 176 ± 115 168 ± 110 
Pulses (g) 10.0 ± 16.7 10.1 ± 17.1 9.9 ± 13.3 9.5 ± 13.9 
Soya products (g) 3.1 ± 17.8 2.0 ± 9.4 2.7 ± 9.9 0.4 ± 1.5 
Milk (g) 312 ± 208 285 ± 189 * 288 ± 193 * 284 ± 188 
Cheese (g) 25.9 ± 22.6 24.2 ± 20.8 23.1 ± 20.0 * 30.4 ± 24.4 
Eggs (g) 15.6 ± 11.7 16.2 ± 11.1 15.3 ± 10.0 18.7 ± 14.7 * 
a Colon and rectal cases do not sum to total colorectal cancer cases because rectosigmoid cases were not evaluated 
separately. 
b Mean ± SD, all such values. 
c Intake based on raw meat weight. 
d Includes beef, pork, minced meat, liver and other meat. 
* Statistically significant different from non-cases (using the χ2 test for categorical variables and ANOVA for 
continuous variables). 
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The percentage of vegetarians was lowest in rectal cancer cases while the proportion of 6-7 
day/week meat consumers was highest in this group. The latter is also reflected in a higher 
total energy intake, and consumption of pork and processed meat among the rectal cancer 
cases compared to non-cases (P<0.05). However, non-cases had higher daily intakes of milk 
and cheese, but lower intakes of alcohol than cases (P<0.05). Rectum cancer cases 
consumed more eggs than non-cases.  
Table 2A and Table 2B show hazard rate ratios and 95% confidence intervals for colorectal 
and colon and rectal cancer, respectively, according to meat consumption group, 
vegetarian status and meat consumption status, adjusted for age and sex alone and with 
further adjustment for confounders. There was no evidence of an interaction by sex for any 
of the comparisons made (P-interaction>0.05). A borderline statistically significant reduced 
risk of colorectal cancer for 1 day/week meat consumers was found when compared to 6-7 
days/week meat consumers (HR=0.72, 95%CI: 0.52-1.00). 
 
Table 2A: Hazard rate ratios (HR) and 95% confidence intervals (CI) for colorectal cancer according to meat 
consumption group, vegetarian status and meat consumption status. 
PY 
Colorectal cancer
Factor Category Cases HR (95%CI)a HR (95%CI)b 
Meat consumption 
group vegetarian c 11277 22 0.73 (0.47-1.13) 0.83 (0.53-1.31) 
pescetarian 6429 14 0.80 (0.47-1.39) 0.88 (0.51-1.51) 
1 day/wk meat 21451 41 0.72 (0.52-1.00) 0.77 (0.55-1.08) 
2-5 day/wk meat 43360 116 0.93 (0.75-1.16) 0.95 (0.76-1.19) 
6-7 day/wk meat 87356 244 1 (ref) 1 (ref)
 Ptrend 0.04 0.19
  
Vegetarianism vegetarianc 11277 22 0.78 (0.51-1.20) 0.89 (0.58-1.39) 
non vegetarian 160598 415 1 (ref) 1 (ref)
     
self-defined vegetariand 18272 42 0.91 (0.66-1.25) 1.04 (0.74-1.44) 
non self-defined vegetarian 154961 402 1 (ref) 1 (ref)
     
Meat consumption No meat  consumers 17706 36 0.81 (0.57-1.14) 0.90 (0.63-1.29) 
Meat consumers 154169 401 1 (ref) 1 (ref)
    
≤ 1 day/wk meat 39158 77 0.75 (0.58-0.97) 0.82 (0.63-1.06) 
  >1 day/wk meat 132717 360 1 (ref) 1 (ref)
PY (person years at risk). 
a Adjusted for age (y) and sex. 
b Adjusted for age (y), sex, total energy intake (kcal), cigarette smoking (never, ever, current), alcohol 
consumption (g/day), BMI (kg/m2), non-occupational physical activity (<30,30-60,60-90, > 90 min/d), and level 
of education (lower vocational,  second and medium vocational, university and higher vocational). 
c Confirmed vegetarians based on the extensive FFQ (defined as individuals who consume a diet void of meat 
and fish).  
d NLCS-MIC includes 1,133 self-defined vegetarians of whom 109 reported to consume meat but were not part 
of the randomly selected subcohort. These individuals are only included in analyses when comparing all self-
defined vegetarians (either FFQ confirmed or not) to non-self-defined vegetarians, and not for all other 
contrasts. 
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Further adjustment for confounding attenuated this association (HR=0.77, 95%CI: 0.55-
1.09). A similar though not statistically significant pattern was observed for colon cancer, 
while the HR for rectal cancer was lowest among the vegetarians (HR=0.21, 95%CI: 0.03-
1.51) and increased with increasing frequency of meat intake (P-trend=0.03 (age-/energy-
adjusted model)). There was only one rectal cancer case that adhered to a vegetarian diet. 
The inverse association between risk of colorectal cancer and confirmed or self-reported 
vegetarian status did not reach statistical significance, but was notably attenuated using 
self-definition (HR=0.78, 95%CI: 0.51-1.20 and HR=0.91, 95%CI: 0.66-1.25, respectively). 
Similar findings were observed for rectal cancer, whereas HRs around 1 were observed for 
colon cancer risk.  Although the effect of the five meat consumption groups did not differ 
between colon and rectal cancer cases, the effect of vegetarian status (confirmed versus 
complementary group of non-confirmed vegetarians) was significantly different between 
both endpoints (P-heterogeneity=0.02). When vegetarians, pescetarians and 1 day/week 
meat consumers were combined and compared against individuals eating meat >1 
day/week, a statistically significant 25% reduction in risk of colorectal cancer was observed, 
which was no longer significant after adjustment for confounders. 
Within the colon, the risks for proximal or distal tumors were not statistically different for 
either meat consumption group (P-heterogeneity=0.26) or confirmed vegetarian status (P-
heterogeneity=0.06). Estimates for distal colon cancer were most comparable to those 
observed for rectal cancer (Supplemental Table 1). Moreover, in a lag analysis excluding 
the first 2 years of follow-up (408 colorectal cancer cases), the findings for meat 
consumption group and vegetarian status did not change appreciably (data not shown).  
Table 3 shows the percent change in HR for overall colorectal cancer risk across the meat 
consumption groups, firstly adjusted for age and sex, then further adjusted for energy and 
each food group, or lifestyle factor in turn. Fiber intake contributed most to the observed 
inverse risk of colorectal cancer when comparing vegetarians, pescetarians, and 1 day-week 
meat eaters to 6-7 day-week meat. When all confounding dietary and lifestyle factors were 
added together in one model simultaneously, the HRs approached the null. Comparable 
patterns were observed when examining colon and rectal cancer separately.  
In addition, we observed evidence that substituting 5% of energy from protein from meat 
by 5% of energy from dairy protein was associated with a 24% reduced risk of colorectal 
cancer, after adjustment for confounding variables (P=0.055) (Supplemental Table 2). 
Substituting protein from meat by other sources of protein (e.g. protein from plant sources, 
eggs or fish) had no statistically significant effect on risk for colorectal cancer. 
Supplemental Table 3 shows the HRs for colorectal cancer according to meat consumption 
group and vegetarian status stratified by time of adherence to the vegetarian and 1 
day/week meat diet (≤10 years versus >10 years). The HRs were comparable to the overall 
effects presented in Table 2 but none of the comparisons reached statistical significance. 
No striking differences between short term and long term adherence to a vegetarian or low 
meat diet were observed regarding colorectal cancer risk.  
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Table 3: Difference in Hazard rate ratios (HR) for colorectal cancer between vegetarians, pescetarians, 1 day/wk 
meat and 6-7 days/wk meat consumers after adjustment for individual dietary and lifestyle factors.  
Colorectal cancer
Vegetarian Pescetarian 1 day/ 6-7 day/ 
wk meat wk meat 
Factor adjusted for a HR 
% change
 in HR HR 
% 
change 
 in HR HR 
% change 
 in HR HR 
Age and sex 0.73 − 0.80 − 0.72 − 1 (ref) 
Dietary Factors 
Energy (kcal) 0.73 0% 0.80 0% 0.71 -1% 1 (ref) 
Energy + alcohol (g) 0.77 5% 0.82 2% 0.74 3% 1 (ref) 
Energy + fiber (g) 0.82 12% 0.89 11% 0.76 6% 1 (ref) 
Energy + fruits (g) 0.75 3% 0.82 2% 0.72 0% 1 (ref) 
Energy + vegetables (g) 0.72 -1% 0.79 -1% 0.71 -1% 1 (ref) 
Energy + pulses (g) 0.71 -3% 0.78 -3% 0.70 -3% 1 (ref) 
Energy + soy products (g) 0.78 7% 0.87 9% 0.73 1% 1 (ref) 
Energy + milk (g) 0.76 4% 0.83 4% 0.74 3% 1 (ref) 
Energy + cheese (g) 0.77 5% 0.84 5% 0.74 3% 1 (ref) 
Energy + eggs (g) 0.73 0% 0.80 0% 0.71 -1% 1 (ref) 
Energy + Supplement use (0, 1 , ≥ 2 ) 0.75 3% 0.83 4% 0.73 1% 1 (ref) 
  
Full model including dietary factorsb 0.99 36% 1.04 30% 0.86 19% 1 (ref) 
     
Lifestyle Factors 
Smokingc  0.72 -1% 0.79 -1% 0.71 -1% 1 (ref) 
Non-occupational physical activityd 0.73 0% 0.81 1% 0.72 0% 1 (ref) 
BMI (kg/m2) 0.77 5% 0.84 5% 0.74 3% 1 (ref) 
Level of educatione 0.75 3% 0.83 4% 0.73 1% 1 (ref) 
  
Full model including dietary and lifestyle 
factorsb 1.06 45% 1.11 39% 0.89 24% 1 (ref) 
a All adjusted for age and sex. 
b Including all the above listed variables . 
c Smoking categories: never, ever, and current smokers. 
d Non occupational physical activity categories:  <30, 30-60, 60-90, > 90 min/d. 
e Level of education categories: lower vocational,  second and medium vocational, university and higher vocational. 
 
No clear association was observed when the relation was examined between dietary intake 
of individual meat types and the risk of overall colorectal cancer (Table 4A). Similar findings 
were observed for colon cancer risk (Table 4B).  When restricting analyses to the rectal 
cancer subtype, we observed HRs below 0.65 (not statistically significant) for fresh meat, 
fresh red meat, and pork consumers when comparing for the non-consumers to those in 
the highest tertile (Table 4B). A statistically significant increased risk for rectal cancer was 
observed with each 25 g-day increment in processed meat intake (HR: 1.36, 95%CI: 1.01-
1.81) as well as a significant trend across categories of intake (P-trend=0.008).  
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Table 4A: Hazard rate ratios (HR) and 95% confidence intervals (CI) for colorectal cancer according to sex-specific 
quintiles and categories of intake of fresh meat, types of fresh meat, and processed meat. 
Median intake 
PY 
Colorectal cancer
Food item Men Women Cases HR (95%CI)a HR (95%CI)b 
Total fresh meat (g/day)c 
      Non consumers 0 0 20022 42 0.90 (0.64-1.28) 1.09 (0.75-1.59) 
      T1 56.6 30.0 49317 111 0.93 (0.72-1.20) 1.04 (0.79-1.35) 
      T2 99.5 85.7 51037 161 1.32 (1.04-1.66) 1.37 (1.08-1.74) 
      T3 142.6 123.8 51499 123 1 (ref) 1 (ref)
      Ptrend 0.28 0.88
      Continuous (50g/day intake increment) 1.04 (0.94-1.13) 0.97 (0.88-1.08) 
Fresh red meat (g/day)c 
      Non consumers 0 0 21571 42 0.75 (0.53-1.06) 0.83 (0.58-1.21) 
      T1 47.3 24.9 48721 121 0.92 (0.72-1.18) 0.99 (0.77-1.28) 
      T2 85.5 71.2 50679 138 1.02 (0.80-1.29) 1.05 (0.83-1.34) 
      T3 127.6 106.9 20904 136 1 (ref) 1 (ref)
      Ptrend 0.12 0.48
      Continuous (50g/day intake increment) 1.04 (0.95-1.15) 1.00 (0.90-1.11) 
Beef (g/day)c 
      Non consumers 0 0 37701 87 0.89 (0.68-1.18) 0.96 (0.72-1.30) 
      T1 8.6 6.3 44979 106 0.89 (0.68-1.15) 0.92 (0.71-1.20) 
      T2 24.1 19.3 45099 125 1.05 (0.81-1.34) 1.07 (0.83-1.37) 
      T3 48.9 43.2 44096 119 1 (ref) 1 (ref)
      Ptrend 0.24 0.58
      Continuous (50g/day intake increment) 1.02 (0.84-1.25) 0.96 (0.78-1.18) 
Pork (g/day)c 
      Non consumers 0 0 30814 62 0.82 (0.61-1.12) 0.88 (0.62-1.25) 
      T1 11.1 6.1 46148 109 0.93 (0.72-1.21) 1.01 (0.77-1.32) 
      T2 35.0 28.5 47628 148 1.24 (0.98-1.58) 1.32 (1.03-1.68) 
      T3 66.9 58.3 47285 118 1 (ref) 1 (ref)
      Ptrend 0.10 0.45
      Continuous (50g/day intake increment) 1.10 (0.94-1.28) 1.02 (0.86-1.21) 
Minced meat (g/day)c 
      Non consumers 0 0 40870 81 0.82 (0.61-1.10) 0.85 (0.62-1.16) 
      T1 6.8 5.5 43368 112 1.04 (0.80-1.36) 1.07 (0.82-1.41) 
      T2 16.7 14.0 44180 137 1.26 (0.98-1.62) 1.27 (0.99-1.64) 
      T3 34.0 29.0 43456 107 1 (ref) 1 (ref)
      Ptrend 0.10 0.32
      Continuous (50g/day intake increment) 1.06 (0.80-1.40) 0.97 (0.72-1.32) 
Liver (g/day)c 
      Non consumers 0 0 120706 300 0.92 (0.75-1.13) 0.93 (0.75-1.14) 
      Consumers 4.1 3.3 51169 137 1 (ref) 1 (ref)
      Continuous (25g/day intake increment) 1.08 (0.60-1.94) 1.10 (0.60-2.01) 
Chickenc,d 
      Non consumers 0 0 56451 137 0.91 (0.70-1.17) 0.96 (0.74-1.25) 
      C1 5.3 5.3 39581 97 0.91 (0.69-1.20) 0.94 (0.72-1.24) 
      C2 13.2 13.2 36198 95 0.97 (0.74-1.28) 0.97 (0.74-1.28) 
      C3 22.8 22.8 39645 108 1 (ref) 1 (ref)
      Ptrend 0.40 0.73
      Continuous (50g/day intake increment) 0.96 (0.69-1.33) 0.89 (0.64-1.25) 
Processed meat (g/day) 
      Non consumers 0 0 43461 98 0.80 (0.61-1.04) 0.80 (0.59-1.09) 
      T1 3.9 2.3 42977 100 0.79 (0.60-1.03) 1.78 (0.59-1.03) 
      T2 13.2 8.4 43249 117 0.93 (0.72-1.19) 0.91 (0.70-1.18) 
      T3 30.8 20.3 42188 122 1 (ref) 1 (ref)
      Ptrend 0.05 0.09
      Continuous (25g/day intake increment) 1.13 (0.97-1.31) 1.12 (0.95-1.33) 
 
Continues on the next page 
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 Median intake 
PY 
Colorectal cancer
Food item Men Women Cases HR (95%CI)a HR (95%CI)b 
Fishe 
      Non consumers 0 0 53879 113 0.83 (0.62-1.10) 0.86 (0.65-1.15) 
      C1 4.6 4.6 37645 112 1.17 (0.88-1.55) 1.19 (0.90-1.58) 
      C2 14.8 14.8 48056 128 1.04 (0.78-1.36) 1.03 (0.78-1.36) 
      C3 32.8 30.2 32295 84 1 (ref) 1 (ref)
      Ptrend 0.21 0.39
      Continuous (25g/day intake increment) 1.06 (0.97-1.15) 0.95 (0.82-1.09) 
PY (person years at risk). 
a Adjusted for age (y) and sex 
b Adjusted for age (y),  sex, total energy intake (kcal), cigarette smoking (never, ever, current), alcohol consumption 
(g/day), BMI (kg/m2), non-occupational physical activity (<30,30-60,60-90, > 90 min/d), and level of education 
(lower vocational, second and medium vocational,  university and higher vocational). If applicable, additionally 
adjusted for complementary meat groups holding total meat constant.  
c Intake based on raw meat weight. 
d Categories of intake 0, >0-<6.6, ≥6.6-<22.8, and ≥ 22.8 g/day. 
e Categories of intake:  0,  >0-<10, ≥10-<20 ,and  ≥20 g/day. 
DISCUSSION 
Results from this prospective cohort study showed a modest, non-significantly decreased 
risk of colorectal cancer for vegetarians, pescetarians, and 1 day/week meat eaters 
compared to 6-7 day/week meat consumers.  
Although the risk of colorectal and especially rectal cancer was lower in vegetarians than in 
non-vegetarians, this was not statistically significant. Nonetheless, our null findings are in 
line with a report from the Oxford Vegetarian Study [1], and a pooled analysis combining 
data from two prospective studies in the United Kingdom [3]. Colorectal cancer mortality 
also did not differ between vegetarians and non-vegetarians in a collaborative analysis of 
five protective cohort studies [15]. In contrast, the colorectal cancer rate was higher among 
vegetarians than non-vegetarians in the EPIC-Oxford study, but this cohort included a 
relative health conscious population of non-vegetarians [4]. The Adventist Health Study-I 
reported that vegetarians had a significantly lower risk of colorectal cancer than non-
vegetarians [2] (average meat consumption of ~3.5 servings/week), and the absence of 
tobacco and limited use of alcohol among this population reduces the likelihood of 
confounding by these factors. However, in line with other studies, we previously reported 
that vegetarianism is not merely characterized by a diet void of all flesh foods, but rather 
extends into a complete healthy diet and lifestyle [8].  
We examined to what extent the associations between the diet-groups could be explained 
by other factors than the frequency of meat consumption. After adjusting the analyses for 
major risk factors of colorectal cancer such as total cigarette smoking, alcohol 
consumption, BMI, and physical activity, our results attenuated slightly suggesting that the 
lower risk observed in vegetarians and low meat consumers was only partly due to these 
lifestyle differences between meat consumption groups.  
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While it has been proposed that the lower disease risk in vegetarians may be explained by 
selective factors related to who chooses to become and remain a vegetarian [16], 
adjustment for e.g. level of education did not change the estimates notably either. In 
contrast, fiber accounted for the greatest change in HRs when comparing vegetarians and 
low meat consumers to 6-7 day/week meat consumers.  In this respect, the WCRF expert 
panel concluded that there is convincing evidence that dietary fiber protects against 
colorectal cancer [17]. All other dietary factors that characterize a vegetarian and low meat 
diet had negligible individual effects, but when combined they attenuated the risk 
estimates, by at least 17 percent, approaching the null. This suggests that the effect of a 
single food group or lifestyle variable may be too small to detect, but the cumulative cancer 
preventive effects of multiple connected dietary and non-dietary factors may be sufficiently 
large to be demonstrable [18].  
No study previously examined the effect of very low meat diets on colorectal cancer 
incidence. Our findings suggest that especially very low meat consumers may have a 
reduced risk of colorectal cancer compared to frequent meat consumers which was mainly 
observed for the colon cancer subgroup. Recent analyses from the Adventists Health Study-
II suggest that, after an average of 4 years follow-up, compared to non-vegetarians the 
lowest risk of all gastro-intestinal cancers combined was observed among semi-vegetarians 
who ate red meat, poultry or fish once/month to once/week  (age-adjusted HR=0.64; 
95%CI:0.42-0.99)[5]. Whether a vegetarian diet is nutritionally adequate remains equivocal 
[19], and is outside the scope of this paper. It is however, interesting to observe that a strict 
vegetarian diet does not seem to have an additional colorectal cancer preventive effect 
over 1 day/week meat consumption in our population. Nonetheless, future studies with 
larger numbers of no and low meat consumers should replicate these findings. 
Individuals adhering to a no or low meat diet often replace the meat in their diet with other 
(protein rich) food groups. Our observation that these individuals may have a lower 
colorectal cancer risk than high meat consumers is supported by our findings that 
substituting protein from meat with an equal percentage of energy from dairy protein 
significantly reduced the risk of colorectal cancer. In fact, dairy products have been 
hypothesized to protect against colorectal cancer risk due to their high calcium content [17, 
20].  
The operationalization of vegetarianism differs between studies, and the usefulness and 
reliability of self-reported vegetarianism in etiological studies remains unclear. For this 
purpose, we examined the association between vegetarianism and colorectal cancer risk 
using both self-definition and FFQ confirmed vegetarian status. Although both methods of 
classification yielded statistically non-significant protective effects, the association was 
considerable stronger for confirmed vegetarians than for non-vegetarians, suggesting that 
some attenuation occurs when merely relying on self-definition for classification purposes. 
Based on our sub-site analyses, all the risk estimates appeared to be more strongly 
associated with rectal tumors, except for low meat consumption, which mainly decreased 
the risk of colon, but not rectal, cancer. Previous studies suggest that meat, subtypes of 
meat, and  meat-related carcinogens may act differently at various locations in the 
colorectum [7, 21], possibly as a result of e.g. sub-site differences in bacterial composition 
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and bacterial metabolic capacity, enzyme activity, and transit time [6, 22-24]. Although the 
number of especially rectal cancer cases among the vegetarians and low meat consumers in 
our population was low, our observation that distal colonic tumors exerted a similar 
pattern of association, strengthens our findings.  
As a result of our sampling strategy, our population has a large contrast in meat intake 
which should aid the further specification of associations between subtypes of meat and 
colorectal cancer risk. We found no clear association between total fresh and fresh red 
meat intake and colorectal cancer risk. Processed meat was only associated with rectal 
cancer; again, comparable findings were observed for distal colon, but not for proximal 
colon cancer risk. Although processed meat is widely recognized risk factor for colorectal 
cancer [17, 25], this endpoint heterogeneity was not observed in a recent meta-analysis 
[25]. Processed meat is known to be the major source of human exposure to nitrite, and 
contains all the necessary precursors for N- nitroso compound (NOC) formation [26]; both 
have been specifically associated with increase rectal cancer risk only [21, 27, 28]. 
The NLCS attempted to enlarge the exposure contrast in the cohort by extra recruitment of 
vegetarian subjects [10], vegetarian dietary patterns were taken into consideration when 
designing the FFQ, and vegetarian status was taken into account for nutrient calculation of 
composite recipes. The number of vegetarians and low meat consumers in the NLCS 
subcohort was, however, not large enough for analyzing the effect of no and low meat 
dietary habits on cancer risk using the case-cohort approach that is traditionally used in 
NLCS-analyses. For this reason, we created the NLCS-MIC cohort – an analytical cohort 
over-represented with persons at the lower end of the meat consumption spectrum.  
Our analyses have been performed using baseline FFQ data resulting in an inability to 
assess and account for changes in dietary intakes over time. However, the validity of the 
FFQ has been tested and shown to be representative for dietary habits over a period of at 
least 5 years [29]. Although we have information on time that people had adhered to their 
special dietary regimen at the start of follow-up (1986), stratified analyses (≤10 years 
versus >10 years) yielded similar findings, possibly due to small numbers. The prospective 
design eliminates the potential for recall bias, and the nearly complete follow-up makes 
selection bias unlikely. Detailed information on diet and potential risk factors of colorectal 
cancer enabled us to control for most known risk factors, although misclassification of 
exposure may have occurred.  
In summary, vegetarians, pescetarians, and especially 1 day/week meat eaters showed a 
modest, non-significantly decreased risk of colorectal cancer compared to 6-7 day/week 
meat consumers, mainly due to differences in dietary patterns other than meat intake.  
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ABSTRACT 
Background: The few prospective studies that examined lung, female breast and prostate 
cancer risk in vegetarians have yielded mixed results, while none have studied the effects 
of low meat diets. In addition, little is known about the explanatory role of (non-)dietary 
factors associated with these diets.  
Methods: The Netherlands Cohort Study – Meat Investigation Cohort (NLCS-MIC) is an 
analytical cohort of 11082 individuals including 1040 self-reported vegetarians. At baseline 
(1986), subjects completed a questionnaire on dietary habits and other risk factors for 
cancer and were classified into vegetarians (n=691), pescetarians (n=389), 1 day/week- 
(n=1388), 2-5 day/week- (n=2965), and 6-7 day/week meat consumers (n=5649). After 20.3 
years of follow-up, 279 lung, 312 female breast, and 399 prostate cancer cases (including 
136 advanced) were available for analyses.  
Results: In age- and sex adjusted analyses, a statistically significant reduced risk of lung 
cancer for vegetarians and pescetarians was found when compared with 6-7 days/week 
meat consumers (HR: 0.44, 95%CI: 0.21-0.94, and HR: 0.28, 95%CI: 0.09-0.88 respectively). 
Further adjustment for confounding (especially smoking) attenuated these associations 
such that they were no longer significant (HR: 0.85 and 0.54, respectively). No associations 
were observed for female breast- and overall prostate cancer. After adjustment for 
confounders individuals consuming meat 1 day/week were at a 75% increased risk of 
advanced prostate cancer compared to 6-7 days/week meat consumers (95%CI 1.03-2.97).  
Conclusion: Vegetarians, pescetarians and 1 day/week meat consumers did not have a 
reduced risk of lung, female breast and overall prostate cancer compared to individuals 
consuming meat on a daily basis after taking confounders into account.  Our observation 
that ≤1day/week meat consumption was associated with increased risk of advanced 
prostate cancer warrants investigation in other studies. 
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INTRODUCTION 
Although vegetarian diets are primarily defined by the absence of meat and fish, they are 
also shown to be associated with high intakes of fruits and vegetables, and a favorable 
distribution of non-dietary factors [1, 2]. Consequently, vegetarian diets may reduce the 
risk of different types of cancers through multiple mechanisms depending on the etiology 
and preventability of the tumor [3, 4]. 
We previously reported a non-significantly reduced risk of vegetarian and low meat diets 
on colorectal, and especially rectal, cancer [5] and set out to study its effect on three other 
major cancers.  Although meat consumption has been hypothesized to be implicated in the 
etiology of lung, female breast and prostate cancer, data are not consistent across studies 
and meat subtypes [6-8]. However, based on the existing body of literature, vegetarians 
may be at a lower risk of developing lung cancer (due to lower smoking rates), and to 
female post-menopausal breast cancer (due to lower alcohol consumption, lower BMI and 
higher physical activity levels). While the role of diet in the etiology of prostate cancer 
remains poorly understood [4, 9], incidence levels of, especially localized, prostate cancers 
may be related to prostate specific antigen (PSA) screening utilization which was shown to 
differ between vegetarians and non-vegetarians [10]. Nonetheless, the few prospective 
cohort studies that intentionally included a large proportion of vegetarians, reported mixed 
and inconsistent results regarding lung, female breast and prostate cancer risk [11-15]. 
Although the above findings may partly reflect international differences in vegetarian diets, 
some of these inconsistencies may also be due to differences in population sampling 
strategies. Furthermore, it has been argued that advanced stage prostate cancer is 
different from non-advanced prostate cancer [16], but effects of vegetarian diets for these 
subtypes of prostate cancer have not been previously reported. In addition, studies with a 
large number of vegetarians and low meat eaters offer the opportunity to examine 
whether complete abstinence of meat might have an additional cancer preventive effect 
over low meat consumption, or vice versa.  
Within the “Netherlands Cohort Study-Meat Investigation Cohort” (NLCS-MIC), we 
investigated the association of vegetarianism and (low) meat consumption with the risk of 
lung, female breast, and prostate cancers, including prostate cancer subgroups by disease 
stage. We investigated the effect of time of adherence to the dietary regimen, the 
reliability of self-reported vegetarianism, and the contribution of individual dietary and 
lifestyle factors to the observed risk estimates.  
METHODS 
Study population and cancer follow-up 
The NLCS ‘Meat Investigation Cohort’ (NLCS-MIC) is an analytical cohort embedded in the 
ongoing prospective Netherlands Cohort Study (NLCS). The total NLCS study was initiated in 
September 1986 and includes 120852 men and women aged 55-69 years at baseline. All of 
the women were presumed to be postmenopausal. At the start of the study, participants 
completed a self-administered questionnaire on dietary habits, lifestyle characteristics, 
medical history, and other potential risk factors for cancer [17]. Because the NLCS 
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traditionally uses the case-cohort design for efficiency; questionnaire data were only 
available for a randomly selected subcohort and all cancer cases. Therefore, NLCS-MIC is 
specifically extracted from the total NLCS to study the health effects of vegetarian and low 
meat diets and consists of the random subcohort of 10000 subjects and all self-reported 
vegetarians (n=1040) and 1 day/week meat consumers from the total NLCS cohort. The 
latter were selected based on two questions on the first page of the questionnaire that was 
processed for all 120852 cohort members: “Do you have any special eating habits?”, and 
“How many days on average per week do you eat meat?” The 150 item food frequency 
questionnaire (FFQ) was used to categorize NLCS-MIC (n=11082) into five meat 
consumption categories: confirmed vegetarians (n=691) and pescetarians (n=389), 1 
day/week- (n=1388), 2-5 days/week- (n=2965), and 6-7 days/week meat consumers 
(n=5649). Full details of the study design have been described elsewhere [1]. The NLCS has 
been approved by the institutional review boards of the TNO Quality of Life Research 
Institute (Zeist, the Netherlands) and Maastricht University (Maastricht, the Netherlands). 
Questionnaire 
The FFQ estimated the average frequency and amount of foods and beverages consumed 
over 12 months preceding baseline. The questionnaire also assessed the time since the 
start of any special eating habits and weekly frequency of meat consumption (for 0-1 
day/week meat consumers), in years until baseline (1986). In addition, the FFQ contained 
14 items on the consumption of meat with the hot meal (mainly fresh meat, including 
chicken), 5 items on the consumption of meat products used as sandwich fillings, and 3 
items on fish consumption (with the hot meal, for lunch, as a snack in between meals).  
Statistical analyses 
We estimated the association between meat consumption group (confirmed vegetarian, 
pescetarian, 1 day/week-, 2-5 days/week-, and 6-7 days/week meat consumers (reference 
group)) and the risk of lung, female breast, and prostate cancer. In addition, the association 
of cancer incidence with self-reported vegetarian status (self-reported versus 
complementary group of non-self-reported-vegetarians) and confirmed vegetarian status 
(confirmed vegetarian versus complementary group of non-vegetarians) was examined. In 
case a statistically significant association was observed, we assessed to what extent this 
association could be explained by other dietary and lifestyle variables associated with a 
vegetarian or low meat (i.e. meat for 1 day/week) diet. Therefore, we calculated the 
percentage change in risk estimate, firstly adjusting for age and sex, then further adjusting 
for energy and each food group, or lifestyle factor in turn. Furthermore, the association 
with meat consumption group and confirmed vegetarian status was stratified by duration 
of adherence to the specific diet (≤10 years, >10 years). 
The following food groups and foods were also selected for analyses (in g/day): fresh meat 
(beef, pork, minced meat, chicken, liver), processed meat, fish, fresh red meat (fresh meat 
without chicken) and beef, pork, minced meat, chicken, and liver as separate types. For the 
individual meat types, subjects were classified into non-consumers, and tertiles of 
consumers (highest tertile as reference group), and as continuous variables (per 25 or 50 
gram increase). For some meat types, categories were used instead of tertiles (liver: a non-
user and a user group (>0g/day); chicken: 0, 0-<6.6, ≥6.6-<22.8 and ≥ 22.8 g/day; fish 0, 0-
<10, ≥10-<20 and ≥ 20 g/day). 
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For all the above described contrasts, age and sex adjusted and multi-variable adjusted 
hazard rate ratios (HRs) and their corresponding 95% confidence intervals (95% CI) were 
estimated using Cox proportional hazards models. The proportional hazards assumption 
was tested using the scaled Schoenfeld residuals. If there was an indication for violation of 
the assumption for a variable, we further investigated this by adding a time-varying 
covariate for that variable to the model. Sensitivity analyses excluding the first 2 years of 
follow-up were performed. The covariates included in the multivariable analyses were 
either a priori selected risk factors of lung, female breast and prostate cancer, or variables 
that changed the risk estimates for meat consumption group, vegetarian status or total 
fresh meat intake by 10% or more. For all investigated cancers, this resulted in a final 
model including age (years), total energy intake (kcal/day), cigarette smoking 
(never/ever/current), alcohol consumption (g/day), BMI (kg/m2), non-occupational physical 
activity (≤30/>30-≤60/>60-≤90/>90 minutes/day), and level of education (lower vocational, 
secondary-/medium-vocational, university and higher vocational). Lung cancer analyses 
were additionally adjusted for sex, frequency of smoking (n/day), and duration of smoking 
(years). Associations for female breast cancer were additionally adjusted for height (cm), 
age at menarche (years), age at first child (years), number of children, age at menopause 
(<50 years/≥ 50 years/unknown), oral contraceptive use (never/ever), hormone 
replacement therapy (yes/no/don’t know), and first-grade family history of breast cancer 
(yes/no). Prostate cancer analyses were also adjusted for first-grade family history of 
prostate cancer. The independent contribution of the individual meat categories was 
examined by constructing addition models that summed to total meat. 
To enable comparison, the age (and sex)-adjusted analyses were restricted to subjects 
included in multivariable-adjusted models.  After 20.3 years of follow-up and exclusion of 
prevalent cancer cases at baseline, 279 lung cancer cases (ICD-O C34), 312 female breast 
cancer cases (C50), and 399 prostate cancer cases (C61) (including 136 advanced (TNM 
stage III/IV: T3+, N+, or M1 at diagnosis)) remained eligible for analyses. Linear trends were 
evaluated with the Wald test by entering the categorical exposure variables as a continuous 
term in the Cox regression model. 
All tests were two-tailed and differences were regarded as statistically significant at P<0.05. 
All analyses were performed using STATA Statistical Software (Intercooled STATA, version 
12; Stata-Corp LP, College Station, TX). 
RESULTS 
The distribution of demographic and (non-) dietary characteristics according to meat 
consumption group has already been extensively described [1]. Baseline characteristics for 
cases and non-cases for the cancers under study are described in Table 1.  
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Table 1: Baseline characteristics (means or percent) and dietary intakes of exposures of interest of lung, female breast, 
and lung cancer cases and non-cases in the NLCS-MIC, 1986-2006.  
Lung Cancer Female Breast Cancer Prostate Cancer
Characteristics Non cases Cases Non cases Cases Non cases 
All Prostate  
cancer cases 
Advanced 
prostate  
cancer cases 
N 9494 279 4906 312 4465 399 136 
Meat consumption 
group (%) 
   Vegetarian  6% 3%* 8% 6% 4% 5% 5% 
   Pescetarian  4% 1% 4% 5% 3% 4% 5% 
   1 day/wk meat  13% 10% 15% 17% 9% 10% 14% 
   2-5 days/wk meat 27% 26% 27% 8% 26% 26% 23% 
   6-7 days/wk meat 51% 61% 45% 45% 59% 55% 53% 
   
Sex (% men) 45% 85%* 0% 0% 100% 100% 100% 
Age (y) 61.3 ± 4.2 62.3 ± 4.2 61.4 ± 4.2 61.2 ± 4.3 61.2 ± 4.2 62.1 ± 4.1* 62.2 ± 4.0* 
Current smokers (%) 24% 66%* 18% 17% 34% 28% 23%* 
BMI (mean) 24.7 ± 3.2 24.6 ± 2.8 24.6 ± 3.6 25.1 ± 3.5* 24.8 ± 2.7 24.7 ± 2.2 24.9 ± 2.2 
Physical activity (non-occupational) (%) 
    <30 min/day 21% 23% 23% 25% 18% 18% 13% 
    30-60 min/day 30% 32% 31% 32% 30% 25% 28% 
    60-90 min/day 23% 16% 24% 22% 20% 26% 26% 
    >90 min/day 26% 28% 22% 20% 31% 31% 34% 
Level of education (%) 
    Low 46% 53%* 50% 42%* 42% 39%* 38% 
    Medium 37% 35% 38% 47% 36% 31% 34% 
    High 17% 12% 12% 11% 22% 29% 29% 
   
Supplement use 
 (% users) 35% 24%* 42% 43% 26% 26% 21% 
   
Energy (kcal) 1880 ± 518 2081 ± 492* 1668 ± 412 1692 ± 406 2134 ± 512 2179 ± 546 2195 ± 474 
Fiber (g) 28.2 ± 7.6 27.3 ± 7.3* 26.6 ± 6.6 26.8 ± 7.3 30.0 ± 8.1 29.6 ± 7.9 29.6 ± 8.0 
Alcohol (g) 9.1 ± 13.7 15.1 ± 16.4* 5.3 ± 9.3 6.8 ± 12.0* 13.9 ± 16.3 14.7 ± 17.4 14.6 ± 15.1 
Total fresh meat (g) b 80.4 ± 52.4 96.3 ± 55.4 71.4 ± 50.6 72.4 ± 50.8 92.1 ± 52.7 87.2 ± 52.2 81.2 ± 53.6* 
    Fresh red meat (g) c 68.9 ± 48.8 86.2 ± 52.9* 61.3 ± 46.6 62.2 ± 46.3 81.3 ± 49.6 76.8 ± 48.9 72.3 ± 49.5* 
    Beef (g) 21.3 ± 23.5 26.5 ± 29.1* 18.8 ± 22.3 19.4 ± 20.7 24.7 ± 25.1 23.3 ± 24.0 23.3 ± 25.4 
    Pork (g) 30.1 ± 29.6 37.5 ± 31.7* 26.6 ± 28.1 26.2 ± 27.5 35.1 ± 31.0 33.6 ± 29.6 31.7 ± 28.4 
    Minced meat (g) 14.8 ± 16.1 17.7 ± 20.6* 12.8 ± 14.6 13.2 ± 14.6 17.2 ± 17.8 16.1 ± 17.8 14.7 ± 14.5 
    Liver (g) 1.6 ± 4.0 2.2 ± 4.9 1.3 ± 3.5 1.6 ± 4.1 1.9 ± 4.4 1.7 ± 4.6 0.95 ± 2.32* 
    Chicken (g) 11.4 ± 14.9 11.1 ± 14.1 10.8 ± 14.7 10.7 ± 17.5 11.9 ± 14.7 11.4 ± 13.4 9.4 ± 12.9* 
Processed meat (g) 10.8 ± 14.0 15.0 ± 18.8* 8.2 ± 11.2 7.2 ± 9.1 14.5 ± 16.8 12.5 ± 15.3 11.0 ± 13.3* 
Fish (g) 13.0 ± 17.9 14.6 ± 22.1 11.8 ± 16.4 11.5 ± 16.2 14.4 ± 19.4 15.1 ± 18.7 14.1 ± 19.4 
   
Vegetables (g) 200 ± 89 190 ± 85 201 ± 88 211 ± 112 197 ± 88 200 ± 88 200 ± 79 
Fruits (g) 186 ± 128 138 ± 113* 203 ± 129 213 ± 129 162 ± 124 164 ± 118 157 ± 96 
Pulses (g) 10.1 ± 16.8 9.9 ± 14.9 8.8 ± 15.1 9.4 ± 14.1 11.4 ± 18.7 11.4 ± 15.9 12.1 ± 15.7 
Soya products (g) 3.1 ± 18.0 0.99 ± 6.1* 3.2 ± 21.0 3.6 ± 17.7 2.8 ± 13.5 2.7 ± 11.8 4.0 ± 14.8 
Milk (g) 313 ± 207 309 ± 219 313 ± 200 307 ± 193 311 ± 215 311 ± 222 317 ± 194 
Cheese (g) 26.0 ± 22.6 23.0 ± 21.1* 25.5 ± 21.0 26.8 ± 21.3 26.1 ± 24.1 27.4 ± 24.4 26.4 ± 21.7 
Eggs (g) 15.5 ± 11.6 16.9 ± 12.6 14.5 ± 10.7 15.2 ± 11.2 16.8 ± 12.5 16.9 ± 13.0 16.0 ± 14.8 
All of the women were presumed to be postmenopausal
a mean ± SD, all such values 
b Intake based on raw meat weight 
c Includes beef, pork, minced meat, liver and other meat 
* Statistically significant different from non-cases (using the χ2 test for categorical variables and ANOVA for continuous 
variables) 
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The imbalanced sex distribution between lung cancer cases and non-cases, likely resulted in 
between-group differences in baseline variables (e.g. lung cancer cases were more often 
current smokers, had higher intakes of total kcal, alcohol, and meat, but consumed lower 
amounts of fiber, fruits, soy products and cheese compared to non-cases). This is also 
reflected in a smaller percentage of vegetarians and pescetarians among lung cancer cases 
compared to non-cases. No large differences between female breast cancer cases and non-
cases were observed. Advanced stage prostate cancer cases were older, and consumed 
smaller amounts of meat compared to non-cases.  
After adjustment for age and sex, a statistically significant reduced risk of lung cancer for 
vegetarians and pescetarians was found when compared to 6-7 days/week meat 
consumers (HR:0.44, 95%CI:0.21-0.94, and HR:0.28, 95%CI:0.09-0.88 respectively) (Table 
2A). Further adjustment for confounding attenuated these associations such that they were 
no longer significant (HR:0.84, 95%CI:0.39-1.84, and HR:0.54, 95%CI:0.17-1.70 respectively). 
A similar pattern was observed when comparing non-meat consumers to meat consumers, 
and vegetarians (confirmed or self-reported) to their complementary group of non-
vegetarians.  
There was no evidence of an interaction by sex for any of the comparisons made. However, 
the number of lung cancer cases among the vegetarians and pescetarians was small (n= 7 
and n=3, respectively). No statistically significant associations for female breast cancer 
were observed in the age and multivariable adjusted models (Table 2A). Although no 
associations were observed between the risk of all prostate cancers and meat consumption 
group, a statistically significant trend across meat consumption groups was observed for 
advanced prostate cancer risk after adjustment for confounders (P=0.05) (Table 2B). 
Individuals consuming meat ≤ 1 per week had a 67% higher risk of advanced prostate 
cancer compared to those consuming meat for two or more days per week (95%CI: 1.10-
2.54).  In a lag analysis excluding the first 2 years of follow-up, the findings for meat 
consumption group and vegetarian status did not change appreciably (data not shown). 
To further unravel how confounding by diet and lifestyle factors affected the observations 
for lung and advanced prostate cancer we calculated the percent change in HR across the 
meat consumption groups, firstly adjusted for age (and sex), then further adjusted for 
energy and each food group, or lifestyle factor in turn (Table 3). Although statistical power 
was limited, smoking status and -duration, but not smoking frequency, contributed most to 
the observed inverse risk of lung cancer of vegetarians, pescetarians, and 1 day-week meat 
eaters when compared to 6-7 day-week meat eaters. Nonetheless, a model including all 
dietary variables combined was also able to explain most of the observed risk reduction for 
vegetarians, although this may largely result from residual confounding by smoking. In 
contrast, risk estimates for prostate cancer tended to further increase away from the null 
after adjustment for dietary and lifestyle factors.  
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After multivariable adjustment, 1 day/week meat consumers adhering to their diet for less 
than 10 years were at an increased risk of female breast, lung and overall prostate cancer; 
although this only reach statistical significance for breast cancer. In contrast, long term 
adherers (> 10 years) were at a non-statistically significant reduced risk of all three cancers 
under study compared to 6-7 days/week meat consumers (Supplemental Table 1). The 
number of advanced prostate cancers was too small to present these stratified results.  
Low consumption of total fresh meat, fresh red meat, beef, pork and minced meat was 
associated with a significantly reduced lung cancer risk in the age and sex adjusted models 
(Table 4A). However, these attenuated and were no longer statistically significant after 
adjustment for confounders. No association between breast cancer (Table 4B) and overall 
prostate cancer Table 4C) and any of the meat items was observed. Individuals reporting 
not to consume chicken, and processed meat were at an increased risk of advanced 
prostate cancer compared to those in the highest category of consumption after 
adjustment for confounders (HR:1.88, 95%CI:1.14-3.12; HR:1.77  95%CI:1.00-3.14, 
respectively). 
Table 4A: Hazard rate ratios (HR) and 95% confidence intervals (CI) for lung cancer according to sex-specific 
quintiles and categories of intake of fresh meat, types of fresh meat, and processed meat.  
Median  intake Lung Cancer
Food item Men  Women PY Cases HR (95%CI)a HR (95%CI)b 
Total fresh meat (g/day)c 
      Non consumers 0.0 0.0 19623 11 0.37 (0.20-0.69) 0.66 (0.34-1.26) 
      T1 56.8 30.4 47777 89 0.98 (0.73-1.32) 1.18 (0.87-1.61) 
      T2 99.7 85.8 49336 87 0.96 (0.71-1.28) 0.99 (0.74-1.34) 
      T3 142.3 123.9 49863 92 1 (ref) 1 (ref)
      Ptrend 0.04 0.90
      Continuous (50g/day intake increment) 1.17 (1.05-1.31) 1.03 (0.91-1.17) 
Fresh red meat (g/day)c 
      Non consumers 0.0 0.0 21075 11 0.35 (0.19-0.65) 0.65 (0.34-1.24) 
      T1 47.1 25.0 47273 84 0.94 (0.70-1.26) 1.19 (0.87-1.62) 
      T2 85.5 71.1 48965 93 1.03 (0.77-1.37) 1.13 (0.84-1.52) 
      T3 127.5 107.1 49285 91 1 (ref) 1 (ref)
      Ptrend 0.01 0.94
      Continuous (50g/day intake increment) 1.21 (1.08-1.36) 1.05 (0.92-1.19) 
Beef (g/day)d 
      Non consumers 0.0 0.0 36658 33 0.55 (0.37-0.88) 0.66 (0.44-1.01) 
      T1 8.6 6.3 43572 83 0.97 (0.72-1.32) 1.03 (0.76-1.40) 
      T2 24.2 19.3 43617 79 0.95 (0.70-1.29) 1.02 (0.75-1.39) 
      T3 48.8 43.0 42751 84 1 (ref) 1 (ref)
      Ptrend 0.02 0.17
      Continuous (50g/day intake increment) 1.27 (1.02-1.59) 1.13 (0.90-1.42) 
Pork (g/day)c 
      Non consumers 0.0 0.0 30036 22 0.48 (0.30-0.77) 0.77 (0.46-1.28) 
      T1 11.1 6.1 44916 79 0.92 (0.68-1.26) 1.14 (0.83-1.57) 
      T2 35.0 28.6 46276 94 1.10 (0.82-1.48) 1.25 (0.92-1.68) 
      T3 67.0 58.1 45370 84 1 (ref) 1 (ref)
      Ptrend 0.007 0.82
      Continuous (50g/day intake increment) 1.25 (1.05-1.50) 1.01 (0.83-1.23) 
Continues on the next page 
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Median  intake Lung Cancer
Food item Men  Women PY Cases HR (95%CI)a HR (95%CI)b 
Minced meat (g/day)c 
      Non consumers 0.0 0.0 39674 43 0.69 (0.48-1.00) 0.95 (0.64-1.42) 
      T1 6.7 5.5 41869 79 1.00 (0.73-1.37) 1.03 (0.75-1.42) 
      T2 16.7 14.0 42903 78 0.97 (0.71-1.32) 0.99 (0.72-1.35) 
      T3 34.0 29.0 42152 79 1 (ref) 1 (ref)
      Ptrend 0.11 0.95
      Continuous (50g/day intake increment) 1.24 (0.91-1.70) 1.00 (0.72-1.39) 
Liver (g/day)c 
      Non consumers 0.0 0.0 116814 183 0.89 (0.69-1.13) 1.04 (0.81-1.34) 
      Consumers 4.1 3.3 49784 96 1 (ref) 1 (ref)
      Continuous (25g/day intake increment) 1.76 (0.98-3.15) 1.28 (0.67-2.45) 
Chickenc,d 
      Non consumers 0.0 0.0 54414 93 1.12 (0.82-1.54) 1.13 (0.82-1.56) 
      C1 5.3 5.3 38513 68 1.13 (0.80-1.58) 1.01 (0.72-1.43) 
      C2 13.2 13.2 35299 53 0.91 (0.63-1.30) 0.86 (0.60-1.24) 
      C3 22.8 22.8 38372 65 1 (ref) 1 (ref)
      Ptrend 0.95 0.30
      Continuous (50g/day intake increment) 0.86 (0.56-1.31) 0.90 (0.58-1.40) 
Processed meat (g/day) 
      Non consumers 0.0 0.0 42240 46 0.72 (0.50-1.04) 1.12 (0.75-1.67) 
      T1 3.9 2.3 41689 77 0.96 (0.70-1.32) 1.14 (0.82-1.60) 
      T2 13.2 8.2 42071 80 0.99 (0.72-1.35) 1.13 (0.82-1.56) 
      T3 30.7 20.3 40598 76 1 (ref) 1 (ref)
      Ptrend 0.11 0.51
      Continuous (25g/day intake increment) 1.19 (1.01-1.40) 1.00 (0.83-1.21) 
Fishe 
      Non consumers 0.0 0.0 52234 77 0.93 (0.66-1.30) 1.08 (0.77-1.52) 
      C1 4.6 4.6 36743 62 0.97 (0.68-1.39) 1.12 (0.78-1.59) 
      C2 14.8 14.8 46395 80 0.97 (0.69-1.35) 1.13 (0.81-1.58) 
      C3 32.8 29.9 31226 60 1 (ref) 1 (ref)
      Ptrend 0.67 0.74
      Continuous (25g/day intake increment) 1.05 (0.91-1.21) 0.99 (0.85-1.15) 
PY (person years at risk). 
a  Adjusted for age (y), and sex 
b Adjusted for age (y),  total energy intake (kcal), cigarette smoking (never, ever, current), frequency of smoking 
(n/day), duration of smoking (y), alcohol consumption (g/day), BMI (kg/m2), non-occupational physical activity 
(<30,30-60,60-90, > 90 min/d), and level  of education (lower vocational,  second and medium vocational, university 
and higher vocational). 
c Intake based on raw meat weight. 
d Categories of intake 0, >0-<6.6, ≥6.6-<22.8, and ≥ 22.8 g/day. 
e Categories of intake:  0,  >0-<10, ≥10-<20,and  ≥20 g/day. 
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Table 4B: Hazard rate ratios (HR) and 95% confidence intervals (CI) for female breast cancer according to quintiles 
and categories of intake of fresh meat, types of fresh meat, and processed meat.  
Breast Cancer
Food item  Median intake PY Cases HR (95%CI)a HR (95%CI)b 
Total fresh meat (g/day)c 
      Non consumers 0.0 12902 36 0.82 (0.55-1.20) 0.81 (0.53-1.23) 
      T1 30.0 25069 94 1.10 (0.83-1.47) 1.13 (0.83-1.53) 
      T2 85.7 26282 88 0.98 (0.73-1.32) 0.99 (0.74-1.34) 
      T3 123.8 26373 90 1 (ref) 1 (ref) 
      Ptrend 0.69 0.76
      Continuous (50g/day intake increment) 1.02 (0.91-1.14) 
Fresh red meat (g/day)c 
      Non consumers 0.0 13949 39 0.83 (0.57-1.21) 0.90 (0.60-1.35) 
      T1 25.0 24719 89 1.08 (0.80-1.44) 1.16 (0.86-1.58) 
      T2 71.2 26007 93 1.07 (0.80-1.43) 1.10 (0.82-1.48) 
      T3 106.8 25952 87 1 (ref) 1 (ref) 
      Ptrend 0.73 0.97
      Continuous (50g/day intake increment) 1.02 (0.91-1.15) 
Beef (g/day)c 
      Non consumers 0.0 2927 71 0.85 (0.62-1.17) 0.82 (0.58-1.17) 
      T1 6.3 22633 66 0.80 (0.58-1.11) 0.84 (0.60-1.17) 
      T2 19.3 23097 91 1.08 (0.80-1.46) 1.12 (0.82-1.51) 
      T3 43.3 21970 80 1 (ref) 1 (ref) 
      Ptrend 0.12 0.15
      Continuous (50g/day intake increment) 1.07 (0.84-1.36) 
Pork (g/day)c 
      Non consumers 0.0 19649 58 0.91 (0.65-1.28) 0.88 (0.59-1.33) 
      T1 6.1 22973 84 1.13 (0.83-1.55) 1.12 (0.81-1.56) 
      T2 28.4 24118 89 1.14 (0.84-1.55) 1.16 (0.85-1.58) 
      T3 58.3 23887 77 1 (ref) 1 (ref) 
      Ptrend 0.69 0.77
      Continuous (50g/day intake increment) 0.98 (0.80-1.20) 
Minced meat (g/day)c 
      Non consumers 0.0 24939 73 0.90 (0.65-1.24) 0.85 (0.59-1.24) 
      T1 5.5 21824 84 1.18 (0.86-1.62) 1.18 (0.85-1.64) 
      T2 14.0 22107 80 1.11 (0.81-1.53) 1.12 (0.81-1.54) 
      T3 29.0 21757 71 1 (ref) 1 (ref) 
      Ptrend 0.59 0.59
      Continuous (50g/day intake increment) 1.07 (0.73-1.55) 
Liver (g/day)c 
      Non consumers 0.0 65971 214 0.85 (0.66-1.08) 0.87 (0.68-1.13) 
      Consumers 3.3 24646 94 1 (ref) 1 (ref) 
      Continuous (25g/day intake increment) 1.55 (0.77-3.12) 
Chickenc,d 
      Non consumers 0.0 31484 111 1.08 (0.79-1.47) 1.17 (0.84-1.61) 
      C1 5.3 21204 77 1.12 (0.80-1.56) 1.16 (0.83-1.62) 
      C2 13.2 18584 57 0.94 (0.66-1.35) 0.93 (0.65-1.33) 
      C3 22.8 19355 63 1 (ref) 1 (ref) 
      Ptrend 0.44 0.20
      Continuous (50g/day intake increment) 1.00 (0.67-1.45) 
Processed meat (g/day) 
      Non consumers 0.0 27388 97 1.16 (0.84-1.59) 1.30 (0.91-1.87) 
      T1 2.3 21362 64 0.98 (0.69-1.39) 1.04 (0.73-1.49) 
      T2 8.2 20913 83 1.30 (0.94-1.80) 1.31 (0.94-1.82) 
      T3 20.3 20963 64 1 (ref) 1 (ref) 
      Ptrend 0.76 0.34
      Continuous (25g/day intake increment) 0.81 (0.61-1.08) 
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Breast Cancer
Food item  Median intake PY Cases HR (95%CI)a HR (95%CI)b 
Fishe 
      Non consumers 0.0 31075 100 1.01 (0.71-1.42) 1.11 (0.78-1.58) 
      C1 4.6 19647 71 1.15 (0.80-1.66) 1.21 (0.84-1.75) 
      C2 14.8 24848 88 1.11 (0.78-1.58) 1.18 (0.82-1.67) 
      C3 29.9 15047 48 1 (ref) 1 (ref)
      Ptrend 0.87 0.70
      Continuous (25g/day intake increment) 0.98 (0.82-1.16) 
All of the women were presumed to be postmenopausal; PY (Person years at risk)
a  Adjusted for age (y)  
b  Adjusted for age (y),  total energy intake (kcal), cigarette smoking (never, ever, current), alcohol consumption 
(g/day), BMI (kg/m2), non-occupational physical activity (<30,30-60,60-90, > 90 min/d),  level of education (lower 
vocational,  second and medium vocational, university and higher vocational), family history of breast cancer 
(yes/no), age menarche (y), age menopause (<50, ≥50, unknown), age first child (y), hormone replacement therapy 
(yes/no), use of oral contraceptives (yes/no), and number of children. 
c Intake based on raw meat weight. 
d Categories of intake 0, >0-<6.6, ≥6.6-<22.8, and ≥ 22.8 g/day. 
e Categories of intake:  0,  >0-<10, ≥10-<20,and  ≥20 g/day. 
DISCUSSION 
Results from this prospective cohort study showed that, in age- and sex- adjusted models, 
vegetarians and pescetarians were at a reduced risk of lung cancer compared to individuals 
consuming meat on a daily basis. This effect disappeared after taking confounders, 
especially smoking, into account. We did not observe an association between meat 
consumption group and the risk of female breast and overall prostate cancer, whereas 
individuals consuming meat ≤1 for day/week were at an increased risk of advanced 
prostate cancer compared to 6-7 days/week meat consumers. 
Although non-meat consumers (vegetarians and pescetarians) were at a >50% lower risk 
for lung cancer, this was largely the result of their lower prevalence of smoking. 
Comparable null findings after multivariable adjustment were previously observed [11-13]. 
Fruits and vegetables have also previously been reported to reduce lung cancer risk [18, 19] 
and our results suggest that these factors indeed explain some of the observed risk 
reduction among vegetarians (up to 18 and 5%, respectively). However, given that smoking 
is such a strong risk factor for lung cancer, these latter observations were likely due to 
residual confounding by smoking; when we corrected for smoking the effect of fruits and 
vegetables disappeared (results not shown) 
Our null findings regarding post-menopausal breast cancer risk are in line with other 
prospective studies comparing vegetarians to non-vegetarians and with a pooled analysis of 
five cohort studies on breast cancer mortality. In contrast, the UK Women’s Cohort Study 
reported a lower post-menopausal breast cancer risk among non-meat consumers 
compared to high meat consumers [14] although this was not observed in their dietary 
pattern analyses [15]. Vegetarian diets are rich in fiber and soy. Fiber was associated with a 
reduced risk of breast cancer in a meta-analysis of prospective studies [20] and soy 
contains isoflavones, which have previously been associated with a significant reduced risk 
of post-menopausal breast cancer in Asian populations [21].  
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However, compared to the average soy intake in four Asian countries (ranging from 38 – 
134 gr/day [22]), the soy product intake among vegetarians in our population was likely too 
low to exert an effect (~15 gr/day). The vegetarians in our population were not at an 
increased risk for breast cancer based on their reproductive and hormonal characteristics 
[1]. However, compared to individuals that consume meat on a daily basis, vegetarians had 
lower levels of alcohol consumption, a lower BMI, and higher levels of physical activity [1], 
which are all associated with a lower risk of breast cancer. We had too little statistical 
power to stratify our analyses by hormone receptor status of the tumor since this 
information was only available for 45% of all cases.  
Contrary to our hypothesis, we observed a statistically significant increased risk of 
advanced, but not overall, prostate cancer for 1 day/week meat consumers compared to 
those with the highest meat intake (6/7 days/week). A similar, though non-significant, 
increased risk was found for vegetarians and pescetarians. In contrast, vegetarians were at 
lower risk of overall prostate cancer in the AHS I [11] after adjustment for age, but this may 
result from differences in PSA screening practices [10]. Although both the vegetarians and 
meat consumers in the AHS were generally non- smokers and non-alcohol users, these 
results were not reproduced by others who also corrected for additional lifestyle factors 
[12, 13].  
We are the first to investigate vegetarianism and low meat consumption in prostate cancer 
subgroups based on disease stage, and provide further evidence that risk factors for 
prostate cancer may indeed differ for advanced and non-advanced tumors [16]. The 
increased risk of advanced prostate cancer for the non- and low meat consumers could not 
be explained by other dietary and non-dietary factors than the frequency of meat 
consumption. When further examining meat subgroups, we found inverse associations with 
chicken, processed meat, and liver but not for all other meat items, which contrasts 
previous studies that generally reported positive or null associations between advanced 
prostate cancer and meat and meat carcinogens (e.g. ref [23, 24]). As a result, we are 
careful interpreting these findings and future studies, with a larger number of advanced 
prostate cancer cases, vegetarians and low meat consumers, should replicate our findings.  
The incidence of female breast and prostate cancers increased after the introduction of 
screening [25, 26]. Although we previously reported a lower breast cancer screening 
mammography rate among vegetarians (23%) compared to the highest meat consumers 
(29%)[1], correcting for these screening practices did not change our risk estimates 
noticeably.  A recent investigation in the AHS II, showed that vegetarians are also less likely 
to follow prostate cancer screening guidelines compared to non-vegetarians [10]. However, 
PSA testing became more common in the Netherlands after 1990 [27] and is not 
propagated as a screening tool. Whether PSA testing could be responsible for the 
differences in risk estimates for advanced prostate cancer between the meat consumption 
groups is questionable. 
Strengths of our study include the prospective design, the long, nearly complete follow-up, 
and detailed information on diet and potential risk factors of cancer. Although our analyses 
have been performed using baseline FFQ data only, the validity of the FFQ has been tested 
and shown to be representative for dietary habits over a period of at least 5 years [28].  
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In conclusion, vegetarians, pescetarians and low meat consumers did not have a reduced 
risk of lung, female breast and overall prostate cancer compared to individuals consuming 
meat on a daily basis after taking confounders, especially smoking, into account. Our 
observation that ≤1day/week meat consumption was associated with increased risk of 
advanced prostate cancer may be due to chance and warrants investigation on other 
studies. 
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ABSTRACT 
Background: Evidence linking dietary factors to ovarian cancer is conflicting but several 
epidemiological studies have suggested that consumption of dietary fat and meat may 
increase the risk of ovarian cancer.  
Objective: We studied the association of intake of total fat, sources and subtypes of fat, 
fresh meat, processed meat and fish with ovarian cancer risk within the Netherlands Cohort 
Study (NLCS). 
Methods: The NLCS includes 62573 postmenopausal women, aged 55-69 y at baseline, who 
completed a baseline questionnaire on dietary habits and other risk factors for cancer in 
1986. After 16.3 years of follow-up, 340 ovarian cancer cases and 2161 subcohort members 
were available for case-cohort analysis. Multivariable rate ratios (RR) were adjusted for age 
at baseline, total energy intake, oral contraceptive use, and parity. 
Results: No clear association between intake of total fat, saturated fat, mono- and 
polyunsaturated fats, animal fat, plant based fat, dairy fat, other fat sources, fresh meat, 
processed meat and fish and ovarian cancer risk was observed. Consumption of trans-
unsaturated fatty acids was positively associated with ovarian cancer risk. The multivariable 
RR for women in the highest compared to the lowest quintile of intake was 1.51 (95%-
confidence interval, 1.04, 2.20; P-trend=0.01). Although no statistically significant 
interactions by oral contraceptive use or parity were found, effect sizes were generally 
more pronounced and significant in never pill users and parous women. 
Conclusion: This prospective study suggests that trans-unsaturated fatty acids, but no other 
types of fat or meat, are associated with increased ovarian cancer risk.   
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INTRODUCTION 
Research suggests that the etiology of ovarian cancer is predominantly related to hormones 
and reproduction; the strongest known protective factors being oral contraceptive use and 
parity [1, 2]. In contrast, evidence linking dietary factors to ovarian cancer is inconsistent 
and limited although several epidemiological studies have suggested that consumption of 
dietary fat and meat may increase the risk of ovarian cancer.  
Ecologic and migrant studies were the first to provide epidemiological support for a direct 
association between the intake of dietary fat, particularly animal fat, and meat and ovarian 
cancer mortality [3, 4]. Since then, numerous case control [5-17] but only a few prospective 
cohort studies [18-22] have published on total, animal or saturated fat intake, or meat 
consumption and ovarian carcinogenesis at the individual level. Nonetheless, a recent 
Expert Panel Report concluded that these epidemiological data were either of too low 
quality, too inconsistent or the number of studies too few to allow conclusions to be 
reached [23]. 
Dietary fat and meat are hypothesized to affect ovarian carcinogenesis primarily via 
hormone related mechanisms. High intake of dietary fat is suggested to expose the ovarian 
epithelium to high concentrations of endogenous circulating estrogens which may, through 
cell- damage and proliferation, increase the likelihood of cancer development [24-26]. 
Although this mechanism is not supported by all studies [27-29], a meta-analysis of dietary 
intervention studies to lower total fat intake observed significant reductions in serum 
estradiol levels [30] and research showed higher urinary estrogen excretion levels in 
omnivore compared to vegetarian post-menopausal women [31]. Likewise, meat 
consumption is suggested to increase ovarian carcinogenesis either via its relatively high fat 
content or alternatively through the cancerous effect of meat specific mutagens; N-nitroso 
compounds, heterocyclic amines and polycyclic aromatic hydrocarbons can be derived from 
natural food or during the process of food preservation and preparation [32].  
Nevertheless, little is known concerning the association of ovarian cancer risk and different 
sources and types of fat and meat. Therefore, the objective of the present study was to test 
the hypothesis that dietary intake of fat and specific sources of fat, and intakes of fresh 
meat, processed meat and fish is associated with the subsequent risk of ovarian cancer 
among postmenopausal women in a large prospective cohort study including extensive 
quantitative food frequency and lifestyle information and a large number of ovarian cancer 
cases in the Netherlands. Because the effect of fat and meat intake may vary according to 
parity and oral contraceptive use we also examined whether the associations differed by 
these well-established protective factors of ovarian cancer. 
METHODS 
Study population and cancer follow-up 
The Netherlands Cohort Study was initiated in September 1986 and includes 62573 women 
aged 55-69 years at baseline, originating from 204 municipalities with computerized 
population registries. Full details of the study design have been described elsewhere [33]. 
At the start of the study, participants completed a self-administered questionnaire on 
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dietary habits, lifestyle characteristics, medical history, and other potential risk factors for 
cancer. The case-cohort approach was used for reasons of efficiency in questionnaire 
processing and follow-up. Case subjects were enumerated from the entire cohort, whereas 
the accumulated person years of the entire cohort were estimated from a random 
subcohort of 2589 women, chosen immediately after baseline. The entire cohort is being 
monitored for cancer occurrence by annual record linkage to the Netherlands Cancer 
Registry and the Netherlands Pathology, together providing a near 100% coverage [34]. 
None of the female subcohort members were lost to follow-up.  
For cases and subcohort members, all prevalent cancer cases at baseline other than non-
melanoma skin cancer were excluded. After 16.3 years of follow-up (until December 2002) 
421 incident, microscopically confirmed, primary ovarian carcinomas were detected. 
Following the exclusion of non-epithelial tumors (n= 13), borderline invasive tumors (n= 
14), and cases with incomplete or inconsistent dietary data [35] (n= 42), 352 cases 
remained eligible for analyses. In the subcohort, women who had reported at baseline to 
have undergone an oophorectomy (n= 32), and women with incomplete or inconsistent 
dietary data (n= 190) were excluded, leaving 2216 subcohort members (including 16 
ovarian cancer cases) for analysis. The NLCS has been approved by the institutional review 
boards of the TNO Quality of Life Research Institute (Zeist, the Netherlands) and Maastricht 
University (Maastricht, the Netherlands).  
Questionnaire 
All participants completed a 150 item semi-quantitative food-frequency questionnaire 
(FFQ) at baseline, estimating the average frequency and amounts of foods and beverages 
consumed over the previous 12 months. Daily mean nutrient intakes were calculated from 
the FFQ dietary data by summing the multiplied frequencies and number of serving sizes of 
all food items with their tabulated nutrient contents from the Dutch food composition 
table [36].   
Intake of specific fatty acids was based on a separate database with specific fatty acids 
derived from the TRANSFAIR study [37]. In the database, total fat included triglycerides and 
other lipids, such as phospholipids and sterols. The percentage of triglycerides in total fat is 
assumed to be 93% on average, but it varies across food sources. The concentrations of 
fatty acids were based on the concentrations before 1995, when changes in trans- content 
of manufactured products, such as margarines, led to a substantial decrease in the intake 
of trans unsaturated fatty acids (TFA). Coding of fresh meat items was based on raw weight 
to take into account the amount of fat originally present in the meat but eventually ending 
up in the gravy, which is usually consumed as well. Processed meat was defined as meat 
items that had undergone some form of preservation (mostly treatment with nitrate salt, 
sometimes smoked or fermented). 
The FFQ has been validated and tested for reproducibility [35, 38]. Crude (energy and 
gender adjusted between brackets) Pearson correlation coefficients (r2) between the 
questionnaire and the 9-day diet record (kept over 3-day periods, 4-5 months apart) were 
0.74 for energy, 0.72 (0.52) for total fat, 0.73 (0.58) for saturated fatty acids (SFA) and 0.73 
(0.75) for poly unsaturated fatty acids (PUFA). The Spearman correlation coefficients for 
fresh meat, processed meat, and fish were 0.46, 0.54 and 0.53 respectively [35].  
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Statistical analyses 
The comprehensive set of exposure variables in our analyses included the intake of the 
following nutrients (in g/day): total fat, fat from plant foods, fat from animal products (milk, 
eggs, meat and fish), ratio of plant based to animal fat, fat from meat, dairy fat, fat from 
margarines, SFA, mono unsaturated fatty acids (MUFA), PUFA, TFA.  
Fat from plant foods covers fat naturally present in all plant foods (including vegetable oils), 
but exclude (partly hydrogenated) vegetable fat from margarine. Fat from meat refers to 
fat from fresh meats and fat from processed meats. Fat from fish was not analyzed 
separately because fish intake was measured with limited accuracy only (no differentiation 
oily- vs. whitefish), whereas fat from margarines was assessed comprehensively in the 
NLCS. We intentionally included TFAs in analyses; these are characterized by part 
hydrogenation of plant based oils which are hypothesized to have distinct carcinogenic 
effects. Intakes of fat items were all adjusted for energy intake by the residual method [39]. 
Also the following food groups and foods were selected (in g/day): fresh meat (beef, pork, 
minced meat, chicken, liver), processed meat, fish, fresh red meat (fresh meat without 
chicken) and beef, pork, minced meat, chicken, and liver as separate items.  
Age and energy adjusted and multi-variable adjusted incidence rate ratios (RRs) and their 
corresponding 95% confidence intervals (95% CI) were estimated using Cox proportional 
hazards models. The total person-years at risk, estimated from the subcohort, were used in 
analyses [40]. Standard errors were estimated using the robust Huber-White sandwich 
estimator to account for additional variance introduced by sampling from the cohort [41]. 
The proportional hazards assumption was tested using the scaled Schoenfeld residuals; in 
case of violation the follow-up period was stratified into 3 categories (<5; 5-10; ≥10 years of 
follow-up) and a test for interaction between the determinant and time was calculated and 
time-stratified results were estimated.  
The covariates included in the multivariate analyses were either a priori selected risk 
factors of ovarian cancer or variables that changed the risk estimates for total fat or total 
fresh meat intake by 10% or more. The latter criterion was not met for any other than the 
predefined covariates resulting in a final model including age (y), use of oral contraceptives 
(ever versus never), and number of children (n). Total energy intake (kcal/day) was included 
in both the age and the multivariable-adjusted model. RRs for energy-adjusted total fat and 
fatty acids can be interpreted as the effect of an increase in these variables relative to a 
decrease of an equivalent amount of energy from other energy delivering nutrients (i.e., 
substituting these exposure nutrients for other energy delivering nutrients). In addition, to 
assess the independent contribution of SFA, MUFA, PUFA TFA total fat intake was also 
included in the respective multivariable adjusted models. To further explore our data, we 
ran an additional model including all fatty acids together (SF, MUFA, PUFA, and TFA) to 
investigate the relative contribution of each fatty acid. The independent contribution of the 
individual meat categories (total fresh meat, fresh red meat, beef, pork, minced meat, 
chicken, and liver) was examined, by creating a model in which the complementary meat 
items were also included in the respective multivariable adjusted models.  
Subjects were classified into quintiles of consumption (with the lowest quintile regarded as 
the reference group), and as continuous variables. The latter were reported in one 
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standard deviation increase of consumption for the fat and fatty acid items, an increase of 
0.2 in the ratio of plant based to animal fat, and 25 g/day increase for all meat items and 
for fish. For some variables, categories were used instead of quintiles. For liver intake, 
there was a non-user and a user group (>0 g/day). For both chicken and fish a non-user and 
3 user categories (0-<13.2, ≥13.2-<22.8 and ≥ 22.8 g/day for chicken; 0-<10, ≥10-<20 and ≥ 
20 g/day for fish) were defined. 
To enable comparison, the age and energy-adjusted analyses were restricted to subjects 
included in multivariable-adjusted analyses (e.g., with no missing values on confounding 
variables), leaving 2161 subcohort members and 340 ovarian cancer cases for analyses. For 
each analysis, trends were evaluated with the Wald test by assigning participants the 
median value for each level of the categorical exposure variables among the subcohort 
members and this variable was entered as a continuous term in the Cox regression model. 
Interaction of meat and fat intake by use of oral contraceptives or parity was tested using 
cross-product terms between continuous variables of meat or fat intake on one hand and 
oral contraceptive use and parity as a dichotomous variable (categories being ever use and 
never use; nulliparous (0 children) and parous (≥ 1 children), respectively) on the other 
hand. 
All analyses were performed using STATA Statistical Software (Intercooled STATA, version 
10; Stata-Corp LP, College Station, TX). All tests were two-tailed and differences were 
regarded as statistically significant at P<0.05.    
RESULTS 
After 16.3 years of follow-up of 62573 women, 394 invasive epithelial ovarian cancer cases 
occurred, 340 of which were in women with complete and consistent dietary data. Table 1 
lists the baseline characteristics for cases and subcohort members of which the greater part 
did not differ between ovarian cancer cases and subcohort members. However, the 
percentage of women who reported ever use of oral contraceptives and the percentage of 
current smokers was higher among subcohort members than among cases.  Fewer cases 
reported to have undergone a hysterectomy and cases had a smaller number of children 
than subcohort members. No striking differences between cases and subcohort members 
were observed regarding baseline dietary intakes of the exposures of interest.  
No association was found when examining the relation between the risk of ovarian cancer 
and the dietary intake of total fat, fat from meat, fat from animal products, fat from 
margarines, SFA, MUFA, PUFA, in the multivariable model (Table 2). Regarding fat from 
plant foods, an inverse association was found, showing a statistically significant decreased 
risk of ovarian cancer for all quintiles compared to the lowest quintile (multivariable RRs = 
1.00, 0.58, 0.67, 0.67 and 0.64, respectively, P-trend= 0.05) (Table 2). A statistically 
significant increased ovarian cancer risk per 1 SD intake of dairy fat intake as a continuous 
variable was observed (multivariable RR = 1.13, 95%CI: 1.01, 1.27), but no evidence of a 
linear trend was found (Table 2).  
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Table 1:Baseline characteristics (means or percent) and dietary intakes of exposures of interest of ovarian cancer 
cases and subcohort members, NLCS 1986-2002  
Characteristics Ovarian cancer cases Subcohort 
N 340 2161 
Age (y) 61.8 ± 4.31 61.4 ± 4.3 
Current smokers (%) 17.6 21.2 
Years of smoking (y)  26.8 ± 12.4 27.8 ± 12.5 
BMI (kg/m2) 25.1 ± 3.5 25.1 ± 3.5 
Physical activity (non-occupational) (%)       
    <30 min/day 27.1 24.2 
    30-60 min/day 31.5 30.7 
    60-90 min/day 23.2 22.6 
    >90 min/day 17.1 21.2 
Level of education (%)   
    Low 58.8 56.7 
    Medium 33.2 34.5 
    High 8.0 8.8 
   
Reproductive and hormonal factors   
    Age at menarche (y) 13.7 ± 1.8 13.7 ± 1.8 
    Age at menopause (y) 49.2 ± 4.0 48.7 ± 4.5 
    Use of oral contraceptives (% ever) 18.5 24.9 
    Hysterectomy (% yes) 7.4 14.2 
    Use of post-menopausal hormones (% ever) 12.1 12.4 
    Parity (%)   
        0 children 23.2 18.0 
        1 child 9.7 8.2 
        2 children 25.6 21.7 
        >2 children 41.5 52.1 
    Age at first birth (y) 21.1 ± 12.2 22.1 ± 11.0 
    Family history of ovarian cancer (%) 0.6 0.0 
    Family history of breast cancer (%) 7.9 8.7 
   
Dietary factors, daily intake (g)   
Total fat and specific fatty acids2   
    Total fat  74.1 ± 9.9 73.9 ± 10.3 
          Fat from plant based products  8.5 ± 6.4 9.0 ± 6.8 
          Fat from animal sources, total  40.1 ± 13.6 38.6 ± 13.1 
              Fat from meat fat  15.6 ± 6.6 15.9 ± 7.1 
              Fat from dairy products  20.4 ± 13.7 18.5 ± 12.6 
          Fat from margarines  25.5 ± 13.0 26.3 ± 13.2 
    Saturated fatty acids  30.6 ± 6.3 29.7 ± 5.8 
    Monounsaturated fatty acids  27.5 ± 4.8 27.5 ± 5.0 
    Polyunsaturated fatty acids  14.5 ± 6.3 15.0 ± 6.1 
    trans Unsaturated fatty acids  2.6 ± 1.0 2.5 ± 0.9 
       
Types of fresh meat 3, processed meat, fish and eggs       
    Total fresh meat  92.0 ± 34.4 93.4 ± 40.0 
          Fresh red meat  80.0 ± 33.4 80.7 ± 38.6 
          Beef  26.0 ± 21.6 24.2 ± 21.7 
          Pork  34.0 ± 24.6 35.5 ± 28.4 
          Minced meat  16.0 ± 14.2 16.9 ± 15.5 
          Liver  1.7 ± 4.1 1.7 ± 4.0 
          Chicken  12.9 ± 14.2 13.4 ± 15.6 
          Other meat (e.g. horsemeat, lamb) 2.2 ± 6.5 2.4 ± 7.0 
    Processed meat  10.4 ± 11.3 10.5 ± 11.8 
    Fish  10.9 ± 11.8 11.7 ± 13.5 
    Eggs  15.3 ± 10.3 14.8 ± 9.8 
1 Mean ± SD (all such values) 
2 Energy-adjusted intake 
3 Intake based on raw meat weight 
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Table 2: Relative risks (RR) and 95% confidence intervals (CI) for ovarian cancer according to quintiles of intake 
of total fat - fat sources and specific fatty acids - NLCS 1986-20021 
   Total ovarian cancer cases
Food item   
Median 
intake2 PY Cases RR3 (95%CI) RR4 (95%CI) 
Total fat5 (g/day)   
1 6  61.0 6399 70 1.00 1.00  
2  69.1 6462 60 0.86 (0.59-1.24) 0.86 (0.59-1.25) 
3  73.9 6388 74 1.08 (0.75-1.54) 1.07 (0.75-1.53) 
4  78.9 6408 61 0.88 (0.61-1.27) 0.87 (0.60-1.26) 
5  86.5 6466 75 1.06 (0.74-1.50) 1.04 (0.73-1.49) 
Ptrend   0.73 0.80  
   Continuous 1 SD  1.02 (0.91-1.13) 1.01 (0.90-1.13) 
Fat from plant sources5 (g/day)  
1 6  2.8 6324 95 1.00 1.00  
2  5.8 6495 56 0.57 (0.40-0.83) 0.58 (0.40-0.84) 
3  8.0 6365 64 0.67 (0.46-0.96) 0.67 (0.46-0.96) 
4  10.6 6421 64 0.68 (0.47-0.97) 0.67 (0.47-0.96) 
5  15.9 6519 61 0.63 (0.45-0.90) 0.64 (0.45-0.91) 
Ptrend   0.06 0.05  
   Continuous 1 SD  0.93 (0.81-1.06) 0.93 (0.81-1.07) 
Fat from animal sources5 (g/day)  
1 6  23.9 6436 71 1.00 1.00  
2  31.4 6407 61 0.85 (0.59-1.23) 0.84 (0.58-1.22) 
3  36.7 6511 58 0.81 (0.56-1.17) 0.81 (0.56-1.18) 
4  43.6 6442 56 0.78 (0.53-1.13) 0.78 (0.53-1.13) 
5  56.6 6327 94 1.31 (0.94-1.84) 1.30 (0.93-1.83) 
Ptrend   0.19 0.19  
   Continuous 1 SD 1.12 (0.98-1.25) 1.11 (0.99-1.25) 
Ratio plant based vs animal fat  
1 6  0.06 6302 76 1.00 1.00  
2  0.13 6430 69 0.89 (0.63-1.27) 0.92 (0.65-1.31) 
3  0.20 6462 76 0.99 (0.70-1.40) 1.00 (0.70-1.41) 
4  0.30 6364 66 0.88 (0.61-1.26) 0.90 (0.63-1.29) 
5  0.53 6550 53 0.69 (0.47-1.01) 0.70 (0.48-1.02) 
Ptrend   0.08 0.09  
   Continuous 1 SD 0.95 (0.86-1.05) 0.95 (0.86-1.06) 
Fat from fresh and processed meats5 (g/day)  
1 6  7.6 6633 75 1.00 1.00  
2  12.2 6558 67 0.91 (0.64-1.31) 0.93 (0.65-1.34) 
3  15.2 6456 70 0.97 (0.68-1.38) 0.96 (0.67-1.36) 
4  18.8 6652 64 0.86 (0.60-1.23) 0.88 (0.61-1.26) 
5  24.6 6653 64 0.87 (0.60-1.24) 0.90 (0.62-1.29) 
Ptrend   0.39 0.50  
   Continuous 1 SD 0.96 (0.86-1.07) 0.98 (0.87-1.09) 
Fat from dairy products5 (g/day)  
1 6  5.3 6627 70 1.00 1.00  
2  11-0 6434 62 0.90 (0.62-1.30) 0.89 (0.62-1.29) 
3  15.6 6457 51 0.74 (0.50-1.08) 0.72 (0.49-1.06) 
4  22.6 6325 64 0.92 (0.64-1.33) 0.90 (0.62-1.30) 
5  36.2 6381 93 1.33 (0.95-1.87) 1.28 (0.91-1.80) 
Ptrend   0.11 0.17  
   Continuous 1 SD  1.15 (1.03-1.28) 1.13 (1.01-1.27) 
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   Total ovarian cancer cases
Food item   
Median 
intake2 PY Cases RR3 (95%CI) RR4 (95%CI) 
Fat from margarines5 (g/day)  
1 6  9.7 6424 80 1.00 1.00  
2  19.3 6368 61 0.78 (0.54-1.12 0.77 (0.54-1.11) 
3  26-0 6456 69 0.87 (0.61-1.23) 0.87 (0.61-1.23)  
4  32.7 6519 60 0.76 (0.53-1.09) 0.75 (0.52-1.08) 
5  42.5 6357 70 0.88 (0.62-1.25) 0.87 (0.61-1.23) 
Ptrend   0.49 0.42  
   Continuous 1 SD  0.94 (0.84-1.05) 0.93 (0.83-1.05) 
Saturated fatty acids5,7 (g/day)  
1 6  23.1 6401 68 1.00 1.00  
2  26.7 6427 64 0.98 (0.66-1.46) 0.98 (0.66-1.46) 
3  29.2 6530 57 0.88 (0.58-1.35) 0.90 (0.59-1.37) 
4  32.3 6403 57 0.89 (0.57-1.41) 0.89 (0.56-1.40) 
5  37.5 6363 94 1.50 (0.95-2.38) 1.48 (0.94-2.34) 
Ptrend   0.12 0.14  
   Continuous 1 SD  1.23 (1.05-1.43) 1.21 (1.04-1.41) 
Monounsaturated fatty acids5,7 (g/day)  
1 6  21.7 6410 66 1.00 1.00  
2  25.1 6418 78 1.12 (0.78-1.64) 1.16 (0.80-1.68) 
3  27.4 6381 65 0.95 (0.63-1.42) 1.00 (0.66-1.51) 
4  29.8 6436 66 0.92 (0.60-1.41) 0.97 (0.63-1.49) 
5  33.5 6479 65 0.84 (0.52-1.37) 0.90 (0.55-1.46) 
Ptrend   0.29 0.44  
   Continuous 1 SD 0.92 (0.78-1.09) 0.85 (0.80-1.12) 
Polyunsaturated fatty acids5,7 (g/day)  
1 6  8-0 6381 86 1.00 1.00  
2  11.4 6412 54 0.63 (0.44-0.91) 0.65 (0.44-0.94) 
3  14.1 6473 62 0.73 (0.50-1.05) 0.78 (0.54-1.14) 
4  17.6 6411 78 0.91 (0.64-1.29) 0.93 (0.66-1.32) 
5  23.2 6446 60 0.68 (0.47-0.99) 0.89 (0.47-1.01) 
Ptrend   0.30 0.33  
   Continuous 1 SD 0.90 (0.79-1.03) 0.90 (0.79-1.03) 
trans Unsaturated fatty acids5,7 (g/day)  
1 6  1.5 6435 63 1.00 1.00  
2  2.1 6446 55 0.92 (0.62-1.35) 0.91 (0.62-1.35) 
3  2.4 6407 59 0.99 (0.67-1.47) 0.99 (0.67-1.47) 
4  2.8 6420 77 1.31 (0.90-1.91) 1.33 (0.91-1.94) 
5  3.5 5417 86 1.49 (1.03-2.16) 1.51 (1.04-2.20) 
Ptrend   0.01 0.01  
   Continuous 1 SD   1.14 (1.02/1.26) 1.14 (1.03-1.28) 
PY (person years at risk) 
1 Relative risks were derived from Cox regression analyses 
2 Median intake in subcohort.  
3  Adjusted for age (y) and total energy intake (kcal) 
4 Adjusted for age (y)-total energy intake (kcal)-parity (number of children) and use of oral contraceptives (ever 
versus never)  
5 Energy adjusted intake 
6 Reference category 
7 Additionally adjusted for total energy-adjusted fat intake 
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Table 3: Relative risks (RR) and 95% confidence intervals (CI) for ovarian cancer according to quintiles and categories 
of intake of fresh meat-types of fresh meat-processed meat - NLCS 1986-20021 
    Total ovarian cancer cases
Food item 
  
Median 
intake2 PY Cases RR3 (95%CI) RR4 (95%CI) 
Total fresh meat (g/day)5    
1 6  45.2 6300 52 1.00 1.00   
2  74.4 6500 77 1.44 (0.99-2.09) 1.45 (1.00-2.13) 
3  92-0 6367 80 1.51 (1.04-2.20) 1.54 (1.06-2.42) 
4  107.5 6519 80 1.48 (1.02-2.15) 1.49 (1.03-2.17) 
5  145.8 6438 51 0.94 (0.62-1.42) 0.97 (0.63-1.47) 
Ptrend    0.86 0.96   
   Continuous (25g/day intake increment) 0.97 (0.91-1.04) 0.98 (0.91-1.04) 
Fresh red meat (g/day)7    
1 6  36.2 6491 51 1.00 1.00   
2  61.3 6314 77 1.54 (1.06-2.25) 1.58 (1.08-2.30) 
3  77.9 6389 73 1.45 (0.99-2.12) 1.47 (1.00-2.16) 
4  95.6 6477 92 1.77 (1.23-2.56) 1.78 (1.23-2.58) 
5  129.6 6453 47 0.91 (0.60-1.38) 0.93 (0.61-1.42) 
Ptrend    0.90 0.85   
   Continuous (25g/day intake increment) 0.98 (0.92-1.05) 0.98 (0.92-1.05) 
Beef (g/day)     
1 6  2.2 6445 68 1.00 1.00   
2  10.7 6471 53 0.77 (0.53-1.13) 0.77 (0.52-1.13) 
3  18.9 6478 58 0.98 (0.68-1.41) 0.98 (0.68-1.42) 
4  30.7 6391 67 0.97 (0.67-1.40) 0.95 (0.66-1.38) 
5  50.4 6339 84 1.21 (0.86-1.72) 1.15 (0.81-1.64) 
Ptrend    0.14 0.23   
   Continuous (25g/day intake increment) 1.09 (0.97-1.22) 1.07 (0.95-1.20) 
Pork (g/day)     
1 6  3.5 6489 62 1.00 1.00   
2  18.3 6335 74 1.23 (0.85-1.76) 1.26 (0.87-1.81) 
3  31.1 6417 71 1.18 (0.81-1.69) 1.21 (0.84-1.76) 
4  44.7 6410 67 1.09 (0.75-1.58) 1.14 (0.78-1.66) 
5  71.2 6472 66 1.07 (0.73-1.55) 1.08 (0.75-1.59) 
Ptrend    0.99 0.88   
   Continuous (25g/day intake increment) 0.95 (0.86-1.04) 0.96 (0.87-1.05) 
Minced meat (g/day)8    
1 6  0 6357 66 1.00 1.00   
2  7.6 6281 67 1.02 (0.71-1.47) 1.06 (0.73-1.53) 
3  13.4 6722 83 1.19 (0.84-1.68) 1.26 (0.89-1.80) 
4  21.4 6366 69 1.05 (0.73-1.52) 1.13 (0.78-1.63) 
5  36.6 6398 55 0.82 (0.56-1.21) 0.86 (0.59-1.27) 
Ptrend    0.43 0.64   
   Continuous (25g/day intake increment) 0.89 (0.74-1.07) 0.91 (0.76-1.09) 
Liver (g/day) 9     
1 5  0 21519 227 1.00 1.00   
2  3.3 10604 113 1.04 (0.81-1.33) 1.07 (0.84-1.38) 
   Continuous (25g/day intake increment) 1.15 (0.59-2.25) 1.29 (0.66-2.52) 
Chicken (g/day)9    
1 5  0 7530 76 1.00 1.00   
2  5.3 8304 95 1.15 (0.83-1.59) 1.18 (0.85-1.64) 
3  13.2 7436 79 1.07 (0.76-1.51) 1.14 (0.81-1.61) 
4  22.8 8853 90 1.01 (0.73-1.41) 1.06 (0.76-1.48) 
Ptrend    0.93 0.83  
   Continuous (25g/day intake 
increment)   0.94 (0.78-1.13) 0.96 (0.80-1.14) 
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    Total ovarian cancer cases
Food item 
  
Median 
intake2 PY Cases RR3 (95%CI) RR4 (95%CI) 
Processed meat (g/day)    
1 6  0 6725 80 1.00 1.00   
2  2.7 6268 53 0.71 (0.49-1.03) 0.71 (0.49-1.03) 
3  6.8 6436 70 0.91 (0.65-1.29) 0.91 (0.64-1.29) 
4  13.0 9227 70 0.93 (0.66-1.32) 0.93 (0.65-1.31) 
5  25.6 6466 67 0.85 (0.60-1.21) 0.83 (0.59-1.20) 
Ptrend    0.80 0.74   
   Continuous (25g/day intake increment) 0.97 (0.75-1.25) 0.96 (0.75-1.23) 
Fish (g/day)9     
1 5  0 9879 102 1.00 1.00   
2  4.6 7057 82 1.14 (0.83-1.57) 1.15 (0.84-1.58) 
3  15.5 9729 101 1.00 (0.75-1.36) 1.02 (0.76-1.38) 
4  28.2 5458 55 0.98 (0.69-1.39) 1.01 (0.71-1.43) 
Ptrend    0.81 0.94   
   Continuous (25g/day intake increment) 0.90 (0.73-1.10) 0.91 (0.74-1.12) 
PY (person years at risk). 
1 Relative risks were derived from Cox regression analyses. 
2 Median intake in subcohort.  
3  Adjusted for age (yrs) and total energy intake (kcal). 
4 Adjusted for age (yrs), total energy intake (kcal), parity (number of children) and use of oral contraceptives (ever 
versus never). 
5 Including all types of meat (except processed meat) and chicken. 
6 Reference category. 
7 Including beef-pork-minced meat-liver and other meat. 
8 Including beef and pork. 
9 Categorical cutpoints are for liver: 0->0 g/day; chicken: 0, 0-13.2, 13.2 - 22.8, ≥ 22.8 g/day; fish: 0, 0-10, 10-20, ≥20 
g/day. 
 
For trans-unsaturated fatty acids, a statistically significant increased risk of ovarian cancer 
for the highest versus the lowest quintile of TFA intake (multivariable RR = 1.51, 95%CI: 
1.04, 2.20) was found. Also, a dose-response relation was observed (p for trend = 0.01) and 
a statistically significant increased ovarian cancer risk per 1 SD intake of TFA intake as a 
continuous variable was observed (multivariable RR = 1.14, 95%CI: 1.03, 2.28) (Table 2). 
When including all fatty acids together in one model, the association between SF, MUFA, 
PUFA and TFA and ovarian cancer risk attenuated slightly but the direction of the 
association did not change appreciably (results not shown). A significant inverse trend 
across all quintiles of MUFA intake and ovarian cancer was observed (P-trend = 0.03) but 
the RR for 1 SD increase was similar (RR 0.84; 95%CI 0.88, 1.14) (results not shown). 
Intake of total fresh meat and fresh red meat did not show a clear monotonic increasing 
relation with ovarian cancer risk, but statistically significantly increased RRs in women in 
the intermediate quintiles of intake i.e. quintiles 2 through 4 (multivariable RRs for total 
fresh meat 1.00, 1.45, 1.54, 1.48 and 0.97, respectively; multivariable RRs for fresh red 
meat 1.00, 1.58, 1.47, 1.78 and 0.93 respectively) (Table 3). After adjustment for age and 
energy, no association was found between the intake of beef, pork, minced meat, liver, 
chicken, processed meat and fish separately and the risk of ovarian cancer (Table 3). These 
findings remained after the inclusion of the confounding variables in the multivariable 
model. Additional adjustment for the complementary meat items in the multivariable 
models did not change the results notably (results not shown). For beef and pork 
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consumption the proportional hazards assumption was violated. We observed a statistically 
significant interaction with time for beef (P-interaction=0.022) but not for pork (P-
interaction = 0.092). When stratifying the follow-up period into three categories (data not 
shown), only during the first 5 years of follow-up a statistical significantly increased risk of 
ovarian cancer was observed in quintiles 3 to 5 compared with the lowest quintile of beef 
intake (RRs 1.00, 0.99, 2.30, 2.04, 3.02, respectively) indicating that the association 
between beef intake and ovarian cancer risk attenuates over time.  
When we tested for interactions by use of oral contraceptives or parity, we observed no 
statistically significant interaction (results not shown). Stratified analyses (see 
Supplemental Table 1) showed statistically significant positive associations with ovarian 
cancer only in parous women and those never using oral contraceptives as regards to 
animal fat, dairy fat, TFA, SFA  intake whereas an inverse association with PUFA was 
observed in parous women only.  Stratified analyses regarding meat consumption yielded 
similar results compared to the overall assessment (results not shown). Due to the limited 
use of post-menopausal hormone replacement therapy in our cohort, we were not able to 
test this interaction. 
DISCUSSION 
In this large prospective cohort study, a comprehensive set of different sources and 
subtypes of fat and meat was examined in relation to ovarian cancer risk. Results showed a 
statistically significant positive association between dietary intake of trans unsaturated 
fatty acids and the risk of epithelial ovarian cancer.  
Previously, a meta-analysis of predominantly case control studies [42] has shown an 
increased risk of ovarian cancer for the highest compared to the lowest intakes of total fat, 
animal fat and saturated fat (RRs 1.24, 1.20 and 1.70, respectively). Nevertheless, incidence 
of ovarian cancer was not associated with total fat or any subtype of dietary fat intake 
according the Iowa Women’s Health Study [20] and the Nurses’ Health Study [19], whereas 
case control studies yielded mixed results [8, 13-17].  Although comparable to previous 
studies, the range of energy intake from total fat in the present study was small (varying 
from 32% in the lowest to 46% in the fifth quintile) which might have contributed to the 
lack of association observed. Moreover, habitual fat intake below 30 energy% is considered 
to be difficult to achieve in Western populations. Yet, recent results from the Women’s 
Health Initiative Dietary Modification Trial suggested that a low-fat dietary pattern (24.3 vs. 
35.1 energy% from fat after one year from baseline for the intervention and control group, 
respectively) may reduce the incidence of ovarian cancer among healthy postmenopausal 
women (RR 0.60, low fat diet compared to regular diet after four to eight y of follow-up) 
[43]. 
Thus far, epidemiological evidence linking TFA to any type of cancer is limited [44]; both the 
Nurses’ Health Study [19] and a pooled analysis [45] including data of 4 cohort studies 
found no evidence of an association between intake of TFA and ovarian cancer risk. In 
contrast, we found a positive association between dietary intake of TFA and the risk of 
ovarian cancer. After the substantial reduction of TFAs in margarines in Europe in 1995 
[46], the remaining TFAs in the diet are mainly consumed from fast food products, cakes 
DIETARY FAT AND OVARIAN CANCER RISK 
 
129 
and biscuits [47]. Although these specific dietary sources are likely to be closely related to 
other lifestyle factors or food specific chemicals such as acrylamide, adjustment for these 
did not attenuate the association between TFAs and ovarian cancer risk substantially 
(results not shown). Although a considerable latency period may exist between fat intake 
and cancer risk, we did not observe a statistically significant interaction with time of follow-
up (P-interaction = 0.46) suggesting that the strength of the association did not follow the 
decline in TFA exposure.   
Consumption of fat from plant foods was not associated with ovarian cancer risk in two 
case control studies [8, 12] or in two prospective cohort studies in the US [19, 20] and a 
pooled analysis of 9 cohort studies [45]. Conversely, the present results suggest an inverse 
association between plant-based fat consumption and ovarian cancer risk above the 
threshold of 4.5 g/d. Yet, the direction of the association depends on the choice of the 
reference category; changing this to a higher category would show an increased risk for 
those with the lowest intake. Nevertheless, previous studies often lack to specify whether 
hydrogenated vegetable oils, characteristically more comparable to animal fat, are included 
in this fat source, making comparisons between studies difficult. In the current analyses, 
plant based fat accounts, on average, for only 12% of total fat intake. However, the intake 
is greatly dispersed and likely to reflect a dietary pattern in the extremes. Regarding this, 
factor analyses previously identified five stable dietary patterns among women in the NLCS 
[48]. Although consumption of fat from plant foods was inversely correlated with the “fat 
dairy pattern” (r=0.28, P<0.001) (high loadings on potatoes, non-fermented whole milk, 
margarine, and sweet sandwich spread) adjustment for this pattern did not change the 
results noticeably (results not shown).  Moreover, a borderline statistically significant trend 
towards a protective effect of ovarian cancer for higher intakes of plant based fat relative 
to animal fat (P-trend = 0.086) was observed in the present study.     
We observed a higher ovarian cancer risk per 1 SD increase in dairy fat intake but because 
there was no increasing trend through all quintiles we are prudent interpreting these 
findings. More studies are warranted to further examine this association particularly since 
longitudinal epidemiological evidence is limited and conflicting [18, 19]. 
To date, a direct association between meat consumption and ovarian cancer risk has been 
proposed by several [5-9], but not all case control studies [10-13, 19, 20, 22]. Two 
prospective cohort studies that included a large proportion of vegetarians or low meat 
consumers were indicative of a positive association between total meat consumption and 
ovarian cancer risk [18, 49]. In contrast, four other cohort studies [19-22] and a recent 
meta-analysis [50] with smaller numbers of low or no meat consumers found no clear 
evidence for an association with total or red meat consumption. Yet, our results suggest 
that women at the extremes of the total fresh meat and fresh red meat consumption 
spectrum may be at a lower risk of developing ovarian cancer compared to those with 
intermediate consumption. Such an association has not been reported previously and may 
reflect on a specific dietary and lifestyle pattern high in fresh meat consumption. 
Nevertheless, negligible attenuation in the association with ovarian cancer was observed 
after adjustment for the dietary pattern that correlated most strongly with total fresh meat 
consumption (‘pork, processed meat and potatoes pattern’) [48] (r=0.29, P<0.001)  or when 
adjusting for other potential covariates. Although our reference category is characterized 
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by a considerable wide range of total fresh meat consumption (0-62.5 g/day; 0-7 d/week), 
changing this to a smaller, and more extreme category did not change the results 
appreciably. 
In accordance with the one study previously examining effect modification by hormonal 
and reproductive factors on the association between dietary fat and meat intake and 
ovarian cancer, we observed null results (possibly due to small numbers) [45]. Yet, the 
effect sizes regarding fat exposures were generally more pronounced in never pill users and 
parous women suggesting that hormonal pathways may be of significance in the etiology of 
ovarian cancer. However; in our cohort relatively few women were nulliparous and those 
reporting oral contraceptive use were significantly younger than those not.  
Our analyses have been performed using baseline FFQ data only resulting in an inability to 
assess and account for changes in intake and food compositions over time (e.g. TFA 
content). However, the validity of the FFQ has been tested and shown to be representative 
for dietary habits over a period of at least 5 years [35]. The prospective design reduced the 
potential for recall bias, and the nearly complete follow-up of cases and subcohort 
members, makes selection bias unlikely. Detailed information on diet and potential risk 
factors of ovarian cancer enabled us to control for most known ovarian cancer risk factors, 
although misclassification of exposure may have occurred. Regression parameters proved 
to be robust estimators since adjustment for potential covariates did not change them 
appreciable.  
In conclusion, this prospective study suggests that trans unsaturated fatty acids, but no 
other types of fat or meat, may be associated with increased ovarian cancer risk in this 
population of postmenopausal women.  The risk attributable to different sources and types 
of fats and interactions by oral contraceptive use and parity warrant further investigation.  
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ABSTRACT 
Background: Meat mutagens, including heterocyclic amines (HCAs), polycyclic aromatic 
hydrocarbons (PAHs), and N–nitroso compounds (NOCs), may be involved in colorectal 
carcinogenesis depending on their activation or detoxification by phase I and II xenobiotic 
metabolizing enzymes (XME).  
Methods: Using unconditional logistic regression to estimate odds ratios (OR) and 95% 
confidence intervals (CI), we examined the intake of five meat mutagens and >300 single 
nucleotide polymorphisms (SNPs) in 18 XME genes in relation to advanced colorectal 
adenoma (1,205 cases; 1,387 controls), and colorectal cancer (370 cases; 401 controls) 
within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Dietary intake of 
meat mutagens was assessed using a food frequency questionnaire (FFQ) with a detailed 
meat-cooking module.  
Results: An interaction was observed between 2-amino-3,8-dimethylimidazo[4,5-
f]quinoxaline (MeIQx) intake and the NAT1 polymorphism rs6586714 in the adenoma study 
(P-interaction = 0.001). Among individuals carrying a GG genotype, high MeIQx intake was 
associated with a 43% increased risk of adenoma (95% CI, 1.11-1.85; P-trend = 0.07), 
whereas the reverse was observed among carriers of the A variant (OR=0.50; 95% CI, 0.30-
0.84; P-trend = 0.01). In addition, we observed some suggestive (P<0.05) modifying effects 
for SNPs in other XME genes (UGT1A, CYP2E1, EPHX1, AHR, and GSTM3), but these were 
not significant after adjustment for multiple testing.  
Conclusion: This large and comprehensive study of XME genes, meat mutagens and the risk 
of colorectal tumours found that a NAT1 polymorphism modified the association between 
MeIQx intake and colorectal adenoma risk.  
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INTRODUCTION 
Experimental evidence suggests that the carcinogenic potential of several meat specific 
mutagens may be one of the underlying causal factors for the well-established 
epidemiological association between red and processed meat consumption and colorectal 
cancer risk [1]. Heterocyclic amines (HCAs) are formed when meat is cooked well-done at 
high temperature [2, 3]. Grilled meat may also contain polycyclic aromatic hydrocarbons 
(PAHs) from smoke that coats the meat. PAHs are also present in cigarette smoke, the 
environment, and in other food; although concentrations in foods not prepared by grilling 
or smoking are minor by comparison [2, 3]. N–nitroso compounds (NOCs) are formed from 
nitrate and nitrite that are added as preservatives to processed meat [4]. Despite the 
strong carcinogenic potential of HCAs, PAHs, and NOCs observed in animal studies [5-9], 
evidence in humans remains inconsistent [1]. 
HCAs, PAHs, and NOCs undergo a series of chemical reactions in the human body during 
which they can be activated or detoxified by phase I and phase II xenobiotic metabolizing 
enzymes (XMEs) [10, 11]. Single nucleotide polymorphisms (SNPs) in the genes encoding 
these XMEs may modify the ability to activate or detoxify carcinogens. Previous studies 
examining interactions between XME polymorphisms, meat consumption and the risk of 
colorectal adenomas or carcinomas have reported mixed results [12-26]. In addition, most 
previous studies had a small number of cases or examined only a small set of SNPs from a 
limited number of candidate genes. Because the balance of activating and detoxifying 
enzymes is thought to influence carcinogen metabolism [27], comprehensive studies 
including numerous markers across multiple genes involved in xenobiotic metabolism are 
essential for studying this complex association. Furthermore, the inconsistencies in the data 
may partly result from the inability of most studies to estimate specific HCAs, PAHs, and 
nitrite/nitrate due to lack of information on both cooking technique and doneness level. 
Although many studies ask about the consumption of well-done meat, one needs 
information on both cooking methods and doneness levels to get accurate intake estimate. 
Studies in different populations need specific databases relevant for their consumption 
patterns (e.g., Japan, Sweden, and U.S.). The Computerized Heterocyclic Amines Resource 
for Research in Epidemiology of Disease (CHARRED) software application was specifically 
developed for the U.S. population, therefore, appropriate for our study [3].   
We conducted two nested case-control studies within the Prostate, Lung, Colorectal, and 
Ovarian (PLCO) Cancer Screening Trial to examine the effect of meat-related mutagens and 
their interaction with 513 tag SNPs from 18 selected genes involved in phase I (cytochrome 
P450s (CYP)) and phase II metabolism (sulfotransferases (SULT), N-acetyltransferases (NAT), 
UDP-glucuronosyltransferases (UGT), and glutathione S-transferases (GST)) in relation to 
both colorectal adenoma and colorectal cancer risk.  
METHODS 
Study population 
The PLCO Cancer Screening Trial is a randomized, multi-center clinical trial investigating the 
efficacy of screening for prostate, lung, colorectal, and ovarian cancer [28, 29]. Participants 
aged 55–74 years were recruited from 10 centers in the United States from 1993 to 2001 
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and randomly assigned to the screened or control arm of the trial. The study was approved 
by the Institutional Review Board at the National Cancer Institute and the ten study 
centers, and all participants provided written informed consent. The present investigation 
is restricted to the individuals in the screening arm of the trial (n=77,469) who completed a 
self-administered risk factor questionnaire at baseline, filled out a food frequency 
questionnaire (FFQ) with detailed meat cooking questions, and provided a blood sample.  
We conducted two separate nested case-control studies with two disease outcomes: a) 
advanced colorectal adenoma; and b) colorectal cancer. To be eligible for these analyses, 
participants had to have no history of cancer prior to completion of the FFQ, and no prior 
history of self-reported colon disease (Crohn’s disease, ulcerative colitis, familial polyposis 
or Gardner’s syndrome). Individuals with a prior history of colorectal polyps were also 
excluded from the analyses of adenoma.  
a) Advanced Adenoma Sample 
Adenoma cases were participants found to have at least one advanced colorectal adenoma 
(≥1cm in size, containing villous/tubulovillous characteristics, or had severe dysplasia) of 
the distal colon or rectum at baseline. Controls were subjects who underwent a successful 
sigmoidoscopy exam (defined as insertion to at least 50 cm with ≥ 90% of mucosa visible or 
suspicious lesion found) at baseline and had no evidence of a left-sided polyp. Controls 
were matched to cases on gender, ethnicity, and for a subset, age.  A total of 1,243 
advanced adenoma cases and 1,419 controls with DNA were available for this study.  
b) Colorectal Cancer Sample 
Colorectal cancer cases were identified through self-report from the annual study update 
questionnaire, death certificates, or physician reports, and confirmed by review of 
pathology reports and medical records. Cases were identified through December 31, 2006. 
Controls were subjects without a diagnosis of colorectal cancer at the time the case was 
diagnosed, matched on age, gender, ethnicity, and year of randomization. A total of 371 
cases and 405 controls with DNA were identified and genotyped in this study Five cases 
from the adenoma sample later on developed colorectal cancer and were also included in 
the cancer sample. 
Dietary Assessment 
Participants completed a 137-item FFQ with a detailed meat-cooking module that 
ascertained usual diet during the previous 12 months. Most (89%) study participants 
completed the FFQ prior to or on the same day as the baseline sigmoidoscopy. Using the 
CHARRED (www.charred.cancer.gov) software application [3], we generated intake 
estimates of 3 HCAs (ng/day): 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-
amino-3,4,8-trimethylimi-dazo[4,5-f]quinoxaline (DiMeIQx) and 2-amino-1-methyl-6-
phenyl-imidazo[4,5-b]pyridine (PhIP), as well as benzo[a]pyrene (B[a]P), which is a marker 
of PAH exposure. We estimated nitrate and nitrite from processed meats using a 
nitrate/nitrite database based on laboratory measured values from 10 types of processed 
meat samples (bacon; sausage; hot dogs; roast beef; pork chops; ham; lunch meats, 
including bologna, salami and processed ham) that represented 90% of the processed meat 
consumed in the United States [3, 17] .We multiplied the frequency of consumption of each 
processed meat item by the portion size and by the nitrate or nitrite concentration of the 
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respective item to estimate nitrate and nitrite intake (mg/day). Participants were excluded 
from these analyses if they had ≥ 8 missing or invalid responses of the FFQ or missing data 
on the meat mutagens (n=71 and n=18 for the adenoma and cancer samples, respectively), 
leaving 1,386 advanced adenoma cases (171 rectal, 462 distal colon, 566 multiple adenoma 
(either side), and 6 with unknown location) and 1,205 controls, and 364 cancer cases (182 
proximal colon, 102 distal colon, 79 rectal, 1 unknown location), and 394 controls for 
analyses. 
Genotyping 
A total of 513 tag SNPs were selected for 18 genes or gene regions directly involved in the 
metabolism of HCAs, PAHs, or possibly with NOCs (Aromatic hydrocarbon receptor (AHR), 
CYP1A1/CYP1A2, CYP1B1, CYP2A6, CYP2C9, CYP2D6, CYP2E1, Epoxide hydrolase (EPHX1), 
GSTA1, GSTM1, GSTM3, GSTP1, GSTT1, NAT1, NAT2, NAD(P)H dehydrogenase (quinone 
1)(NQO1), SULT1A1/ SULT1A2, and the UGT1A locus). Tag SNPs were selected including the 
region 20 kb upstream and 10 kb downstream of the genes, using the CEU, JPT, CHB, and 
YRI HapMap populations and the Carlson method [30] as implemented in Tagzilla with a r2 
threshold of 0.8 and minor allele frequency (MAF) ≥5%. SNPs with known or putative 
functional significance (i.e. nonsynonymous, promoter, intron-exon splice sites) were also 
included whenever possible. The SNPs from the Phase I and II genes for putative pathway 
for metabolism of HCAs, PAHs and nitrites/nitrates (Supplemental Figure 1 [11, 31, and 32]) 
were genotyped on a custom iSelect panel utilizing Illumina’s Infinium platform.  
Whole blood or buffy coat DNA was extracted with QIAamp DNA Blood Midi or Maxi Kits. 
For quality control purposes, replicate samples from 195 individuals (~7% of the 
population) were interspersed randomly within the plates. Genotyping was conducted at 
the National Cancer Institute Core Genotyping Facility, National Institutes of Health. We 
required all cases and controls to have a 90% call rate for analysis. The overall concordance 
rate was >99% for replicated samples.  We excluded SNPs with a call rate <90%, MAF <1% 
in the adenoma set and 5% in the cancer set (due to lower power), or Hardy-Weinberg 
Equilibrium p-value < 1 x 10-6 among Caucasian controls. Of the 513 SNPs we selected, 380 
SNPs remained for the adenoma analyses, and 325 SNPs remained for the cancer analyses. 
There were a few highly correlated SNPs among the Caucasians in our study as the tag SNPs 
were selected for multiple populations. SNPs with an r2>0.95 among Caucasians were 
considered to be equivalent for interaction testing.   
Statistical Analysis 
All analyses were conducted separately for the prevalent colorectal adenoma and 
colorectal cancer study populations. Differences in baseline characteristics between cases 
and controls were assessed using chi-square tests for categorical variables, such as sex, and 
t tests for continuous variables, such as age. Due to a skewed intake distribution of the 
meat mutagens, we transformed these variables prior to performing t-tests, using the 
inverse rank transformation. 
Main Effects: Meat Mutagens and SNPs 
In order to confirm what has been previously reported in PLCO subgroup analyses, we 
examined the main effects of each mutagen and SNP on colorectal adenoma and cancer 
risk using unconditional multivariable logistic regression. The main effects of the meat 
Chapter 8 
 
140 
mutagens were adjusted for all relevant covariates (listed as footnotes in the tables). Meat 
mutagens were categorized as low (0-39th percentile), medium (40-79th percentile), and 
high (≥80th percentile) intake, as the distribution of these mutagens is highly skewed with 
the majority of individuals consuming small amounts, and previous analyses, both within 
the PLCO study population and within other studies, have identified the top quintile as 
potentially the most important with regard to cancer risk [33, 34] (e.g., PhIP intake in 
adenoma dataset: quintile 1: range = 0-19.5 mg/d, median = 10.1 mg/d; quintile 5: range = 
166-3069 mg/d, median= 268 mg/d). The main effects of the SNPs were examined using 
PLINK, a whole genome association analysis toolset [35] assuming a log-additive model for 
the genotype, and were adjusted for age, sex, and ethnicity. Results were adjusted for 
multiple testing using the False Discovery Rate (FDR) [36]. We also used a Bonferroni 
correction for the total number of tag SNPs for each individual gene or gene region (gene-
based correction). 
Gene × Environment (GxE) Interactions 
Because the experimental literature on the role of XME genes in relation to HCA, PAH and 
NOC metabolism is far from complete, we did not restrict our analyses to those gene-
mutagen interactions previously reported, but rather used an exploratory approach when 
testing for interactions between the all SNPs and mutagens under study. We used a two-
step test for G×E interactions as described by Murcray et al.[37], to identify SNPs involved 
in a G×E interaction. In the first step, we examined the association of each SNP with each 
mutagen in a linear regression model among cases and controls combined, adjusting for 
age, sex, and ethnicity. Due to a skewed intake distribution, we transformed the exposure 
variables using the inverse normal rank transformation.  Linear regressions were calculated 
using PLINK.  
The subset of m SNPs that exceeded the significance threshold of P<0.10 was taken forward 
to Step 2 for the actual case-control test for a GxE interaction. In Step 2, an unconditional 
logistic regression model, assuming a dominant genetic model, adjusting for age, sex, and 
ethnicity, was calculated with a multiplicative interaction term of the SNP with the 
respective meat mutagen (categorical variable assigning median values), as well as the 
individual main effect terms. Further adjustment for all confounders selected in the 
mutagen main effects analyses did not change the results appreciably. Significance at this 
step was defined as a P-value <α/m, where α was the desired overall Type I error rate of 
10%. When multiple SNPs from the same gene exceeded the P<0.10 threshold level, a Meff 
was calculated to determine the effective number of independent comparisons [38].  
All interactions meeting the significance threshold of P<0.05 were further evaluated using 
logistic regression models to examine the association between the categorical meat 
mutagen intake and colorectal adenoma or cancer, stratified by genotype assuming a 
dominant model. We also conducted stratified analyses by ever and never smokers, rectal 
and non-rectal adenomas, and single versus multiple adenomas. The top interactions in the 
cancer set were also examined by proximal, distal and rectal cancer. Models for Step 2 as 
well as the models for the association of the meat mutagens and colorectal adenoma or 
cancer were calculated using STATA version 9.0.   
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RESULTS 
A total of 1,205 cases and 1,386 controls were available for the advanced colorectal 
adenoma analysis and 364 cases and 394 controls were included in the colorectal cancer 
population (Table 1). Over 90% of the study subjects were Caucasian and over 60% were 
males; in the adenoma study, cases were older than controls.  
Table 1: Distribution of baseline characteristics in nested case control studies of advanced colorectal adenoma and 
colorectal cancer in the PLCO Cancer Screening Trial. 
 Adenoma Cancer  
 Cases Controls Cases Controls   
Characteristic  (n=1205)a (n=1386)a P (n=364)a (n=394)a  P 
Age, years 63.1 ± 5.2 62.6 ± 5.3 0.02 67.6 ± 6.5 67.5 ± 6.3 0.81 
Sex, n (%)  0.83 0.71 
    Male 776 (64.4) 887 (64.0) 216 (59.3) 239 (60.7)  
    Female 429 (35.6) 499 (36.0) 148 (40.7) 155 (40.3)  
Ethnicity, n (%)  0.23 0.97 
    Non-Hispanic white 1136 (94.3) 1284 (92.6) 311 (90.9) 357 (90.6)  
    Non-Hispanic black 29 (2.4) 46 (3.3) 18 (5.0) 21 (5.3)  
    Other 40 (3.3) 56 (4.0) 15 (4.1) 16 (4.1)  
First degree family history 
of colorectal cancer, n (%) 157 (13.1) 136 (9.9) 0.01 56 (15.6) 45 (11.6) 0.11 
Smoking status, n (%)   
    Never 462 (38.4) 657 (47.4) <0.01 157 (43.1) 164 (41.6) 0.90 
    Former cigarette smoker 165 (13.7) 94 (6.8) 167 (45.9) 187 (47.5)  
    Current cigarette smoker 577 (47.9) 635 (45.8) 40 (11.0) 43 (10.9)  
B[a]P (ng/day)    
    median (IQR) 7.0 (1.3, 36.1) 6.9 (1.2, 35.9) 0.17 5.5 (1.2. 23.8) 5.4 (1.0, 36.4) 0.74 
PhIP (ng/day)   
    median (IQR) 65.4 (24.6, 132.6) 61.1 (23.3, 132.3) 0.69 50.0 (21.0. 127.5) 53.8 (22.8, 135.8) 0.23 
MeIQx (ng/day)   
    median (IQR) 22.7 (9.75, 43.2) 20.5(8.94, 41.8) 0.20 18.0 (9.1. 38.7) 18.9 (9.0, 39.6) 0.59 
DiMeIQx (ng/day)   
    median (IQR) 1.02 (0.23, 2.47) 0.95 (0.27, 2.2) 0.39 0.80 (0.18, 2.22) 0.90 (0.22, 2.22) 0.35 
Combined nitrate and 
nitrite (ng/day) 
 
     
   median (IQR) 0.32 (0.13, 0.61) 0.28 (0.12, 0.59) 0.10 0.31 (0.13, 0.61) 0.28 (0.12, 0.55)  0.36 
Data are means ± standard deviations unless otherwise indicated.
IQR = Interquartile Range. 
NSAIDs = non-steroidal anti-inflammatory drugs. 
a Numbers may not sum due to total due to missing values. 
b P-values derived from t test or χ2 test. 
Main Effects: Meat Mutagens 
Consistent with a previous analysis of prevalent adenoma in the PLCO trial [34], there was 
an elevated risk of colorectal adenoma in the top quintile of MeIQx intake when compared 
to the bottom quintile (OR=1.17, 95% CI: 0.94-1.45); however, in the current study 
population with ~2000 fewer adenoma cases, the risk did not reach statistical significance 
and was attenuated after adjustment for confounders (Supplemental Table 1). We 
observed a borderline significant positive association between nitrate and nitrate intake 
from meat and adenoma risk (P-trend = 0.05), but this was attenuated with covariate 
adjustment. B[a]P, PhIP and DiMeIQx intake were not associated with adenoma risk in this 
population. Furthermore, none of the meat mutagens were associated with colorectal 
cancer. Due to subjects with missing values, the number of cases and controls in the 
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multivariable models were lower (adenoma: 1,183 cases, 1,358 controls; cancer: 387 cases, 
358 controls) than in the age, ethnicity and sex adjusted model, however, this did not 
explain the observed attenuation. The ORs for MeIQx and colon cancer in particular 
changed considerably after adjustment for confounders; level of education and total daily 
energy intake contributed the most to this change. 
Main Effects: SNPs 
We found that SNPs from the UGT1A, EPHX1, NAT1 genes were nominally associated with 
both colorectal adenoma (n=11 SNPs) and cancer risk (n=20 SNPs) (P<0.05) (Supplemental 
Table 2). In addition, one SNP from the GSTA1 locus was associated with adenoma risk, 
whereas one SNP at the NQO1 gene was associated with colorectal cancer. After adjusting 
for multiple testing for all the SNPs tested using the FDR, none of these findings remained 
statistically significant in either the adenoma or cancer analysis. However, UGT1A 
rs7569014 remained associated with colorectal cancer risk at P≤0.05 after the gene-based 
multiple testing correction. 
Gene × Environment Interactions  
A schematic representation of the results from the two-step test for G×E interaction for 
both the adenoma and cancer study populations is presented in Figure 1.  The subset and 
number of SNPs that exceeded the significant threshold of P<0.10 in Step 1, differed by 
outcome and mutagen under study. SNPs that passed this initial screening step were taken 
forward to the actual case-control test of GxE interaction analyses in Step 2. 
a) Advanced Prevalent Adenoma  
The GxE interaction analyses performed in Step 2 yielded fifteen interactions with P≤0.10 
between B[a]P, HCAs and several SNPs, including those in the GSTM3, UGT1A, AHR, EPHX, 
NAT1 and CYP2C9 gene regions (Table 2, Figure 1). The most significant interaction was 
between NAT1 (rs6586714) and MeIQx (P-interaction = 0.001) which was the only finding 
that remained significant after adjustment for multiple testing. Various SNPs from the 
UGT1A locus appeared to modify the association between B[a]P (3 SNPs; r>0.79), PhIP (4 
SNPs; r -0.12 – 0.89), and MeIQx intake (1 SNP) and adenoma risk (P<0.10). Two SNPs 
(r=0.39) located within the EPHX1 region (rs2671272 and rs868966) appeared to modify the 
effect of PhIP and DiMeIQx on colorectal adenoma risk (P≤0.05).  
We further explored the risk pattern for all interactions that met the unadjusted 
significance threshold of 0.05. Age, ethnicity and sex adjusted associations between 
mutagen intake and colorectal adenoma stratified by genotype are presented in Table 3. 
There was an increased risk of colorectal adenoma with increasing intake of MeIQx among 
individuals carrying a GG genotype for NAT1 rs6586714 (OR=1.43, 95% CI: 1.11-1.85 for 
high intake compared to low intake; P-trend=0.007), whereas the risk was decreased 
among GA and AA carriers (OR= 0.50 for high intake compared to low intake, 95% CI:0.30-
0.84; P-trend=0.01; Table 3). Increased intake of DiMeIQx was positively associated with 
adenoma risk in individuals carrying an AA genotype for EPHX1 rs868966 (OR= 1.45, 95% CI: 
0.98, 2.15; P-trend=0.06).  
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Table 2: Meat mutagen-SNP interaction and risk of colorectal adenoma and cancer for all interactions with P ≤ 0.10 
   Main effect
  Gene/gene region dbSNP identifier P-valuea P-interactionb 
Adenoma  
 B[a]P  
     GSTM3 c rs15864 0.75 0.07
     UGT1A locus rs1105880 0.96 0.04
     UGT1A locus rs12623271 0.44 0.04
     UGT1A locus rs10168416 0.83 0.07
 PhIP  
     UGT1A locus rs871514 0.06 0.09
     UGT1A locus rs28969701 0.40 0.08
     UGT1A locus rs2018985 0.06 0.05
     UGT1A locus rs10197460 0.37 0.09
     AHR  rs4236290 0.63 0.05
     EPHX1d  rs2671272 0.34 0.08
 MeIQx  
     UGT1A locus rs7571337 0.62 0.07
     NAT1  rs6586714 0.64 0.001† 
 DiMeiQx  
     CYP2C9  rs9332197 0.47 0.09
     EPHX1 d rs2671272 0.34 0.05
     EPHX1 e rs868966 0.27 0.03
 Combined nitrate and nitrite
     –  – – –
Cancer   
 B[a]P  
     AHR  rs2066853 0.21 0.07
     UGT1A locus rs6714486 0.50 0.06
     UGT1A locus rs17868299 0.67 0.05
 PhIP  
     –  – – –
 MeIQx  
     UGT1A locus rs2011404 0.30 0.08
     CYP2E1  rs915908 0.63 0.05
 DiMeiQx  
     UGT1A locus rs6717546 0.52 0.04
 Combined nitrate and nitrite
      UGT1A locus rs12466997 0.17 0.08
a P-value is for main effect of SNP on colorectal adenoma and cancer risk (P-values not corrected for multiple 
testing).  Adjusted for age, sex and ethnicity and assuming a log-additive model. 
b P-value is for a test for interaction using the likelihood ratio test comparing models with and without the cross-
product of SNP for the given gene and the median of the categories of meat mutagen intake. P-values not corrected 
for multiple testing. Adjusted for age, sex and ethnicity and assuming a dominant model. 
c SNP located within 10 kb downstream of EPS8L3. 
d SNP located within 10 kb downstream of TMEM63A. 
e SNP located within 10 kb upstream of LEFTY3. 
† StaƟsƟcally significant at P<0.05 after adjustment for multiple testing. 
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We additionally ran the GxE interaction analyses for total mutagenic activity, a measure 
incorporating mutagenicity of all meat-related mutagens. We found five interactions in the 
adenoma set, whereas one interaction (rs28969701- UGT1A locus) was observed in the 
cancer data. However, these SNPs came from genes similar as those interacting with the 
individual mutagens (CYP2C9, EPHX1, GSTM3, UGT1A locus) (data not shown). The 
correlation between total mutagenic activity and the individual HCAs and PAHs for 
adenomas was highest for MeIQx (r=0.84), followed by PhIP (r=0.78), DiMeIQx (r=0.76), and 
B[a]P (r=0.51). 
Subgroup analyses indicated that the top interactions were similar for the subgroups of any 
rectal (n=377) and any distal adenoma (n=957) and single (N=639) versus multiple 
adenomas (n=566). However, the interaction between PhIP intake and rs2018985 was only 
observed with respect to multiple adenomas but not for single adenomas (data not shown). 
Moreover, our top interaction were similar in direction and magnitude for ever- (n=743) 
and never (n=462) smokers, except for the interaction between DiMeIQx and rs868966 
which was only observed among ever smokers (data not shown). 
b) Colorectal Cancer  
In the carcinoma dataset, seven interactions with P≤0.10 were observed (Table 2, Figure 1).  
We found a suggestive interaction between several SNPs in the UGT1A region and intake of 
B[a]P (rs6714486, rs17868299), MeIQx (rs2011404), DiMeIQx (rs6717546), and combined 
nitrate and nitrite from meat (rs12466997). The association between MeIQx and colorectal 
cancer risk seemed to be modified by a SNP in the CYP2E1 gene (rs915908) (P-interaction = 
0.05). However, neither these nor other interactions for colorectal cancer were deemed 
significant after adjusting for multiple testing.  
Age, ethnicity and sex adjusted associations between mutagen intake and colorectal cancer 
stratified by genotype are presented in Table 3 (SNPs with P-interaction ≤0.05). High 
consumption of B[a]P was associated with an increased risk of colorectal cancer among 
individuals carrying the CT genotype for UGT1A rs17868299 (OR=6.04 for high intake 
compare to low intake; 95% CI: 1.39-24.2; P-trend = 0.06). A suggestive inverse association 
between MeIQx intake and colorectal cancer risk was observed among the wild-type 
variant of rs915908 (CYP2E1) (OR=0.68 for high intake compared to low intake, 95% CI: 
0.40-1.08; P-trend = 0.08).  
Interactions between SNPs in the UGT1A locus and various meat mutagens were observed 
for both the adenoma and cancer endpoints. No strong correlation (r2<0.25) between SNPs 
found in the adenoma and cancer analyses were found (results not shown). However, the 
interaction observed between rs7571337 and MeIQx intake for adenoma could be 
replicated for the cancer endpoint (P-interaction=0.09), and the ORs for the SNP-stratified 
results were in the same direction, though attenuated. The pooled OR(95% CI) combining 
the adenoma and cancer results for high intake compared to low intake was 1.72(1.03-
2.39) for the TT genotype and 0.95(0.70-1.13) for the TC+CC genotype. Nevertheless, all 
other interactions that were significant in the adenoma dataset were not found to be so in 
the cancer study (P>0.10), and vice versa (Supplemental Table 3A and 3B).  
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The OR and 95% CI for the main effects of the SNPs that were found to be involved in a GxE 
interaction (P<0.10) are presented in Supplemental Table 4. Two SNPs from the UGT1A 
locus (rs rs871514 and rs2018985) were marginally associated with colorectal adenoma 
(P=0.06), but did not remain statistically significant after adjustment for multiple testing 
using either the FDR or the gene-based approach.  
We examined the top interactions (as described in Tables 3A and 3B) by proximal, distal 
and rectal cancer sub site and observed that the interaction effect for rs6717546 remained 
present in all endpoints. However, the interaction between B[a]P and rs17868299 was only 
observed in the distal colon, and the magnitude of the SNP stratified associations for the 
variant allele was larger than that in the combined group of cancers (CC genotype: 
ORmedium=4.36 95%CI 1.02-18.55, ORhigh=8.82 95%CI 1.60-48.72) (data not shown); 
however, since the numbers were small, this may be a chance finding. 
DISCUSSION 
We observed that the effect of MeIQx intake on advanced colorectal adenoma risk differed 
by NAT1 genotype. Additional evidence of effect modification of the association between 
various meat-related HCAs, PAHs, and nitrate/nitrite and advanced colorectal adenoma and 
cancer by variants in UGT1A, CYP2E1, EPHX1, AHR, and GSTM3 was observed; however, 
correction for multiple comparisons indicated that these observations may be due to 
chance, despite that this the largest and most comprehensive study to date. 
Our finding that NAT1 modified the effect of MeIQx on the risk of advanced colorectal 
adenoma is in agreement with results from animal and in vitro research. NAT1 is primarily 
expressed in hepatic and colonic tissue and has been extensively shown to be an important 
enzyme in the bio-activation of multiple HCAs via O-acetylation processes [39]. NAT1 
enzyme activity is characterized by strong between population heterogeneity that likely 
results in inter–individual differences in acetylation rates [40]. Functionality of the variant 
observed in our analyses (rs6586714), which is located in the intron region of NAT1, is 
lacking and not strongly correlated with any known functional NAT1 alleles in the iSelect 
panel (r2<0.20). One previous analysis studied the interaction between various NAT1 alleles 
(*3, *4, *10, *11; categorizing participants into slow, normal and fast acetylaters) and meat 
intake in relation to colorectal adenoma risk but reported null results [41]. Nevertheless, 
evidence from the few epidemiological studies that examined interactions between NAT1 
and meat [15, 23, 24] or HCA intake [42] and colorectal cancer risk, points towards an 
increased risk among rapid acetylaters. However, these findings may have bias towards the 
null due to the generally small study samples, lack of detailed HCA exposure information 
and the debatable classification of NAT1 alleles. From our prior research, there is evidence 
that MeIQx is estimated with greater accuracy than other HCAs [43]. In addition, although 
MeIQx is consumed at lower levels in the diet, it is a more potent mutagen than PhIP is 
[44]. Moreover, it could be that this interaction is observed due to linkage disequilibrium 
with another variant in the region that has an effect on a neighboring gene.  
Although we observed some suggestive modifying effects in SNPs in other XME genes, the 
findings were not significant after adjusting for multiple testing. For example, multiple 
UGT1A polymorphisms were suggestively associated with colorectal adenoma and cancer 
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or appeared to interact with meat mutagens and tumor risk. UGTs are phase II conjugation 
enzymes that are primarily expressed in the luminal cells of the gastrointestinal tract, and 
have been implicated in the detoxification of HCAs and B[a]P [45, 46]. Previous 
epidemiological studies suggest that alterations in UGT genes may indeed influence the 
elimination of meat specific mutagens; one case-control reported an interaction between 
B[a]P intake and variants in UGT1A1 promoter polymorphisms at position -53 and -3156 
[47], whereas a suggestive interaction between DiMeIQx and UGT1A7 [48] acetylation 
status was reported in a different study. However, the multiple SNPs located across the 
UGT1A region that were involved in interactions with specific meat mutagens in the 
present study were found in overlapping intron regions of UGTA1 genes (UGT1A3 – A10), 
and mostly highly correlated, making it impossible to differentiate the associations of each 
statistically. Future research is needed to unravel this linkage disequilibrium and focus on 
individual UGT1A isoenzymes to characterize their etiological relevance with meat mutagen 
induced colorectal carcinogenesis.  
We found some other suggestive interactions between SNPs in the CYP2E1, AHR, and 
EPHX1 gene, although results after multiple testing suggests these findings may be due to 
chance. Although these genes are implicated in the metabolism of meat mutagens, there is 
little evidence in the literature for the functionality of the observed SNPs. However 
rs2066853 (AHR) encodes for an amino acid change in the protein (Arg554Lys), whereas 
rs15864 (GSTM3) is correlated (r2=0.81) with rs7483, a missense mutation in the same 
gene responsible for an amino acid substitution (Val224Ile) that significantly alters enzyme 
activity [49]. 
Despite the biological rationale for interactions between meat specific mutagens and 
polymorphisms in phase I and II XME genes in relation to colorectal carcinogenesis, the 
epidemiological evidence remains inconclusive. This lack of consistency may be due to 
inadequate sample size, the high potential for chance findings as a result of multiple 
comparisons, and the over-interpretation of subgroup findings in many gene-environment 
interaction studies. Although the present study is the largest and most comprehensive to 
examine these associations to date, we were still underpowered to detect modest effects 
of single gene variants, especially for the colorectal cancers. To gain power, we applied a 
two-step approach [37], incorporating a preliminary screening step to identify the SNPs 
involved in possible gene-environment interactions, and hence protect against false 
positive results. Moreover, the iSelect genotyping panel was specifically designed to 
capture only tagging SNPs from a priori selected genes involved in carcinogen metabolism 
to reduce the number of tests performed.   
Examination of the same set of SNPs and mutagens yielded different interactions in the 
adenoma and cancer analyses.  Although it may be that some of our findings are false 
positives, the differences we observed may reflect variation in gene-environmental 
interactions between initiation and progression in the carcinogenesis process.  There is 
tremendous heterogeneity among colorectal adenomas, with only a small subset of 
adenomas progressing to cancer.  Therefore, interactions related to the formation of 
adenoma may not be observed for cancer if they do not also stimulate progression to 
cancer.  In contrast, interactions associated with malignant transformation may only be 
observed for cancer.  Nevertheless, we did observe multiple interactions between SNPs at 
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the UGTA1 locus and both colorectal adenoma and cancer, suggesting that this locus may 
be important for progression and transformation. Many of the XME genes under study are 
part of larger multigene families. As a result there could be redundancy among these 
enzymes, such that if the activity of one is modified as a result of a specific genetic 
variation, others may continue to carry out the metabolism of meat mutagens. We were 
not able to examine differences in etiology between proximal and distal adenomas and 
advanced and non-advanced adenomas; the present study was restricted to advanced 
distal and rectal colorectal adenomas only.  
We made use of a comprehensive assessment of meat cooking methods that enabled 
detailed estimation of HCAs, PAHs, and nitrate/nitrite, but this is nonetheless susceptible to 
measurement error. We did not collect information concerning all aspects of meat cooking 
methods that could have influenced carcinogen production, such as microwaving prior to 
cooking [50], marinating the meat[51], or flipping burgers more often [52]. Moreover, 
during meat cooking, numerous other mutagenic compounds could be formed that may be 
correlated with the mutagens under study, and could thus potentially explain the observed 
interactions (e.g. between NAT1 and MeIQx). Our manuscript focuses on meat 
carcinogenesis and, therefore, we did not consider other potential dietary sources of nitrite 
and nitrate. Although the majority of dietary nitrite comes from processed meats [53], 
other food items and drinking water may contribute to intake.  
Given that this study was nested within the screening arm of the PLCO Cancer Screening 
Trial, we examined possible interactions using colorectal adenomas as an endpoint, largely 
asymptomatic precursors of colorectal cancer. Moreover, selection and surveillance bias is 
minimal since both cases and controls had an equal opportunity to have a colorectal 
adenoma or cancer detected. Our colorectal cancer analyses were based on a prospective 
study of incident cases, eliminating the potential for recall bias. However, inherent to the 
nature of the study population, participants were generally more educated, less likely to 
smoke, more physically active and more likely to be Caucasian than the general US 
population, thereby limiting the generalizability of the study results. All adenoma cases and 
controls and the majority of cancer cases and controls underwent at least one 
sigmoidoscopy screening as part of the trial.  Since nearly all polyps found were 
subsequently removed in this heavily screened population, it is possible that the colorectal 
cancers observed were somehow different than what would be observed in the general 
population, perhaps more likely to arise de novo.  It is also possible that some subjects 
changed their diet following screening. However, this is unlikely to have affected the results 
of this study since diet was assessed prior to screening and cancer cases were diagnosed a 
median of 3.2 years later, which is shorter than the predicted time span (10-20 years) of 
the adenoma-carcinoma sequence.  
In conclusion, we found some evidence that common variants in XME genes may modify 
the association between meat mutagens and colorectal neoplasia. The strongest evidence 
for an interaction was observed between MeIQx intake and a NAT1 polymorphism in 
relation to colorectal adenoma risk. Future pooled initiatives that would have larger sample 
sizes should further evaluate this complex interplay to better understand these 
relationships. 
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Supplemental Table 2: OR and 95% CI for the main effect of SNPs in xenobiotic metabolizing enzyme genes with     
P <0.05 on colorectal adenoma and cancer in the PLCO Cancer Screening Trial.                  
  SNP   Gene Risk Allele RAFa OR b 95%CI Pc 
Adenoma    
 rs2302538 UGT1A C 0.12 1.243 1.06- 1.46 0.009 
 rs10179091 UGT1A C 0.43 1.148 1.03- 1.28 0.015 
 rs17862866 UGT1A G 0.47 1.146 1.03- 1.28 0.017 
 rs360063  EPHX1 A 0.37 1,145 1.02- 1.28 0,018 
 rs3755319 UGT1A C 0.44 1.143 1.02- 1.28 0.018 
 rs9367495 GSTA1 G 0.42 1.131 1.01- 1.27 0.032 
 rs3806597 UGT1A G 0.44 1.127 1.01- 1.26 0.035 
 rs4399719 UGT1A G 0.44 1.127 1.01- 1.27 0.035 
 rs4663963 UGT1A G 0.44 1.120 1.00- 1.25 0.046 
 rs7556676 UGT1A G 0.41 1.120 1.00- 1.26 0.046 
 rs7003890 NAT1 T 0.44 1.118 1.00- 1.27 0.047 
     
Cancer      
 rs7569014 UGT1A A 0.02 3.072 1.28-5.97 0.0009d 
 rs6728792 UGT1A C 0.16 1.460 1.12-1.90 0.005 
 rs28969701 UGT1A T 0.02 2.244 1.19-4.22 0.012 
 rs17862836 UGT1A C 0.15 1.414 1.08-1.86 0.013 
 rs1113193 UGT1A A 0.22 1.340 1.05-1.71 0.018 
 rs1901813 UGT1A G 0.22 1.334 1.05-1.71 0.020 
 rs28948382 UGT1A C 0.02 2.047 1.12-3.75 0.020 
 rs17863759 UGT1A T 0.02 2.105 1.10-4.02 0.024 
 rs4663335 UGT1A A 0.16 0.709 0.52-0.96 0.025 
 rs4986989 NAT1 T 0.01 2.316 1.09-4.90 0.028 
 rs1823803 UGT1A T 0.47 0.793 0.64-0.98 0.029 
 rs17863756 UGT1A C 0.11 0.666 0.46-0.97 0.034 
 rs6760588 UGT1A C 0.27 0.774 0.61-0.98 0.035 
 rs1051741 EPHX1 T 0.12 0.694 0.49-0.98 0.035 
 rs2740174 EPHX1 G 0.14 0.707 0.51-0.98 0.037 
 rs11888492 UGT1A G 0.12 0.705 0.51-0.98 0.038 
 rs17299478 NQO1 T 0.13 1.351 1.01-1.80 0.041 
 rs17863766 UGT1A A 0.11 1.375 1.01-1.87 0.043 
 rs3738045 EPHX1 G 0.12 1.370 1.01-1.86 0.044 
  rs2219067 UGT1A G 0.24 0.778 0.61-1.00 0.049 
a RAF, risk allele frequency among Caucasian controls.
b OR per risk allele assuming a log-additive model, adjusted for age, sex and ethnicity. 
c No associations were significant after adjusting for multiple testing using the False Discovery Rate. 
d Significant after gene-based correction. 
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Supplemental Table 4: OR and 95% CI for the main effect of SNPs in xenobiotic metabolizing enzyme genes that 
interact with the meat mutagens P<0.10 on colorectal adenoma and cancer in the PLCO Cancer Screening Trial. 
  SNP   Gene 
Risk 
Allele RAFa ORb 95%CI Pc 
Adenoma    
 rs15864      GSTM3 (downstream)d C 0.31 0,98 0.87-1.11 0.75 
 rs1105880     UGT1A locus G 0.35 1.00 0.89-1.13 0.96 
 rs12623271     UGT1A locus G 0.41 1.05 0.93-1.17 0.44 
 rs10168416     UGT1A locus G 0.33 1.01 0.90-1.14 0.83 
 rs871514      UGT1A locus C 0.44 1,12 0.99-1.25 0.06 
 rs28969701     UGT1A locus T 0.02 0.85 0.59-1.23 0.40 
 rs2018985     UGT1A locus G 0.38 1.11 0.99-1.25 0.06 
 rs10197460     UGT1A locus T 0.39 1.05 0.94-1.18 0.37 
 rs4236290     AHR C 0.12 1.04 0.88-1.23 0.63 
 rs2671272     EPHX1 (downstream)e A 0.21 1.07 0.93-1.22 0.34 
 rs7571337     UGT1A locus T 0.51 1.03 0.92-1.15 0.62 
 rs6586714     NAT1 A 0.12 0.96 0.81-1.14 0.64 
 rs9332197     CYP2C9 C 0.05 1.10 0.85-1.43 0.47 
 rs868966      EPHX1 (upstream)f G 0.44 1,07 0.95-1.19 0.27 
Cancer     
 rs2066853     AHR A 0.10 0.81 0.59-1.12 0.21 
 rs6714486     UGT1A locus A 0.06 0.85 0.53-1.37 0.50 
 rs17868299     UGT1A locus T 0.05 0.90 0.56-1.45 0.67 
 rs2011404     UGT1A locus T 0.14 0.84 0.60-1.17 0.30 
 rs915908      CYP2E1 A 0.15 0,93 0.69-1.25 0.63 
 rs6717546     UGT1A locus A 0.35 0.93 0.76-1.15 0.52 
  rs12466997     UGT1A locus C 0.06 0.75 0.49-1.13 0.17 
a RAF, risk allele frequency among Caucasian controls.
b OR per risk allele assuming a log-additive model, adjusted for age, sex and ethnicity. 
c No associations were significant after adjusting for multiple testing using the False Discovery Rate. 
d SNP located within 10 kb downstream of EPS8L3. 
e SNP located within 10 kb downstream of TMEM63A. 
f SNP located within 10 kb upstream of LEFTY3. 
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ABSTRACT 
Background: Red meat intake has been linked to increased colorectal cancer (CRC) risk. 
Although the underlying mechanisms remain unclear, experimental studies suggest a role 
for dietary heme iron.  Because heme iron was shown to promote specific mutations, it 
would be insightful to link heme iron data to CRC with mutations in key-genes in an 
observational, population-based study.  
Methods: We investigated the association between dietary heme iron intake and risk of 
CRC with mutations in APC (adenomatous polyposis coli) and KRAS (Kirsten ras), and P53 
overexpression in the Netherlands Cohort Study. After 7.3 y of follow-up, excluding the first 
2.3 y due to incomplete coverage of the pathology registry and to avoid pre-clinical disease, 
adjusted hazard ratios (HR) (including adjustment for total meat) and 95% confidence 
intervals (CI) were calculated, using 4026 subcohort members (aged 55-69 y at baseline), 
435 colon and 140 rectal cancer patients.  
Results: When comparing the highest with the lowest tertile of intake, heme iron intake 
was associated with an increased risk of CRC harboring activating mutations in KRAS 
(HR=1.71, 95%CI: 1.15-2.57; P-trend=0.03) and CRC without truncating mutations in APC 
(HR=1.79, 95%CI: 1.23-2.60; P-trend=0.003). We observed a positive association between 
heme iron intake and the risk of CRC with activating G>A mutations in KRAS (P-trend=0.01), 
and overall G>A mutations in APC (P-trend=0.005). No associations were found with CRC 
harboring G>T mutations in KRAS/APC. Heme iron intake was positively associated with the 
risk of P53 overexpressed tumors, but not with tumors without P53 overexpression (P-
heterogeneity=0.12). 
Conclusion: Heme iron intake was associated with an increased risk of colorectal tumors 
harboring G>A transitions in KRAS and APC and overexpression of P53. These novel findings 
suggest that alkylating rather than oxidative DNA damaging mechanisms are involved in 
heme-induced colorectal carcinogenesis. 
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INTRODUCTION 
Although the accumulated evidence from prospective epidemiological studies supports a 
positive association between the consumption of red meat and colorectal cancer risk [1-3], 
very few human studies have comprehensively evaluated the potential underlying 
mechanisms.   
Experimental studies suggest a role for dietary heme iron, which is present at five-fold 
higher concentrations in red than white meat [4] and could explain why white meat, in 
contrast to red meat, is not associated with cancer risk [3]. Nevertheless, epidemiological 
evidence for its carcinogenic potential is inconclusive [5-10]. A recently conducted meta-
analysis of five prospective studies showed a consistent, though modest, increased risk of 
18% comparing the highest to the lowest category of heme iron intake [11].   
Colorectal cancer is a heterogeneous endpoint, and the association between heme iron 
intake and colorectal cancer may become more evident when the underlying molecular 
events are taken into account. Most sporadic colorectal cancers are thought to arise 
through genetic pathways involving a stepwise pattern of mutations in the adenomatous 
polyposis coli (APC) and tumor protein 53 (TP53) tumor suppressor genes and the Kirsten 
ras (KRAS) oncogene [12]. These key genes are frequently altered in colorectal cancer [12]. 
Interestingly, experimental evidence suggests that heme iron and its metabolic products 
may increase the overall mutation rate and promote specific point mutations in the DNA of 
colonic tissue. For example, heme was shown to catalyze the endogenous formation of N-
nitroso compounds (NOC) [13], some of which are direct alkylating agents, whereas others 
need to be metabolized before yielding DNA alkylating intermediates (18). Such 
metabolites may lead to the induction of nitroso-compound-specific DNA adducts, such as 
O-6-methylguanine [14], and have shown to induce G>A transitions in a variety of genes 
including KRAS and TP53 in both rodent and in vitro studies [15-17]. Furthermore, both 
heme iron and NOC may also catalyze the formation of reactive oxygen species that can 
cause DNA damage [18, 19], which, if not repaired, may induce G>T transversions [20]. 
Lastly, heme is thought to promote colonic cytotoxicity and increased cell proliferation 
resulting in an increased overall mutation rate [21-23].   
Linking heme iron exposure data to colorectal cancer with mutations in the colorectal 
cancer key genes APC, TP53 and KRAS in an observational, population-based study may 
provide new insight in the involvement of these genes in meat associated colorectal cancer 
risk. Although phenotypic expression studies in normal colonic tissue suggest that 
environmental factors can indeed influence protein expression patterns of these genes 
[24], previous studies linking meat consumption to (specific) mutations have yielded mixed 
results [25-29]. However, we are the first to hypothesize that heme iron and/or its 
metabolites, contribute to the observed colorectal cancer heterogeneity by increasing both 
the overall mutation rate and the occurrence of specific G>A and G>T genetic alterations in 
the APC and KRAS gene in colon and rectal tumors, that are characteristic for past heme 
iron exposure. Because mutation status of the TP53 gene was unavailable for the current 
analysis, we examined P53 overexpression status in relation to heme iron intake, a 
phenotype which has previously been inconsistently linked to meat intake [30, 31]. We 
further examined whether these associations differ by chlorophyll and dietary calcium 
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intake because these may block the reactivity of heme iron in the gastrointestinal tract and 
thus prevent heme-induced colorectal carcinogenesis [32, 33]. 
METHODS 
The Netherlands Cohort Study was initiated in September 1986 and includes 120852 men 
and women aged 55-69 years at baseline, originating from 204 municipalities with 
computerized population registries. Full details of the study design have been described 
elsewhere [34]. At the start of the study, participants completed a self-administered 
questionnaire on dietary habits, lifestyle characteristics, medical history, and other 
potential risk factors for cancer. The case-cohort approach was used for reasons of 
efficiency in questionnaire processing and follow-up. Case subjects were enumerated from 
the entire cohort, whereas the accumulated person years of the entire cohort were 
estimated from a random subcohort of 5000 men and women, chosen immediately after 
baseline. The entire cohort is being monitored for cancer occurrence by annual record 
linkage to the Netherlands Cancer Registry (NCR) and the Netherlands Pathology Registry 
(PALGA), together providing an almost complete coverage [35].  
Dietary exposure assessment 
All participants completed a 150 item semi-quantitative food-frequency questionnaire 
(FFQ) at baseline, estimating the average frequency and amounts of foods and beverages 
consumed over the previous 12 months. Daily mean nutrient intakes were calculated from 
the FFQ dietary data by summing the multiplied frequencies and number of serving sizes of 
all food items with their tabulated nutrient contents from the Dutch food composition 
table [36].   
The FFQ contained 14 items on consumption of meat with the hot meal, 5 items on 
consumption of processed meat used as sandwich fillings, and 3 items on fish.  The heme 
iron content from these meat items as well as the meat used in mixed dishes was estimated 
as an animal-specific percentage of total iron, derived from data in the literature (e.g. 65, 
39, and 26 percent for cooked beef, pork and chicken or fish, respectively), and has been 
reported in detail elsewhere [7].  
The FFQ has been validated and tested for reproducibility [37, 38]. Crude (energy and 
gender adjusted between brackets) Pearson correlation coefficients ® between the 
questionnaire and the 9-day diet record (kept over 3-day periods, 4-5 months apart) were 
0.74 for energy, 0.72 (0.52) for total fat, 0.73 (0.58) for saturated fatty acids (SFA) and 0.73 
(0.75) for polyunsaturated fatty acids (PUFA). The Spearman correlation coefficients for 
fresh meat, processed meat, and fish were 0.46, 0.54 and 0.53 respectively [37].  
Tissue samples and DNA isolation 
Tumor material from incident colorectal cancer patients identified during 7.3 years of 
follow-up was collected after approval by the Ethical Review Board of Maastricht 
University, PALGA, and the NCR. The first 2.3 years of the follow-up period were excluded 
due to the incomplete coverage of PALGA and to avoid possible pre-clinical disease 
affecting exposure status. The tissue samples were distributed among 54 pathology 
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laboratories throughout The Netherlands. Ninety percent (733 out of 815) of the available 
tissue samples contained sufficient tumor material for molecular analyses [39]. 
APC and KRAS mutation analysis 
Mutation analysis of the mutation cluster region  in the APC tumor suppressor gene 
(codons 1286-1520), and the exon 1 fragment of the KRAS oncogene (codons 12-13) were 
performed using a nested PCR approach, followed by direct sequencing of purified 
fragments. This procedure has been described in details elsewhere [39, 40]. KRAS status 
was available for all, and APC status was available for 90% of the cases. 
TP53 expression analysis 
Immunohistochemical staining for P53 was performed according to the avidin – biotin – 
peroxidase complex method, using the DO-7 mouse monoclonal antibody (DAKO A/S, 
Denmark) as previously described [41]. Immunostained slides and negative controls were 
evaluated semi-quantitatively and independently by two observers without knowledge of 
clinical parameters. We defined cases positive for overexpression of TP53 if 20% or more of 
the tumor cell nuclei showed positive staining with the antibody[41]. For 99% of the cases, 
P53 expression data was available.  
Statistical analysis 
Colorectal cancer was classified according to site: colon (ICD-O codes: 153.0- 153.7); 
rectosigmoid (ICD-O code 154.0) and rectum (ICD-O code 154.1). Rectosigmoid cancer 
cases were not evaluated separately because of the small number of cases (n=69) and the 
higher risk of misclassification [42]. After 7.3 y of follow-up and exclusion of prevalent 
cancer cases at baseline (other than skin cancer (n=226), subjects with an incomplete food 
frequency questionnaires (n=381), or subjects with missing information on confounders 
(n=349), 4026 subcohort members and 644 colorectal (435 colon and 140 rectum cancer 
cases) remained eligible for analyses. 
All analyses were conducted separately for colorectal, colon or rectum tumors with or 
without a truncating mutation in APC, an activating mutation in KRAS and overexpression 
of P53. Truncating APC mutations lead to the introduction of a stopcodon and result in a 
truncated and therefore inactive APC protein. Activating KRAS mutations are defined as 
mutations in codons 12 and 13 of the KRAS gene leading to an altered amino acid resulting 
in an activated RAS protein.  
We additionally classified the colorectal, colon and rectum tumors according to specific 
point mutations (G>A and G>T) in APC and KRAS according to two different methods, either 
focusing on overall mutations or restricting to functional (activating/truncating) mutations. 
Moreover, additional analyses were performed combining tumors with specific genetic 
aberrations in the APC and KRAS gene (e.g. tumors with no G>A mutation in both KRAS and 
APC). 
Hazard ratios (HR) and corresponding 95% confidence intervals (CI) were estimated using 
the multivariate Cox proportional hazards model. The total person-years at risk, estimated 
from the subcohort, were used in analyses [43]. Standard errors were estimated using the 
robust Huber-White sandwich estimator to account for additional variance introduced by 
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sampling from the cohort [44]. The proportional hazards assumption was tested using the 
scaled Schoenfeld residuals. 
Tests for heterogeneity were performed to evaluate differences in the association with 
heme iron between tumors with (specific) aberrations and tumors without any aberrations, 
using the competing risks procedure in STATA. However, the standard error for the 
difference of the log HRs from this procedure assumes independence of both estimated 
HRs, which would overestimate this standard error and thus overestimate the p-values for 
their difference; therefore, parameter estimates were based on a bootstrapping method 
that was developed for the case-cohort design [45]. For each bootstrap sample, X 
subcohort members were randomly drawn from the subcohort of X subjects and Y cases 
from the total of Y cases outside the subcohort, both with replacement, out of the dataset 
of X + Y observations. The log HRs were obtained from this sample using the competing 
risks procedure and recalculated for each bootstrap replication. The CI and p-value of the 
differences in hazard ratio for the molecular subtypes were then calculated from the 
replicated statistics. Each bootstrap analysis was based on 1000 replications [46]. 
The covariates included in the multivariate analyses were either a priori selected risk 
factors of colorectal cancer or variables that changed one of the risk estimates by 10% or 
more. This resulted in a multivariable model including age at baseline (y), sex , intake of 
alcohol (0, 0.1-29.9, >=30 g/day), vegetable consumption (g/day), total energy intake 
(kcal/day), BMI (kg/m2), family history of colorectal cancer (yes, no), smoking status (never, 
former, current), non-occupational physical activity (<30, 30-60, 60-90, >90 min/d).  In 
addition, we calculated a third model in which we additionally adjusted for the intake of 
total fresh meat (g/day) and processed meat (g/day), to assess the effect of heme iron 
independent of meat intake.  
Subjects were classified into tertiles of heme iron consumption based on the subcohort 
(with the lowest tertile regarded as the reference group), and as a continuous variable (1 
mg/day increment). Heme iron intake was adjusted for total energy intake using the 
residual regression method [47]. For each analysis, trends were evaluated with the Wald 
test by assigning participants the median value for each level of the categorical exposure 
variables among the subcohort members and this variable was entered as a continuous 
term in the Cox regression model. 
Possible effect modification by sex, chlorophyll, dietary calcium, BMI, smoking status, and 
physical activity were tested by entering cross-product terms in the model. However, none 
of these interaction terms was statistically significant (P-interaction > 0.01).  
All analyses were performed using STATA Statistical Software (Intercooled STATA, version 
10; Stata-Corp LP, College Station, TX). All tests were two-tailed and differences were 
regarded as statistically significant at P<0.05.    
RESULTS 
The baseline characteristics of subcohort members, colorectal, colon and rectum cancer 
cases, of which the greater part did not differ significantly between the groups, are shown 
in Table 1. Colorectal, colon and rectum cancer patients were older, more often men, had a 
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higher percentage of former smokers and individuals with a family history of colorectal 
cancer as compared to the subcohort.  
Table 1: Baseline characteristics and dietary intakes of exposures of interest of colorectal cancer cases and 
subcohort members within the Netherlands Cohort Study 
Subcohort Colorectal cancer Colon cancer Rectum cancer 
Characteristic cases cases  cases 
N 4026 644 435 140 
Age (y) 61.3 ± 4.2 a 62.8 ± 4.1 62.9 ± 4.1 62.3 ± 4.0 
Sex (% male) 49.8 56.5 54.1 65.7 
Dietary factors 
    Total heme iron intake (mg/day) 1.1 ± 0.5 1.1 ± 0.5 1.1 ± 0.5 1.1 ± 0.4 
    Total fresh meat intake (g/day) b 99.5 ± 41.7 99.0 ± 37.5 99.5 ± 36.3 96.2 ± 38.4 
    Total processed meat intake (g/day) 14.3 ± 15.6 14.9 ± 16.3 14.8 ± 15.9 14.8 ± 13.8 
    Chlorophyll (mg/day) 52.2 ± 29.5 52.3 ± 27.4 51.3 ± 26.9 52.1  ± 27.4 
    Vegetables (g/day) 194.1 ± 82.1 193.6 ± 85.0 191.6 ± 81.5 193.1  ± 92.0 
    Energy intake  (kJ/day) 8072 ± 2161 8094 ± 2018 8057 ± 2007 8343 ± 1891 
    Alcohol (%) 
        0 (g/day) 23.3 23.1 25.5 19.3 
        0.1-29.9 (g/day) 67.6 64.6 62.8 65.7 
        >=30 (g/day) 9.1 12.3 11.7 15.0 
Family history of colorectal cancer (% yes) 5.7 11.0 12.0 10.7 
Body mass index  (kg/m²) 25.0 ± 3.1 25.5 ± 3.1 25.5 ± 3.2 25.2 ± 2.9 
Smoking status (%)
    Never 35.3 32.3 35.6 29.3 
    Former 36.4 45.3 44.1 45.0 
    Current 28.4 22.4 20.2 25.7 
Non-occupational physical activity (%) 
<30 min/day 20.4 20.4 20.7 22.1 
30-60 min/day 31.6 31.1 32.0 27.9 
60-90 min/day 20.9 21.5 20.7 22.1 
>90 min/day 27.0 27.2 26.7  27.9 
a Mean ± SD (all such values). 
b Intake of fresh meat items were based on raw-meat weights. 
 
No differences between colon and rectum cancer patients and subcohort members were 
observed regarding baseline heme iron intake in women (mean intake of 0.99, 0.99 and 
0.97 mg/day, respectively).  In men, daily heme iron intake was highest in colon cancer 
cases (1.23 mg), followed by the subcohort (1.15 mg), and lowest in rectum cancer cases 
(1.10 mg) (results not shown). Also, no statistically significant differences in heme iron 
intake were observed between colon or rectum cancer cases characterized by specific 
molecular tumor characteristics in both men and women (results not shown). The 
correlation of heme iron intake and total fresh meat, processed meat, and fresh and 
processed meat combined, were 0.60, 0.42, and 0.68 respectively, for men and 0.59, 0.45, 
and 0.68 respectively, for women (results not shown). Among the colorectal cancer cases, 
56% had overexpression of P53 in the cell nucleus, 33% had an activating KRAS mutation, 
and 36% had a truncating APC mutation.  
Age- and sex adjusted (model 1), multivariable adjusted (model 2) and multivariable and 
fresh- and processed meat intake adjusted (model 3) HRs and corresponding 95% CI for 
different molecular endpoints of colorectal, colon and rectum cancer according to tertiles 
of heme iron intake are presented in Table 2A (colorectal) and Table 2B (colon and 
rectum).  
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Table 2A: Hazard ratios (HR) and 95% confidence intervals (CI) for colorectal cancer with different molecular 
characteristics according to tertiles (T) of heme iron intake in the NLCS (7.3 years of follow-up)a 
Colorectal cancer
Molecular endpoint PY Cases HR (95% CI)b HR (95% CI)c HR (95% CI)d 
APC: without introduction of stopcodon  
T1 6496 98 1 1 1
T2 6484 133 1.35 (1.02-1.77) 1.31 (0.99 - 1.73) 1.49 (1.09-2.05) 
T3 6480 137 1.41 (1.08-1.85) 1.39 (1.05 - 1.84) 1.79 (1.23-2.60) 
P-trend 0.02 0.03 0.003 
Continuous (1 mg/d intake increment) 1.17 (0.98-1.41) 1.17 (0.96-1.42) 1.40 (1.06-1.84) 
APC: introduction of stopcodon 
T1 6496 68 1 1 1
T2 6484 64 0.93 (0.66-1.33) 0.89 (0.62 - 1.26) 0.89 (0.60-1.33) 
T3 6480 77 1.14 (0.82-1.60) 1.06 (0.75 - 1.48) 1.03 (0.65-1.64) 
P-trend 0.41 0.69 0.82 
Continuous (1 mg/d intake increment) 1.24 (0.94-1.64) 1.16 (0.86-1.56) 1.22 (0.79-1.89) 
P-heterogeneity : APC with stopcodon vs. APC without stopcodon   0.16 
 
KRAS: wildtype 
T1 6496 134 1 1 1
T2 6484 133 0.99 (0.77-1.27) 0.94 (0.73. 1.22) 0.99 (0.74-1.32) 
T3 6480 159 1.20 (0.94-1.53) 1.16 (0.90. 1.49) 1.25 (0.89-1.76) 
P-trend 0.13 0.2 0.16 
Continuous (1 mg/d intake increment) 1.19 (0.99-1.44) 1.18 (0.96-1.45) 1.33 (0.99-1.77) 
KRAS: activating mutation 
T1 6496 55 1 1 1
T2 6484 85 1.53 (1.08-2.17) 1.49 (1.04-2.12) 1.71 (1.15-2.57) 
T3 6480 74 1.36 (0.95-1.95) 1.30 (0.90-1.87) 1.73 (1.08-2.77) 
P-trend 0.12 0.21 0.03 
Continuous (1 mg/d intake increment) 1.16 (0.90-1.48) 1.10 (0.85-1.42) 1.35 (0.93-1.94) 
P-heterogeneity : mutated KRAS vs. wildtype KRAS  0.14 
 
TP53: without overexpression  
T1 6496 79 1 1 1
T2 6484 106 1.33 (0.98-1.80) 1.28 (0.94-1.75) 1.29 (0.91-1.83) 
T3 6480 93 1.19 (0.87-1.63) 1.15 (0.83-1.58) 1.15 (0.75-1.76) 
P-trend 0.31 0.47 0.63 
Continuous (1 mg/d intake increment) 1.06 (0.85-1.32) 1.03 (0.81-1.30) (0.95 (0.67-1.35) 
TP53: overexpression 
T1 6496 108 1 1 1
T2 6484 109 1.00 (0.76-1.32) 0.97 (0.73. 1.28) 1.10 (0.80-1.50) 
T3 6480 138 1.29 (0.98-1.68) 1.25 (0.95-1.63) 1.58 (1.10-2.27) 
P-trend 0.05 0.09 0.008 
Continuous (1 mg/d intake increment) 1.27 (1.04-1.56) 1.25 (1.01-1.55) 1.66 (1.25-2.21) 
P-heterogeneity :  TP53 with overexpression vs. TP53 without overexpression 0.12 
T (tertile of heme intake); PY (Person years at risk).
a HR, hazard ratio. T1 was the reference category. HRs were derived from Cox regression analyses. 
b Adjusted for age at baseline (y) and sex. 
c Adjusted for gender, age at baseline (y),BMI (kg/m2), family history of colorectal cancer (yes, no), smoking (never, 
former, current), non-occupational physical activity (<30, 30-60, 60-90, >90 min/d), total energy intake (kcal/day), 
alcohol consumption (0, 0.1-29.9, >= 30 g/day) and total vegetable consumption (g/day) 
d Adjusted for gender, age at baseline (y),BMI (kg/m2), family history of colorectal cancer (yes, no), smoking (never, 
former, current), non-occupational physical activity (<30, 30-60, 60-90, >90 min/d), total energy intake (kJ), alcohol 
consumption (0, 0.1-29.9, >= 30 g/day), total vegetable consumption (g/day),  total fresh meat intake (g/day) and 
total processed meat intake (g/day). 
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The HRs for heme iron and colorectal cancer were stronger when additionally adjusting the 
models for total fresh and processed meat. Heme iron intake was not associated with the 
risk of colorectal tumors harboring a stopcodon in APC. In contrast, a significantly increased 
HR between heme iron intake and the risk of colorectal tumors without mutations leading 
to the introduction of a stopcodon was observed (multivariable HR (model 3) highest versus 
lowest tertile: 1.79; 95% CI: 1.23, 2.60; P-trend=0.003; HR per 1 mg/day increase: 1.40; 95% 
CI: 1.06-1.84). Heme iron intake was significantly associated with colorectal tumors with 
activating KRAS gene mutations (multivariable HR (model 3) highest vs. lowest tertile: 1.73; 
95% CI: 1.08-2.77; P-trend= 0.03) and P53 overexpression in the cell nucleus (multivariable 
HR (model 3) for highest vs. lowest tertile: 1.58; 95% CI: 1.10-2.27; P-trend= 0.008), but not 
with tumors without these aberrations. Comparable results were observed for colon cancer 
but not for rectum cancer (Table 2B).  
Table 3A: Hazard ratios (HR) and 95% confidence intervals (CI) for colorectal cancer with specific functional point mutations 
in colorectal key genes according to tertiles (T) of heme iron intake in the NLCS (7.3 years of follow-up) a 
Colorectal cancer 
Molecular endpoint PY Cases HR (95% CI)b HR (95% CI)c HR (95% CI)d 
APC: without G>T and G>A mutations  
T1 6496 67 1 1 1 
T2 6484 94 1.39 (1.01-1.92) 1.33 (0.96-1.85) 1.34 (0.93-1.93) 
T3 6480 87 1.31 (0.94-1.82) 1.27 (0.91-1.79) 1.28 (0.81-2.03) 
P-trend 0.13 0.20 0.36 
Continuous (1 mg/d intake increment) 1.22 (0.96-1.55) 1.21 (0.93-1.56) 1.23 (0.82-1.85) 
APC: truncating G>A mutations in APC  
T1 6496 44 1.00 1.00 1.00 
T2 6484 40 0.90 (0.58-1.40) 0.84 (0.55-1.30) 1.04 (0.63-1.74) 
T3 6480 45 1.03 (0.68-1.57) 0.92 (0.61-1.40) 1.34 (0.76-2.33) 
P-trend 0.86 0.76 0.29 
Continuous (1 mg/d intake increment) 1.01 (0.71-1.43) 0.92 (0.64-1.30) 1.30 (0.84-2.01) 
P-heterogeneity: truncating G>A in APC vs. no G>A and G>T in APC 0.17 
APC: truncating G>T mutations in APC 
T1 6496 11 1 1 1 
T2 6484 9 0.82 (0.34-1.98) 0.75 (0.31-1.85) 0.75 (0.28-2.03) 
T3 6480 17 1.55 (0.72-3.32) 1.41 (0.66-3.01) 1.31 (0.46-3.73) 
P-trend 0.23 0.31 0.52 
Continuous (1 mg/d intake increment) 1.62 (0.99-2.63) 1.53 (0.88-2.67) 1.55 (0.71-3.40) 
P-heterogeneity: truncating G>T in APC vs. no G>A and G>T in APC 0.27 
  
KRAS: without G>T and G>A mutations  
T1 6496 137 1 1 1 
T2 6484 141 1.02 (0.79-1.31) 0.98 (0.76-1.27) 1.02 (0.77-1.39) 
T3 6480 161 1.18 (0.93-1.51) 1.15 (0.90-1.48) 1.23 (0.88-1.72) 
P-trend 0.16 0.23 0.19 
Continuous (1 mg/d intake increment) 1.16 (0.96-1.40) 1.15 (0.94-1.41) 1.27 (0.86-1.69) 
KRAS: activating G>A mutations 
T1 6496 32 1 1 1 
T2 6484 44 1.36 (0.86-2.17) 1.32 (0.82-2.12) 1.62 (0.95-2.77) 
T3 6480 49 1.55 (0.99-2.44) 1.47 (0.93-2.34) 2.19 (1.20-3.98) 
P-trend 0.06 0.1 0.01 
Continuous (1 mg/d intake increment) 1.23 (0.93-1.62) 1.17 (0.87-1.57) 1.52 (1.03-2.24) 
P-heterogeneity: activating G>A in KRAS vs. no G>A and G>T in KRAS 0.55 
KRAS: activating G>T mutations 
T1 6496 19 1 1 1 
T2 6484 32 1.67 (0.94-2.96) 1.62 (0.91-2.88) 1.77 (0.91-3.44) 
T3 6480 21 1.12 (0.60-2.10) 1.07 (0.57-2.00) 1.27 (0.55-2.94) 
P-trend 0.82 0.96 0.69 
Continuous (1 mg/d intake increment) 1.14 (0.69-1.86) 1.09 (0.67-1.80) 1.36 (0.64-2.88) 
P-heterogeneity: activating G>T in KRAS vs. no G>A and G>T in KRAS 0.17 
Continues on the next page 
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 Colorectal cancer 
Molecular endpoint PY Cases HR (95% CI)b HR (95% CI)c HR (95% CI)d 
APC and KRAS: without G>T and G>A mutations  
T1 6496 59 1 1 1 
T2 6484 66 1.11 (0.77-1.59) 1.06 (0.74-1.54) 1.04 (0.69-1.57) 
T3 6480 66 1.13 (0.79-1.62) 1.11 (0.77- 1.61) 1.06 (0.63-1.78) 
P-trend 0.52 0.58 0.83 
Continuous (1 mg/d intake increment) 1.09 (0.82-1.46) 1.10 (0.80-1.49) 1.05 (0.65-1.70) 
APC and/or KRAS: activating and/or truncating G>A mutations 
T1 6496 65 1 1 1 
T2 6484 75 1.15 (0.81-1.61) 1.09 (0.77-1.55) 1.33 (0.90-1.98) 
T3 6480 86 1.34 (0.96-1.86) 1.25 (0.89-1.74) 1.79 (1.15-2.78) 
P-trend 0.08 0.19 0.008 
Continuous (1 mg/d intake increment) 1.16 (0.91-1.46) 1.09 (0.85-1.39) 1.43 (1.04-1.96) 
P-heterogeneity: functional G>A in APC and/or KRAS vs. no G>A and G>T in APC and KRAS 0.68 
APC and/or KRAS: activating and/or truncating G>T mutations 
T1 6496 29 1 1 1 
T2 6484 39 1.34 (0.82-2.17) 1.27 (0.78-2.08) 1.29 (0.74-2.24) 
T3 6480 38 1.32 (0.81-2.16) 1.24 (0.76-2.03) 1.24 (0.64-2.41) 
P-trend 0.28 0.42 0.58 
Continuous (1 mg/d intake increment) 1.32 (0.92-1.89) 1.26 (0.86-1.83) 1.34 (0.75-2.39) 
P-heterogeneity: functional G>T in APC and/or KRAS vs. no G>A and G>T in APC and KRAS 0.90 
T (tertile of heme intake; PY (Person years at risk). 
a HR, hazard ratio. T1 was the reference category. HRs were derived from Cox regression analyses. 
b Adjusted for age at baseline (y) and sex. 
c Adjusted for gender, age at baseline (y),BMI (kg/m2), family history of colorectal cancer (yes, no), smoking (never, former, 
current), non-occupational physical activity (<30, 30-60, 60-90, >90 min/d), total energy intake (kcal/day), alcohol 
consumption (0, 0.1-29.9, >= 30 g/day) and total vegetable consumption (g/day). 
d Adjusted for gender, age at baseline (y),BMI (kg/m2), family history of colorectal cancer (yes, no), smoking (never, former, 
current), non-occupational physical activity (<30, 30-60, 60-90, >90 min/d), total energy intake (kJ), alcohol consumption (0, 
0.1-29.9, >= 30 g/day), total vegetable consumption (g/day),  total fresh meat intake (g/day), and total processed meat 
intake (g/day). 
 
Additional analyses were performed to evaluate the association between heme iron intake 
and the risk of colorectal, colon and rectum tumors harboring specific functional 
(truncating/activating) point mutations (G>A transitions and/or G>T transversions) in APC 
and KRAS (Table 3A (colorectal) and Table 3B (colon and rectum)). Again, associations were 
stronger after additional adjustment for total meat intake. No clear dose-response 
associations were observed between heme iron intake and the risk of colorectal, colon or 
rectum tumors harboring specific truncating mutations in APC, nor for tumors without such 
G>A and G>T mutations.   
In contrast, heme iron intake was associated with an increased risk of colorectal tumors 
harboring activating G>A KRAS mutations (multivariable HR (model 3) highest vs. lowest 
tertile of intake: 2.19; 95% CI: 1.20, 3.98; P-trend= 0.01; HR per 1 mg/day increase: 1.52; 
95% CI: 1.03-2.24). Such association was not found when focusing on activating G>T 
mutations, or when looking at colorectal tumors without G>T and G>A mutations in KRAS. 
Similar associations were observed for colon but not for rectum cancer. In addition, heme 
iron intake was also associated with increased risk of colorectal tumors harboring 
activating/truncating G>A mutations in either APC and/or KRAS (multivariable HR (model 
3): 1.79; 95%CI: 1.15, 2.78; P-trend= 0.008; HR per 1 mg/day increase: 1.43; 95% CI: 1.04-
1.96), but not with tumors harboring G>T mutation, nor for tumors without such mutations 
in APC and KRAS combined.  
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When classifying the colorectal tumors according to specific point mutations, while 
focusing on overall mutations instead of restricting to functional mutations, we generally 
found similar results (Table 4). In addition, heme iron intake was significantly associated 
with an increased risk of colorectal tumors harboring overall G>A APC mutations 
(multivariable HR (model 3) highest vs. lowest tertile of intake: 1.71; 95% CI: 1.16, 2.50; P-
trend= 0.005; HR per 1 mg/day increase: 1.43; 95% CI: 1.08-1.88).  
None of the tests for heterogeneity comparing the association with heme iron between 
molecular subgroups (e.g. tumors with specific mutations versus tumors without the 
specific mutations) in any of the analyses presented herein were statistically significant (all 
P-heterogeneity > 0.05).  
Table 4: Hazard ratios (HR) and 95% confidence intervals (CI) for colorectal cancer with specific overall point 
mutations in colorectal key genes according to tertiles (T) of heme iron intake in the Netherlands cohort study on 
diet and cancer (7.3 years of follow-up)a 
Colorectal cancer 
Molecular endpoint PY Cases HR (95% CI)b HR (95% CI)c HR (95% CI)d 
APC: without G>T and G>A mutations  
T1 6496 67 1 1 1 
T2 6484 94 1.39 (1.01-1.92) 1.33 (0.96-1.85) 1.34 (0.93-1.93) 
T3 6480 87 1.31 (0.94-1.82) 1.27 (0.91-1.79) 1.28 (0.81-2.03) 
P-trend 0.13 0.20 0.36 
Continuous (1 mg/d intake increment) 1.22 (0.96-1.55) 1.21 (0.93-1.56) 1.23 (0.82-1.85) 
APC: G>A mutations 
T1 6496 93 1 1 1 
T2 6484 99 1.06 (0.79-1.42) 1.03 (0.76-1.38) 1.23 (0.88-1.73) 
T3 6480 117 1.27 (0.96-1.69) 1.21 (0.91-1.62) 1.71 (1.16-2.50) 
P-trend 0.09 0.17 0.005 
Continuous (1 mg/d intake increment) 1.12 (0.91-1.38) 1.08 (0.87-1.35) 1.43 (1.08-1.88) 
P-heterogeneity:  G>A in APC vs. no G>A and G>T in APC 0.25 
APC: G>T mutations 
T1 6496 12 1 1 1 
T2 6484 9 0.75 (0.31-1.78) 0.67 (0.28-1.62) 0.70 (0.26-1.87) 
T3 6480 19 1.59 (0.77-3.29) 1.41 (0.69-2.88) 1.43 (0.53-3.90) 
P-trend 0.18 0.27 0.38 
Continuous (1 mg/d intake increment) 1.62 (1.02-2.59) 1.52 (0.90-2.58) 1.63 (0.78-3.40) 
P-heterogeneity: G>T in APC  vs. no G>A and G>T in APC   0.16 
   
KRAS: without G>T and G>A mutations  
T1 6496 137 1 1 1 
T2 6484 141 1.02 (0.79-1.31) 0.98 (0.76-1.27) 1.02 (0.77-1.39) 
T3 6480 161 1.18 (0.93-1.51) 1.15 (0.90-1.48) 1.23 (0.88-1.72) 
P-trend 0.16 0.23 0.19 
Continuous (1 mg/d intake increment) 1.16 (0.96-1.40) 1.15 (0.94-1.41) 1.27 (0.86-1.69) 
KRAS: G>A mutations 
T1 6496 33 1 1 1 
T2 6484 45 1.35 (0.86-2.13) 1.29 (0.81-2.06) 1.60 (0.94-2.70) 
T3 6480 51 1.57 (1.00-2.45) 1.46 (0.93-2.32) 2.19 (1.22-3.92) 
P-trend 0.05 0.10 0.01 
Continuous (1 mg/d intake increment) 1.25 (0.95-1.64) 1.18 (0.88-1.58) 1.55 (1.06-2.25) 
P-heterogeneity:G>A in KRAS vs. no G>A and G>T in KRAS 0.47 
KRAS: G>T mutations 
T1 6496 19 1 1 1 
T2 6484 32 1.67 (0.94-2.96) 1.62 (0.91-2.88) 1.77 (0.91-3.44) 
T3 6480 21 1.12 (0.60-2.10) 1.07 (0.57-2.00) 1.27 (0.55-2.94) 
P-trend 0.82 0.96 0.69 
Continuous (1 mg/d intake increment) 1.13 (0.69-1.86) 1.09 (0.67-1.80) 1.36 (0.64-2.88) 
P-heterogeneity: G>T in KRAS vs. no G>A and G>T in KRAS 0.12 
Continues on the next page 
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 Colorectal cancer 
Molecular endpoint PY Cases HR (95% CI)b HR (95% CI)c HR (95% CI)d 
APC and KRAS: without G>T and G>A mutations  
T1 6496 59 1 1 1 
T2 6484 66 1.11 (0.77-1.59) 1.06 (0.74-1.54) 1.04 (0.69-1.57) 
T3 6480 66 1.13 (0.79-1.62) 1.11 (0.77- 1.61) 1.06 (0.63 - 1.78) 
P-trend 0.52 0.58 0.83 
Continuous (1 mg/d intake increment) 1.09 (0.82-1.46) 1.10 (0.80-1.49) 1.05 (0.65-1.70) 
APC and/or KRAS: G>A mutations 
T1 6496 111 1 1 1 
T2 6484 128 1.14 (0.86-1.49) 1.11 (0.85-1.46) 1.30 (0.96-1.76) 
T3 6480 142 1.30 (1.00-1.69) 1.25 (0.86- 1.63) 1.68 (1.18-2.39) 
P-trend 0.05 0.10 0.03 
Continuous (1 mg/d intake increment) 1.15 (0.95-1.39) 1.11 (0.91-1.35) 1.41 (1.09-1.82) 
P-heterogeneity:  G>A in APC and/or KRAS  vs. no G>A and G>T in APC and KRAS 0.84 
APC and/or KRAS: G>T mutations 
T1 6496 30 1 1 1 
T2 6484 39 1.29 (0.80-2.09) 1.22 (0.75-1.99) 1.26 (0.73-2.18) 
T3 6480 40 1.35 (0.84-2.19) 1.26 (0.78-2.04) 1.32 (0.69-2.53) 
P-trend 0.23 0.35 0.44 
Continuous (1 mg/d intake increment) 1.33 (0.94-1.89) 1.26 (0.87-1.83) 1.37 (0.79-2.41) 
P-heterogeneity: G>T in APC and/or KRAS  vs. no G>A and G>T in APC and KRAS 0.78 
T (tertile of heme intake); PY (Person years at risk). 
a HR, hazard ratio. T1 was the reference category. HRs were derived from Cox regression analyses. 
b Adjusted for age at baseline (y) and sex. 
c Adjusted for gender, age at baseline (y),BMI (kg/m2), family history of colorectal cancer (yes, no), smoking (never, former, 
current), non-occupational physical activity (<30, 30-60, 60-90, >90 min/d), total energy intake (kcal/day), alcohol 
consumption (0, 0.1-29.9, >= 30 g/day) and total vegetable consumption (g/day) . 
d Adjusted for gender, age at baseline (y),BMI (kg/m2), family history of colorectal cancer (yes, no), smoking (never, 
former, current), non-occupational physical activity (<30, 30-60, 60-90, >90 min/d), total energy intake (kcal/day), alcohol 
consumption (0, 0.1-29.9, >= 30 g/day), total vegetable consumption (g/day)  total fresh meat intake (g/day) and total 
processed meat intake (g/day). 
DISCUSSION 
To the best of our knowledge, this is the first prospective study to report a positive 
association between heme iron intake and the risk of colorectal tumors harboring G>A 
transitions in KRAS and APC and overexpression of P53.  
Heme iron intake was dose-dependently associated with an increased risk of colorectal 
cancer with KRAS codon 12 and 13 mutations but not with wild type KRAS tumors. More 
specifically, we observed a clear dose-response relation between heme iron consumption 
and colorectal cancers with specific G>A activating transitions in KRAS. Similar findings were 
observed with overall G>A mutations in APC, which is in line with a recent case only study 
from EPIC-Norfolk [26]. These G>A transitions are characteristic for alkylating agents such 
as NOC or their metabolites [15]. The endogenous formation of NOC is catalyzed by heme 
[13]. Some NOC have shown to react with DNA in vitro to give rise to the NOC specific DNA 
adducts such as O6-carboxymethyldeoxyguanine (O6CMG) [14], which was increased in 
exfoliated colonic cells from human volunteers who were fed a high red meat diet for 
fifteen days [48]. O6CMG adducts may cause DNA polymerase to misread the O6-guanine 
as an adenine which results in miss-pairing with thymine, causing G>A transitions [49]. 
Supporting these data, N-methyl N-nitrosourea, a potent and direct acting NOC, has shown 
to induce G>A transitions at codons 12 and 13 of the KRAS gene in rat colon tumors when 
infused intrarectally [16].  
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Heme iron also catalyses the formation of hydroxyl radicals that can cause oxidative DNA 
lesions [18, 19] which can promote G>T transversions [20]. Moreover, NOC-metabolism has 
been shown to generate reactive oxygen species, which was associated with the 
deregulation of gene expression patterns that may be of relevance in human colorectal 
carcinogenesis (18). However, in both KRAS and APC the magnitude of our findings for G>T 
mutations was smaller as compared to our G>A specific associations, if present at all. 
Although the tests for heterogeneity between these molecular subgroups were not 
statistically significant, this may imply that the heme stimulated alkylating effect of NOC 
might play a larger role in colorectal carcinogenesis than its oxidative potential. Indeed, it 
has been proposed previously that DNA alkylation is probably the most relevant genotoxic 
effect induced by NOC [50]. However, G>A mutations can, next to alkylating damage, also 
result from other endogenous mechanisms. Nonetheless, the number of subjects with G>A 
and G>T mutations was relatively small and more research in larger samples is required.   
Although heme iron intake was not significantly associated with the risk of tumors with 
(specific) mutations leading to the introduction of a stopcodon in APC, a significant positive 
trend between heme iron intake and tumors without an APC stopcodon was observed. 
These findings are supported by epidemiological studies examining red meat intake in 
relation to APC truncation status in the NLCS [28] and a Dutch colorectal adenoma case 
control study [51], but contradict those from a cancer case control study [52] and a case 
only study [26].  
The initial focus of our analyses was on functional mutations; inactivation of the APC gene 
and activation of KRAS are thought to drive the development of a carcinoma and are 
considered key events in early colorectal tumorigenesis [53]. The potential impact of non-
functional mutations in colorectal cancer development is not yet understood. Nevertheless, 
we only observed an association between heme iron intake and APC tumors without the 
introduction of a stopcodon. However, only half of all APC mutations led to the 
introduction of such a stopcodon which prompted us to examine the group of tumors 
harboring any APC mutation more closely for specific point mutation status, regardless of 
its functionality. These analyses showed an increased risk for tumours harbouring overall 
G>A mutations in APC which was not found when restricting to functional mutations only. 
This could suggest that the carcinogenic mechanism behind heme intake involves exposure-
specific mutations that may not necessarily entail inactivation of APC. The wide spectrum of 
the APC mutation cluster region mutations could, in contrast to codon 12 and 13 mutations 
in the KRAS gene (harbouring mainly G changes), serve as a potential useful fingerprint for 
long term exposure to dietary heme iron.  However, these conclusions are speculative and 
our findings need to be reproduced in future research. 
In line with previous experimental evidence, we showed that heme iron intake was 
positively associated with the risk of P53 overexpressed colorectal tumors. However, 
because the absence of P53 overexpression does not necessarily imply the absence of TP53 
mutations, and P53 overexpression may occur in the absence of mutations and vice versa 
[54, 55] we are prudent when interpreting these findings.  
The observed risk estimates were weaker and more unstable in rectum cases compared to 
colon cases. Although this may partly be attributed to the lower number of rectum cancer 
Chapter 9 
 
176 
cases, previous studies suggest that dietary risk factors for colon and rectum cancer may 
differ as a result of, for instance, physiologic and biochemical sub-site differences [9, 56] 
that could affect the carcinogenic potential of meat mutagens such as heme iron. 
Nonetheless, tests for heterogeneity suggest that there is no statistical heterogeneity 
between the rectum and the colon endpoint, and results should be interpreted with 
caution.  
The present study illustrates that when unraveling the mechanisms underlying the 
association between heme iron and colorectal cancer risk, it is valuable to take both 1) 
specific meat carcinogens such as heme iron, and 2) the molecular heterogeneity of the 
colorectal endpoint into account. Failure to do so may result in attenuated risk estimates as 
reflected in previous analyses from our cohort [7, 27, 28]. 
Remarkably, the associations presented herein were stronger after additional adjustment 
for fresh and processed meat intake. This may be explained by the previously reported 
suggestive inverse associations between total meat intake, particularly pork consumption, 
and the risk of colon and rectal cancer harboring specific mutations in this population [27, 
28]. However, heme iron captures the variation in red meat intake better than pork 
consumption alone, which is consumed at relatively high amounts in our population. By 
adjusting the associations for total meat intake we attempted to partly adjust for all other 
mechanism by which meat intake may cause colorectal cancer, and our findings may 
indeed suggest that heme iron itself is an important player in meat induced carcinogenesis. 
In addition, when adjusting our analyses for total meat intake, an increase in heme iron 
intake results from a displacement in the composition of total fresh meat intake (e.g. pork 
to beef ratio). If other characteristics (e.g. cooking methods) differ for specific subtypes of 
meats and are relevant to colorectal cancer, this could result in residual confounding. In 
addition, other dietary characteristics specific to high heme iron consumers that are not 
captured by the covariates in the model could also result in residual confounding. 
Our heme iron database was based on the total iron content of each meat item in the 
Dutch food composition database whereby an animal-specific proportion of heme iron 
relative to total iron was applied, as derived from analytical data reported in the literature 
for cooked meats. Heme iron values were available for all meat items in the FFQ, including 
specific Dutch items and cuts. Nevertheless, our method fails to account for effect of the 
cooking- method and duration on the conversion of heme iron to non heme iron; 
information that is available in the database developed at NCI [57, 58]. To evaluate the 
accuracy of our heme iron estimates, we compared the heme iron concentrations of meat 
items from our database to the NCI database, for those meat items for which an American 
equivalent was available [58]. The concentrations heme iron in pork, chicken and processed 
meat were comparable across both databases but the heme iron content of beef items (i.e. 
steak and hamburger) was considerable higher in the NLCS database.  
We were not able to account for other, possibly correlated, meat mutagens such as 
heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) which are formed 
in meats when cooked well-done at high temperatures [59, 60]. Although both groups of 
mutagens have shown to be implicated in DNA-adduct formation [61, 62] and colorectal 
carcinogenesis [59], they cannot explain the differential carcinogenic effect of white and 
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red meat in the colon. Also a recent dietary intervention study with red meat showed that 
the observed increase in fecal genotoxicity was not likely to be explained by increased 
levels of HCAs or PAHs, but most likely due to heme iron mediated processes [63].  
Our analyses have been performed using baseline FFQ data, resulting in an inability to 
assess and account for changes in intake and food compositions over time. However, the 
FFQ has shown to be representative for dietary habits over a period of at least 5 years [38]. 
The prospective design reduced the potential for recall bias, and the nearly complete 
follow-up of cases and subcohort members, makes selection bias unlikely. Detailed 
information on diet and potential risk factors of colorectal cancer enabled us to control for 
most known risk factors, although misclassification of exposure may have occurred. Finally, 
although our results support prior biological hypotheses we cannot rule out the possibility 
of chance findings given the relatively small subgroups of mutation specific colorectal 
tumors and the numerous associations investigated.  
In conclusion, this is the first cohort study reporting the association between heme iron 
intake and the risk of colorectal cancer harboring specific mutations in key genes. Our 
results suggest that heme iron intake is especially associated with an increased risk of 
colorectal tumors harboring G>A transitions in KRAS and APC and overexpression of P53. 
These novel findings suggest that alkylating rather than oxidative DNA damaging 
mechanisms are involved in heme-induced colorectal carcinogenesis. 
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In the previous chapters we described a series of studies aimed at comprehensively 
investigating the association between meat consumption and cancer risk focusing on meat-
related dietary patterns and specific meat-related carcinogenic pathways.  This chapter 
contains a discussion of the most important findings in light of some important strengths 
and weaknesses of the study designs and analyses. Furthermore, recommendations for 
future epidemiological research are given.  
MAIN FINDINGS 
In part A of this thesis, we focused our analyses on meat consumption as part of a dietary 
pattern. This section started with two studies on meat consumption patterns and non-
cancer health outcomes (i.e. weight change and risk of vitamin B12 and folate deficiency), 
since these may affect or explain some of the association between vegetarian and low 
meat diets and cancer risk. Although baseline BMI values were strongly positively 
associated with meat intake, we found no association between total meat intake and 
changes in BMI over 14 years of prospective follow-up in the Netherlands Cohort Study 
(NLCS). Nonetheless, modest differential BMI change effects were observed for some 
subtypes of meat. In the EPIC-Oxford study, we showed that vegetarians, and especially 
vegans, were at an increased risk of developing a vitamin B12 deficiency. Because low meat 
consumers are likely at a reduced risk of developing nutrient deficiencies, we subsequently 
investigated if they also had an additional beneficial cancer preventive effect over 
vegetarians when compared to individuals who consume meat on a daily basis.  In order to 
study how a vegetarian or low meat diet (i.e. meat 1 day/week) influences the risk of 
cancer compared to a more common high meat diet, we extracted the NLCS-Meat 
Investigation Cohort (NLCS-MIC) from the total NLCS cohort. In line with our expectations, a 
baseline comparison of this cohort indicated that vegetarians, pescetarians, and individuals 
consuming meat for 1 day/week had a more favorable distribution of (non-)dietary cancer 
risk factors (e.g. high intakes of fruit and vegetables, lower smoking rates) compared to 
regular meat consumers. Additionally, we observed that as much as 50% of all the 
individuals who classified themselves as vegetarian (based on 1 item on the first page of 
the questionnaire) reported (some) meat or fish consumption on the extensive FFQ. 
However, the misclassification that occurred in terms of baseline diet (other than meat) 
and lifestyle characteristics using these self-reports was relatively small.  
Our hypothesis that low meat diets result in a similar or perhaps even a lower cancer risk 
than vegetarian diets when compared to a high meat diet could only partly be verified. 
Compared to high meat consumers (defined as individuals who eat meat for 6-7 
days/week), both non- and low meat consumers had a non-significantly decreased risk of 
colorectal, especially rectal, cancer which attenuated after adjustment for confounders. In 
age and sex adjusted models, a decreased risk of lung cancer was observed for vegetarians 
and pescetarians, but this effect disappeared after taking confounders, especially smoking, 
into account. No associations between meat consumption group and female breast cancer 
were observed, while low meat consumers had an increased risk of advanced prostate 
cancer. However, this latter observation is likely due to chance. As a result of our sampling 
strategy, we had a wide distribution of meat intake in the NLCS-MIC compared to many 
other population-based studies. This prompted us to also examine the association between 
individual (sub) types of meat and cancer risk next to the previously described dietary 
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pattern analyses. In these analyses, we did not observe clear associations between total 
fresh and fresh red meat intake and any of the investigated cancers. However, high 
consumption of processed meat was associated with an increased risk of rectal cancer, and 
an unexpected reduced risk of advanced prostate cancer. 
In part B of this thesis, we investigated several of the proposed meat-related carcinogenic 
pathways in relation to the cancer endpoints most likely to be affected. Contrary to our 
hypothesis that the high fat content from meat may be responsible for the meat-cancer 
association, no clear evidence for an association between dietary fat and meat intake and 
ovarian cancer risk was found in the NLCS. Although trans unsaturated fatty acids were 
associated with an increased risk of ovarian cancer, the majority of this type of fat at the 
time of the baseline assessment, does not originate from meat, but stems from margarines, 
packaged baked products and fast foods. In addition, consumption of heterocyclic amines 
(HCAs), polycyclic aromatic hydrocarbons (PAHs), and nitrite/nitrate was not strongly 
associated with the risk of colorectal adenomas and colorectal cancer in the PLCO 
Screening Trial. By using novel data reduction techniques (i.e. a two-step test for G×E 
interactions) we found evidence that a genetic variant in the NAT1 gene modified the effect 
of MeIQx intake on colorectal adenoma risk. Additional effect modification of the 
association between other compounds and colorectal adenoma and cancer risk by variants 
in other xenobiotic metabolizing enzymes (XME) genes were also observed. However 
correction for multiple comparisons indicated that these latter were likely due to chance. In 
our next study, we found supportive evidence for the role of heme iron in colon 
carcinogenesis in the NLCS. Our analyses suggest that heme iron probably results in 
alkylating DNA damage in the colon by initiating specific G>A transitions in several 
colorectal cancer key genes (e.g. APC and KRAS).  
METHODOLOGICAL CONSIDERATIONS 
Because the study of vegetarian and low meat diets can introduce specific sources of bias 
that are less likely to occur when studying individual food items, this section will highlight 
several methodological issues. 
Selection bias 
It is unlikely that selection bias has distorted the results presented in this thesis. Selection 
bias due to selection of the study population in a cohort study as the NLCS (including the 
NLCS-MIC) and EPIC-Oxford is unlikely because the entire population is disease free at 
baseline. Selection bias in prospective cohort studies may occur when participants are lost 
to follow up and when this depends on exposure and future outcome status [1]. However, 
in the NLCS the completeness of cancer follow-up was estimated to be >96% [2, 3] and less 
than 1% of the cohort members were lost to follow-up for vital status, making selection 
bias very unlikely. Vegetarians were overrepresented to increase the meat exposure 
contrast in the NCLS, but we do not expect that this has introduced selection bias. The 
colorectal adenoma and cancer analyses in the screening arm of the PLCO trial were 
conducted in two separate nested case-control studies. The nested design and the 
screening nature of the trial minimized the chance of selection bias, since both cases and 
controls had an equal opportunity to have a colorectal adenoma or cancer detected. In 
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addition, we only selected advanced adenoma cases to reduce length-time bias associated 
malignancy differences between adenomas. 
Information bias 
All the studies included in this thesis used food frequency questionnaires to estimate 
habitual dietary intake. While faced with certain limitations [4], this is often the most 
practical and economical method of dietary data collection in large scale epidemiological 
studies [5]. Although the FFQs used in the NLCS, the EPIC-Oxford cohort, and the PLCO 
screening trial were specifically designed or adapted for use in their respective population, 
they are still liable to error which may have led to several sources of misclassification. 
However, all the types of misclassification that could have occurred are non-differential, 
meaning that the extent of misclassification does not depend on disease and exposure 
status.   
FFQs are designed to measure long term habitual food intake which is considered the 
conceptually important exposure in etiological studies of cancer [5]. It is, however, likely 
that respondents are unable to exactly report their average consumption of foods (i.e. 
meat), resulting in misclassification of exposure [5]. However, when studying the 
association between diet and cancer, the ranking of subjects according to their dietary 
intake is more important than estimating their absolute intake level. All FFQs used in this 
thesis were validated against some independent superior reference method. For all 
prospective analyses presented in this thesis (Chapters 2, 4-9), the information on dietary 
intake and lifestyle was only ascertained at baseline. However, the questionnaire used in 
the NLCS was shown to be representative for dietary habits over a period of at least 5 years 
[6] whereas the FFQ used in the PLCO Screening trial was adapted from the Willet and 
Block FFQs with moderate to good reliability [7, 8].  
There are additional sources of misclassification that could have arisen specific to the study 
of meat and its associations with cancer. Firstly, the categorization and analysis of meat 
differs between epidemiological studies. Illustrative examples are red meat and processed 
meat [9]. This issue is to some extent also reflected in this thesis, which includes studies 
from the Netherlands, the United Kingdom and the USA. Although in each study it was 
explicitly defined what was meant by red and processed meat, definitions and consumption 
patterns vary by population, which can complicate between-study comparisons. For 
example, in contrast to many other populations, the generation of the NLCS generally eats 
two cold meals a day (for breakfast and lunch) consisting of bread served with a wide 
variety of cold cuts. The types of processed meat consumed also likely differ between these 
three study populations. In addition, the majority of red meat consumed in the Netherlands 
and the United Kingdom consists of pork, whereas beef makes up most of red meat in the 
USA [10].  As a result, the composition of the red and processed meat variable in the NLCS 
is probably different from that in the PLCO screening trial and the EPIC-Oxford cohort, 
which should be taken into consideration when reviewing the literature.  
Secondly, there is no universally accepted definition of vegetarianism. The term vegetarian 
is often used to describe a whole range of diets practiced with varying degrees of animal 
product restriction [11]. In addition, there is substantial inconsistency in how people self-
identify being vegetarian [12, 13]. This challenges the comparison of between-study results. 
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For this reason, we defined vegetarians in the NLCS-MIC using two methods: based on self-
definition and based on their response on the extensive FFQ. Assuming that the latter 
method is most accurate; a cross-comparison suggests that self-definition severely 
overestimated the prevalence of vegetarianism in our population. Although our power was 
somewhat limited, our results suggest that self-defined vegetarian status may attenuate 
risk estimates in etiologic studies of cancer risk. 
Finally, difficulties in quantifying the intake of specific meat mutagens can introduce 
additional information bias. The study of most meat carcinogens is limited to studies that 
have inquired both after 1) type or cut of meat, 2) cooking technique, and 3) doneness level 
[14]. However, many of the early prospective cohort studies, including the NLCS, did not 
incorporate such a detailed meat module in their questionnaire. From the mid-nineties of 
the last century, efforts were made to develop a validated meat-cooking FFQ and meat 
carcinogen database to estimate the intake of HCAs, PAHs, and nitrite/nitrate in 
epidemiological studies [14-17]. Because meat preparation and consumption patterns vary 
greatly between populations, we used a population specific meat cooking module for the 
analysis described in Chapter 8. In contrast, cooking methods do not seem to have a large 
effect on the heme iron content of the meat; a comparison between the literature based 
NLCS database used in Chapter 9 and a database containing measured values from cooked 
meats developed by NCI [18] generally yielded comparable concentrations.  
In the molecular epidemiological studies reported herein (Chapter 8 and 9), there is the 
additional problem of possible measurement error and misclassification of genotype and 
molecular pathological endpoint. It is therefore important to use validated molecular 
markers and perform quality control measurements [19, 20]. In addition, we excluded 
individuals with genotyping call rates below 90% in the PLCO screening trial (Chapter 8), 
and cases with poor quality tumor material (i.e. insufficient DNA) in the NLCS (Chapter 9) 
from all presented analyses.  
At the time of exposure measurement all the populations under study were disease free 
except for the prevalent adenoma study in the PLCO screening trial. However, adenomas 
are largely asymptomatic, and at the time of the questionnaire respondents did not know 
the results of their colonoscopy. Therefore, this has likely not resulted in differential 
reporting of meat consumption in this population. All the above listed sources of non-
differential misclassification tend to bias the effect estimate to the null [5] and can lead to 
attenuation of the true meat-cancer association. This may have resulted in an 
underestimation of the observed effects and might partially explain some of the observed 
null-results.  
Confounding 
Although all observational studies in general should adequately adjust for confounding 
variables in analyses in order to prevent bias [1], issues relating to confounding are of 
particular interest when studying the health effects of vegetarian and low meat diets. A 
common criticism of the causal interpretation of observational studies investigating the 
association between vegetarian diets and cancer risk is that these populations are likely to 
exhibit a number of other potential cancer preventive factors and behaviors next to the 
(near) avoidance of meat. This can result in different levels of confounding ranging from a 
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more beneficial lifestyle and a healthier diet to more subtle self-selection processes, as 
described below.  
Firstly, vegetarians and low meat consumers are committed to a general healthy lifestyle. 
This is reflected in a beneficial distribution of non-dietary factors including physical activity, 
BMI, alcohol consumption and smoking which was also observed in the NLCS-MIC. 
However, most prior studies examining cancer risk in vegetarians have controlled for 
confounding by some but not all of these factors. The Adventist Health Study had the 
unique opportunity to study cancer risk of vegetarians independent of the effect of 
smoking and alcohol consumption since both the vegetarians and meat consumers in this 
population were generally non users [21]. In the NLCS-MIC, correction for all the above 
mentioned lifestyle factors resulted in an attenuation of the association of vegetarians and 
low meat consumers. This was especially true for lung cancer, where the lower risk among 
vegetarians compared to high meat eaters disappeared after adjusting for smoking status, 
duration and to a lesser extent, frequency.  
Secondly, we showed that vegetarian and low meat diets include larger amounts of fruits, 
vegetables, and fiber. Although none of these food groups are unique to these diets, the 
(near) avoidance of meat automatically allows for more plant based food in the diet. An 
abundant consumption of many of these products has been independently related with a 
lower risk for several cancers [9]. This raises the possibility that a high plant-food dietary 
pattern may be the true causal protective factor rather than the simple elimination of meat 
from the diet. For this reason, we set out to investigate to what extent differences in cancer 
risk, if present, could (partially) be attributed by confounding dietary variables other than 
meat intake. We observed that, if an association was found, fiber (and to a lesser extent 
fruits and soy products) explained most of the between group risk estimates. This 
observation, however, may result from multicollinearity with other (un)measured dietary 
variables that characterize a low and no meat diet. Dietary fiber intake may also simply be a 
good overall marker for the vegetarian and low meat diet and adjusting for this may have 
resulted in overcorrection of the risk estimates. Nevertheless, all other dietary factors that 
characterize a vegetarian and low meat diet had negligible individual effects, but when 
combined they changed the risk estimates considerably. This illustrates that the combined 
effect of the entire vegetarian and low meat diet may be more powerful than the effects of 
its individual components, and thus more readily detected.  
Lastly, it has been suggested that the lower disease risk in vegetarians compared to non-
vegetarians may be explained by selective factors related to who chooses to become and 
remain a vegetarian [22, 23]. Vegetarians are suggested to have different social 
backgrounds and education compared to meat eaters, and may have taken up their dietary 
habit because they are health-conscious. This may also lead to different health care seeking 
behavior.  In addition, prior illness may have prompted individuals to adopt a diet void of 
meat. In the NLCS-MIC, we showed that the proportion of prevalent cancer cases was 
highest among the vegetarians and pescetarians and significantly decreased with increasing 
meat intake. This suggests that self-selection mechanisms should be taken into 
consideration in etiologic studies. Compared to the two previously mentioned classes of 
confounding, it is more difficult to accurately adjust for these subtle selective factors in 
analyses. Therefore, we excluded all prevalent cancer cases from analysis and adjusted the 
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risk estimates for level of education. When similar cancer risks are observed across 
different populations of vegetarians it is more likely that the results can be attributed to 
the diet and lifestyle as such rather than any underlying selection processes. Although 
other studies on low meat consumers are scarce, findings from the NLCS-MIC were 
generally comparable to the results from other prospective studies investigating vegetarian 
diets in relation to colorectal, lung, female breast and overall prostate cancer risk [21, 24-
27]; after correction for confounders no large differences in cancer risk were observed 
between vegetarians and non-vegetarians/high meat consumers.  
Depending on the specific research question of interest, adjustment for one or more of 
these three levels of confounding (i.e. lifestyle, diet, and selective factors) is required. For 
example, studies comparing vegetarian to meat eating populations that are mainly 
concerned with the adverse effects of meat on cancer risk, warrant adjustment for all three 
levels in order to extract the individual effect of meat consumption. However, it is equally 
interesting to study the complete vegetarian diet or vegetarian lifestyle in relation to 
disease. For this, one would suffice by adjusting for lifestyle and selective factors or 
selective factors only, respectively. Nonetheless, if an association with a dietary pattern or 
lifestyle is found, one does not know which factor(s) are (primarily) responsible for the 
observed effects. This lack of specificity likely leads to broad, less focused, and potentially 
less effective cancer preventive recommendations. Within the NLCS-MIC we were able to 
study both research questions by adjusting our analysis for multiple levels of confounding. 
Although somewhat underpowered, our study suggests that both dietary and non-dietary 
factors associated with low and no meat diets contribute to differences in colorectal, lung, 
and prostate cancer risk.  
BIOLOGICAL PLAUSIBILITY 
Because studying dietary patterns does not enhance biological insight or mechanistic 
understanding of the meat cancer association [28], we have investigated several of the 
hypothesized pathways of meat-related carcinogenesis (dietary fat, HCAs, PAHs, 
nitrate/nitrite, and heme iron) in the second part of this thesis. Where possible, we 
specified these associations for certain genetic variants or molecular pathological changes 
to provide further evidence for a causal relationship between specific types of meat 
(carcinogens) and cancer. 
Dietary fat and ovarian cancer risk 
We did not find evidence that fat from fresh and processed meats increased the risk of 
ovarian cancer (RR 1SD increase = 0.98; 95% CI: 0.87-1.09). Neither did we find a clear dose 
response association for animal fat, saturated fat, or total fat which may be present in high 
quantities in a meat-rich diet.  Since the publication of our results, the AARP cohort 
(including nearly 700 cases) reported that fat intake from animal sources was positively 
associated with ovarian cancer risk (RRQ5 vs Q1=1.30; 95% CI: 1.02–1.66) [29]. This 
discrepancy in findings may partly result from the wider range of dietary fat intake in the 
AARP population (USA) (percent energy intake from fat p10: 20%; p90: 40%) compared to 
the Dutch in the NLCS (p10: 32%; p90: 46%). The Women’s Health Initiative Dietary 
Modification Trial suggested that a low fat dietary pattern (24.3% compared to 35.1% 
energy from fat after 1 year from baseline for the intervention and control group, 
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respectively) may reduce the incidence of ovarian cancer in post-menopausal women [30]. 
Nonetheless, the overall epidemiological evidence linking dietary (animal) fat to ovarian 
cancer remains inconsistent and is not strongly supportive of the dietary fat hypothesis of 
meat-related carcinogenesis for this cancer endpoint [9]. The absence of such a clear 
association is in line with a meta-analysis of eight cohort studies (including ours) that did 
not observe a dose-response relation between red and processed meat intake and the risk 
of cancer of the ovaries [31].   
G×E interactions, meat carcinogens, and colorectal neoplasia  
Despite the strong carcinogenic potential of individual HCAs, (PhiP, MeIQx, and DiMeIQx), 
PAH (B[a]P), and nitrite/nitrate in animal studies [32-36], evidence in humans remains 
inconsistent [9]. As illustrated in Chapter 8, consumption of these compounds was not 
strongly associated with the risk of colorectal adenomas and colorectal cancer in the PLCO 
Screening Trial. To further elucidate these findings, we investigated the combined effect of 
these mutagens and genetic variants in genes involved in the activation and detoxification 
of these compounds (XME genes). Studying such gene-environment (G×E) interactions may 
also help to identify individuals at highest risk of cancer based on both their meat 
consumption patterns and genetic risk profiles. This knowledge may eventually be used to 
tailor interventions aimed at cancer prevention. Although this is a promising avenue to 
pursue, the application of genetic based personalized nutrition in the immediate future is 
hampered the paucity of reproducible findings. This likely results from the limited power of 
many G×E interactions studies [37].  
There are many approaches that can be used when studying G×E interactions as 
summarized by Hutter [38]. The strategy of choice depends on many factors including the 
study design and the gene and SNP selection strategy (ranging from agnostic genome wide 
comparisons to hypothesis driven studies). Within a nested case control setting we opted 
for a hypothesis based approach aimed at covering the complete genetic variation in the 
genes involved in meat mutagen metabolism pathways. Because the experimental 
literature on the role of XME genes in relation to HCA, PAH and NOC metabolism is far from 
complete, we did not restrict our analyses to those gene-mutagen interactions previously 
reported. We conducted a tagSNP selection (to maximize genetic coverage) and combined 
this with the selection of all SNPs with known or putative functional significance. This 
resulted in the selection of >500 SNPs that were studied in interaction with the five 
different meat mutagens. In order to reduce the multiple testing burden associated with 
this endeavor we applied Murcray’s two-step approach [39], a novel data reduction 
technique, to increase statistical power. The essence of this approach is to screen on 
marginal environmental effects for the individual SNPs, and then test G×E interactions for 
these SNPs. Numerous comparable methods have been proposed in an attempt to improve 
the limited power of G×E interaction studies (as discussed in ref 40-41).  
In line with our hypothesis, we found some evidence that common variants in XME genes 
may modify the association between meat mutagens and colorectal cancer. However, 
genetic variation in these genes could not explain as much of the (lack of) association 
between meat carcinogen intake and colorectal neoplasia as expected a priori. This is a 
common issue in many hypothesis driven G×E interaction studies. Despite many years of 
candidate gene studies in cancer, there are only a handful of examples of replicated and 
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widely agreed-upon successes (e.g. ALDH2, alcohol and esophageal cancer [42]; NAT2, 
smoking and bladder cancer risk [43]). In our attempt to further elucidate the association 
between meat (carcinogens) and cancer risk we may need to shift our focus towards 
identifying novel loci by using agnostic G×E-wide interaction studies (GEWIS). Now that the 
costs of genotyping are rapidly declining, the first genome-wide initiatives to study G×E 
interactions have been reported in the literature (e.g. [44, 45]). However, for GEWIS to be a 
success, it is crucial to form consortia with standardized exposure data in order to increase 
statistical power. 
All the previously discussed methods are single-marker approaches, studying one G×E 
interaction at a time. However, it is generally accepted that cancer results from a complex 
interplay of genetic and environmental risk factors. It may therefore be interesting to apply 
a more global approach that simultaneously considers al the genetic markers in an entire 
pathway of interest [46]. This may provide insight in how the carcinogenic effect of meat 
may vary according to a person’s genetic profile.  
This section illustrates that the study of G×E interactions is a rapidly developing discipline. 
As a consequence, many different designs, gene/SNP selection strategies, and methods of 
analysis are currently being developed and applied in an attempt to further decipher the 
diet related carcinogenesis process (i.e. meat consumption). The future will tell us what 
these new initiatives have brought us and how we can best proceed to move the nutritional 
cancer epidemiology field forward.  
Molecular pathological epidemiology, heme iron, and colorectal cancer  
It has been put forward that in contrast to HCA and PAH intake, the amount of heme iron 
consumption may be able to better explain the differential effect of red and white meat in 
colorectal carcinogenesis [47]. While experimental studies have generated considerable 
mechanistic evidence supportive of the role of heme iron in carcinogenesis, insight in the 
underlying mechanisms from population based observational studies are lacking. Colorectal 
cancer is, like many other cancers, a heterogeneous disease that can be characterized by 
different sets of (epi-)genetic alterations [19]. We therefore classified colorectal cancers 
into a limited number of groups based on their (specific point-) mutation status of a 
number of colorectal cancer key genes (i.e. APC, KRAS) and expression of P53. This enabled 
us to identify tumors that have arisen through common mechanisms and may thus reveal 
underlying mechanisms of carcinogenesis. As extensively discussed in Chapter 9, by 
applying this novel molecular pathological epidemiological approach we were able to show 
that heme iron was most likely associated with colorectal cancer through alkylating, rather 
than oxidative, DNA-damaging mechanisms (as evidenced by an increased risk of colorectal 
tumors with especially G>A mutations).  
Even though genetic aberrations in APC and KRAS are considered early events in colorectal 
carcinogenesis, it remains questionable whether the observed mutations are in fact caused 
by heme iron and have by itself driven cancer initiation or progression [19]. Heme iron 
exposure could also have created an environment that provided a selective advantage for 
clonal expansion of colonic cell with a specific molecular change [19]. Nevertheless, as 
outlined by Ogino et al., even if a given molecular change is consequential rather than 
causal, the change can be a good surrogate marker of a certain cancer pathway, but may 
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also ultimately become a driver in later steps of tumor progression [19]. It is known that 
colorectal tumors often display considerable intratumor heterogeneity. We tried to capture 
some of this heterogeneity by isolating DNA from five separate 20 µm sections of the 
tumor block [48], but may still have missed some relevant genetic tumor variation.  
Comparable to the previously discussed studies of G×E interaction, molecular pathological 
epidemiology is also faced with multiple testing issues. The NLCS is one of the largest 
studies conducted to date that has collected information on molecular endpoints of 
(colorectal) cancer and baseline dietary intake (i.e. meat). However, despite this size, we 
were, like any other molecular pathological epidemiology study, faced with multiple 
exclusions based on the availability of tumor material and valid assay results [19]. In our 
effort to examine the association with heme iron, a subset analysis for different outcomes 
(KRAS mutated versus KRAS wild type tumors) was conducted. The sample size for rarer 
events (e.g. specific KRAS G>A or G>T mutations) may not have been large enough to 
provide adequate statistical power. However, because such specific point mutations (i.e. 
G>A and G>T) are not limited to the genes under study, it may be interesting to sum the 
occurrence of these specific mutations in the entire tumor genome to increase power in 
future analyses using novel cancer genome sequencing techniques.  
One solution to overcome the sample size problem is to pool data from independent 
studies that have both information on dietary exposure and molecular heterogeneity of the 
tumor available. Several large pooling initiatives are currently being developed. For 
example, in the Netherlands, the prestigious BBMRI rainbow initiative sets out to (further) 
enrich several prospective Dutch cohorts (including the NLCS) with tumor tissue material. 
From this, tissue microarrays will be constructed which will enable us to study protein 
expression of hundreds of tumors at the same time. When completed, this yields an 
extremely powerful infrastructure for molecular pathological epidemiology research into 
diet (i.e. meat) and cancer.  
RECOMMENDATIONS FOR FUTURE RESEARCH 
Based on the findings presented in this thesis, future research with respect to the study of 
(low) meat consumption, vegetarianism, and cancer risk may focus on the following: 
• Further investigate the role of vegetarian and low meat diets on cancer risk, 
specifically focusing on cancer subtypes (by stage and location) and the 
explanatory role of specific components characteristic for these diets (e.g. by 
pooling of individual study data). 
• As mentioned above, molecular epidemiology techniques (including G×E 
interactions, molecular pathological epidemiology) should be used to further 
elucidate the mechanisms underlying the meat cancer association.  The field of 
molecular epidemiology is dynamic and new markers and associated statistical 
analysis techniques continue to be developed.  
• The findings from observational molecular epidemiology should ultimately be 
tested in experimental studies to accurately assess the effect of specific dietary 
modifications (e.g. low meat diets) on intermediate biomarkers or cancer 
outcomes in a controlled setting. Such studies can help to design personalized 
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cancer prevention strategies that may be more effective than the existing general 
guidelines (e.g. those from the WCRF [9]). 
• Use the knowledge of specific meat-related carcinogenic pathways to identify 
strategies to change or intervene on the processes that lead to meat carcinogen 
formation such as changing the diet, the production process, or additives. 
Promising examples include adding calcium carbonate [49, 50] (to bind heme iron) 
or vitamin C or E [49, 51] (to inhibit nitrosamine formation) to the diet, developing 
anaerobic storage and packaging techniques [52] (to prevent oxidation), and 
omitting nitrite from curing solutions of processed meat products (e.g. by adding 
phytochemicals [53]).  
CONCLUDING REMARKS 
This thesis illustrates that meat consumption is a complex exposure variable that calls for 
multiple approaches when studying its association with cancer risk. We believe that the 
dietary pattern and meat carcinogen approach that were applied in this thesis have shown 
to provide a valuable addition to the previously more common conducted traditional 
analyses at the food level (i.e. (subtypes of) meat).  
The epidemiological studies described in this thesis do not support a strong association 
between meat consumption and the major cancers under study. When compared to 
individuals consuming meat on a daily basis, our univariate analyses suggest that 
vegetarians and low meat consumers were at a reduced the risk of lung and colorectal 
cancer, respectively, but this effect attenuated and lost statistical significance after 
correction for confounders. Based on our cancer risk estimates, there is no reason to 
completely exclude meat from the diet. In fact, individuals consuming small amounts of 
meat may be less prone to develop vitamin B12 deficiencies as compared to strict 
vegetarians. When consuming meat very infrequently, it could be argued that it may be 
more important to make a sound decision concerning which type of meat to include in your 
diet. Our findings for example suggest that meat rich in heme iron likely increases the risk 
of colorectal cancer.  
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ENGLISH SUMMARY 
Since the early ecological evidence in the seventies of the last century suggested that meat 
consumption was associated with the risk of (especially colorectal) cancer, hundreds of 
individual-level epidemiological studies have reported on the relation between meat and 
cancer. However, despite these scientific efforts, the effect of meat consumption on cancer 
risk remains a controversial issue.   
For this reason, this thesis set out to investigate the association between meat 
consumption and cancer risk using a multi-dimensional epidemiological approach. The first 
chapters of this thesis focus on vegetarian and low meat dietary patterns in relation to 
cancer risk, whereas specific mechanisms of meat-related carcinogenesis (i.e. dietary fat, 
heterocyclic amines (HCAs), polycyclic aromatic hydrocarbons (HCAs), nitrite/nitrate, and 
heme iron) are examined in the second part of this thesis.  
PART A: A Dietary Pattern Approach 
This section starts with two studies on meat consumption patterns and non-cancer health 
outcomes because these may, in turn, affect the association between low meat diets and 
cancer risk.  
It is well-accepted that a large body size is associated with an increased risk of many 
cancers, but the association between meat consumption and prospective weight gain 
remains to be elucidated. In Chapter 2, we assessed the association between meat 
consumption at baseline and change in BMI over six and 14 y of follow-up using data from 
the population based Netherlands Cohort Study (NLCS). At baseline, all participants filled 
out a questionnaire on dietary habits, anthropometry, and other risk factors for cancer. The 
NLCS is a case-cohort design with a subcohort of 5000 individuals randomly selected from 
the larger cohort on recruitment into the study. Follow-up of the subcohort has allowed for 
the additional accumulation of prospective data regarding risk factors for cancer including 
body weight. This subcohort was the study population used in this chapter. We showed 
that total meat consumption at baseline was positively associated with BMI at baseline, but 
it did not strongly affect subsequent weight gain over a 14 y period. Nonetheless, modest 
differential BMI change effects were observed for some subtypes of meat. Results 
remained similar when stratifying on median baseline BMI.   
Individuals following a vegetarian or vegan diet are likely at higher risk of developing 
nutrient deficiencies i.e. vitamin B12. This vitamin is naturally present only in foods of 
animal origin. In Chapter 3 of this thesis we therefore investigated whether vegans and 
strict vegetarians were at an increased risk of developing a deficiency. We used cross-
sectional data from the large European Prospective Investigation into Cancer and Nutrition 
Oxford cohort to show that mean serum vitamin B12 was highest among omnivores 
(n=226), intermediate in vegetarians (n=231), and lowest in vegans (n=232). Nearly half of 
the vegans were categorized as vitamin B12 deficient and would be expected to have a 
higher risk of developing clinical symptoms related to vitamin B12 deficiency. There was no 
significant association between age or duration of adherence to a vegetarian or a vegan 
diet and vitamin B12. Based on these findings, both vegetarians and vegans should ensure a 
regular intake of sufficient vitamin B12 from fortified foods and/or supplements. 
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The few prospective cohort studies that were specifically set out to study cancer incidence 
in vegetarians have reported mixed results. In addition, no study has examined the effects 
of low meat consumption on cancer risk. In order to study how a vegetarian and low meat 
diet (i.e. meat 1 day/week) influences the risk of cancer compared to a more common high 
meat diet, we extracted the NLCS-Meat Investigation Cohort (NLCS-MIC) from the total 
NLCS cohort. The NLCS was followed up for cancer incidence through linkage to the 
Netherlands Cancer Registry, and the Netherlands Pathology Registry. The NLCS aimed to 
over-represent vegetarians and low meat consumers at recruitment by intentionally 
contacting them through health food shops and magazines. By using the extensive dietary 
data from the FFQ, we were able to classify vegetarians based on self-reporting (1 
question) as well as on the more accurate and extensive FFQ data. As a result, the NLCS-
MIC was defined by combining all FFQ-confirmed vegetarians (n=702), pescetarians (n=394) 
and 1 day/week meat consumers (n=1396) from the total NLCS cohort, with a random 
sample of 2-5 days/week and 6-7 days/week meat consumers (n=2965 and 5648, 
respectively). Consequently, we could not only study vegetarianism and low meat 
consumption in relation to major cancer outcomes (colorectal, lung, female breast and 
prostate) but were also able to investigate the reliability of self-defined vegetarianism.  
In line with our expectations, a baseline comparison of the NLCS-MIC (Chapter 4) indicated 
that vegetarians, pescetarians, and individuals consuming meat for 1 day/week had a more 
favorable distribution of (non-)dietary cancer risk factors (e.g. high intakes of fruit and 
vegetables, lower smoking rates) compared to regular meat consumers (defined as 
individuals who eat meat for 6-7 days/week). Additionally, we observed that as much as 
50% of all the individuals who classified themselves as vegetarian (based on 1 item on the 
first page of the questionnaire) reported (some) meat or fish consumption on the extensive 
FFQ. However, the misclassification that occurred in terms of baseline diet (other than 
meat) and lifestyle characteristics using these self-reports was relatively small. We showed 
that the proportion of prevalent cancer cases was highest among the vegetarians and 
pescetarians and significantly decreased with increasing meat intake. This suggests that 
such selection mechanisms should be taken into consideration in etiologic studies. 
We then investigated the association between these meat consumption groups and 
colorectal cancer risk in Chapter 5 in the NCLS-MIC. After 20.3 years of follow-up and 
exclusion of prevalent cancer cases, 437 colorectal cancer cases (307 colon, 92 rectal) were 
available for analyses. Compared to high meat consumers, both non- and low meat 
consumers had a non-significantly decreased risk of colorectal, especially rectal, cancer 
which attenuated after adjustment for confounders. In fact, most of the differences in risk 
estimates between these meat consumption groups could be explained by differences in 
dietary pattern other than meat intake. No statistically significant differences in colorectal 
cancer risk between vegetarians and non-vegetarians were observed, but the inverse 
association was stronger using FFQ-confirmed vegetarian status over self-defined status. 
Chapter 6 describes the association between meat consumption group and the risk of lung, 
female breast and advanced and overall prostate cancer using data from the NLCS-MIC 
after 20.3 y of follow-up. In age- and sex adjusted analyses, a statistically significant 
reduced risk of lung cancer for vegetarians and pescetarians was found when compared 
with 6-7 days/week meat consumers (Hazard Ration (HR): 0.44, 95% confidence interval 
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(CI): 0.21-0.94, and HR: 0.28, 95%CI: 0.09-0.88 respectively). However, further adjustment 
for confounding (especially smoking) attenuated these associations such that they were no 
longer significant (HR: 0.85 and 0.54, respectively). Vegetarians, pescetarians and 1 
day/week meat consumers did not have a reduced risk female breast and overall prostate 
cancer compared to individuals consuming meat on a daily basis. Our unexpected 
observation that ≤1day/week meat consumption was associated with increased risk of 
advanced prostate cancer warrants investigation in other studies. 
PART B: A Mechanistic Approach 
In the second part of this thesis, we set out to study each of the proposed mechanisms of 
meat-related carcinogenicity in relation to the cancer endpoints most likely to be affected.  
Dietary fat, particularly saturated fat, has long been suspected to be responsible for the 
meat-cancer association. However, epidemiological studies have been inconsistent and 
intervention studies aimed at lowering total fat intake failed to confirm any association 
with cancer risk except for cancer of the ovaries. By performing a case-cohort analysis in 
the total NLCS cohort, we did not find evidence that fat from fresh and processed meats 
increased the risk of ovarian cancer after 16.3 y of follow-up (Chapter 7). Neither did we 
find a clear dose response association for animal fat, saturated fat, or total fat which may 
be present in high quantities in a meat-rich diet. The multi-variable HR for the highest 
compared to the lowest quintile of trans-unsaturated fatty acid intake was 1.51 (95%CI: 
1.04-2.20; P-trend=0.01). This type of fat, however, does not stem from meat, but from 
margarines, packaged baked products and fast foods.  
Specific meat mutagens, including HCAs, PAHs, and N–nitroso compounds (NOCs), may be 
involved in colorectal carcinogenesis depending on their activation or detoxification by 
phase I and II xenobiotic metabolizing enzymes (XME). Because large scale studies are 
lacking we wanted to investigate the interplay between five meat mutagens and genetic 
variation in 18 XME genes in relation to advanced colorectal adenoma, and colorectal 
cancer (Chapter 8). To this extent we performed two nested case control studies in the 
Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. Dietary intake of 
meat mutagens was assessed using a food frequency questionnaire (FFQ) with a detailed 
meat-cooking module. After adjusting for multiple testing we observed one interaction 
between HCA 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) intake and a NAT1 
polymorphism in the adenoma study. Despite that this was the largest and most 
comprehensive study to date, genetic variation in XME genes could not explain as much of 
the association between meat carcinogen intake and colorectal neoplasia as expected a 
priori. This is a common issue in many comparable hypothesis driven G×E interaction 
studies. However, the study of G×E interactions is a rapidly developing discipline and much 
effort is being put into developing new study designs, gene/SNP selection strategies, and 
methods of analysis to increase statistical power.   
It has been suggested that the positive association between red meat consumption and 
colorectal cancer can be explained by the high heme iron content of red meat.  Because 
heme iron has shown to promote specific mutations, we set out to link heme iron data to 
colorectal cancer with specific mutations in key-genes. For this study, which is described in 
Chapter 9 we used data from the total NLCS cohort. After 7.3 y of follow-up, tumor tissue 
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samples were collected for nearly all colorectal cancer cases based on which KRAS and APC 
mutation status and P53 expression status could be determined. The results from this 
research support the hypothesis that heme iron increases the risk of colorectal cancer. 
Heme iron intake was associated with an increased risk of colorectal tumors harboring G>A 
transitions in KRAS and APC and overexpression of P53. No associations were found with 
CRC harboring G>T mutations in KRAS or APC. These novel findings suggest that alkylating 
rather than oxidative DNA damaging mechanisms are involved in heme-induced colorectal 
carcinogenesis. In addition, it illustrates that novel molecular pathological epidemiology 
techniques can lead to a better understanding of the underlying pathways.    
This thesis concludes with a summary of the main findings, a discussion about the 
limitations, and implications for future research (Chapter 10). We illustrate that meat 
consumption is a complex exposure variable that calls for multiple approaches when 
studying its association with cancer risk. Overall, our results suggest do not support a 
strong association between meat consumption and the major cancers under study. When 
compared to individuals consuming meat on a daily basis, our univariate analyses suggest 
that vegetarians and low meat consumers were at a reduced the risk of lung and colorectal 
cancer, respectively, but this effect attenuated and lost statistical significance after 
correction for confounders. We paid specific interest to issues relating to confounding 
when studying the health effects of vegetarian and low meat diets since we showed that 
these populations exhibit a number of other potential cancer preventive factors and 
behaviors next to the (near) avoidance of meat. Our observation that heme iron may 
promote colorectal cancer risk through specific alkylating mechanisms provides important 
new mechanistic evidence that red meat consumption may indeed be a risk factor for 
colorectal cancer.  
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NEDERLANDSE SAMENVATTING 
In de jaren zeventig van de vorige eeuw suggereerde ecologisch onderzoek dat een hoge 
vleesconsumptie mogelijk geassocieerd was met een hoger risico op (met name darm-) 
kanker. Sindsdien zijn er honderden epidemiologische studies op het individuele niveau 
uitgevoerd om de relatie tussen vlees en kanker beter te kwantificeren. Ondanks deze 
wetenschappelijke inspanningen blijft de relatie tussen vleesconsumptie en het risico op 
kanker controversieel.  
Om deze reden heeft dit proefschrift als doel de associatie tussen vleesconsumptie en het 
kankerrisico verder te onderzoeken. Hiervoor is gebruik gemaakt van een epidemiologische 
benadering vanuit een tweetal perspectieven. In de eerste hoofdstukken gaat de aandacht 
uit naar de relatie tussen vegetarische en laag vlees voedingspatronen en het risico op 
kanker. In het tweede deel van dit proefschrift is gekeken naar specifieke mechanismes 
waarop vlees het risico of kanker kan beïnvloeden (de hoeveelheid vet, heterocyclische 
amines (HCAs), polyaromatische koolwaterstoffen (PAKs), nitraat/nitriet, en heemijzer).  
DEEL A: Een voedingspatroon benadering 
Deze sectie start met twee studies naar de relatie tussen vleesconsumptie en niet-kanker 
gerelateerde gezondheidseffecten zoals gewichtstoename en vitamine B12 deficiënties. 
Deze gezondheidseffecten kunnen namelijk op hun beurt de relatie tussen vleesconsumptie 
en kanker mogelijk beïnvloeden.  
Alhoewel over het algemeen wordt aangenomen dat een hoog lichaamsgewicht het risico 
op veel verschillende type kankers verhoogd, is er nog maar weinig bekend over de relatie 
tussen vleesconsumptie en gewichtstoename over de tijd. In hoofdstuk 2, hebben we 
bekeken hoe vleesconsumptie (gemeten aan de start van het onderzoek) gerelateerd is aan 
veranderingen in de Body Mass Index (BMI in kg/m2) na 14 jaar follow-up. Dit onderzoek is 
uitgevoerd binnen de Nederlandse Cohort Studie naar voeding en kanker (NLCS). Bij 
aanvang van de studie in 1986 hebben alle 120.852 deelnemers een vragenlijst ingevuld 
over eetgewoonte (middels een voedselfrequentievragenlijst (FFQ)), antropometrie, en 
andere risicofactoren voor kanker. De NLCS hanteert een case-cohort benadering wat 
inhoudt dat bij aanvang van het onderzoek, na de beginmeting, een subcohort van 5000 
personen willekeurig is geselecteerd. Van dit subcohort is na zes en 14 jaar follow-up extra 
informatie verzameld over lichaamsgewicht. Met behulp van deze gegevens hebben wij 
aangetoond dat de totale vleesconsumptie bij aanvang van de studie in 1986 sterk positief 
geassocieerd was met de BMI op dat zelfde tijdstip. De totale vleesconsumptie heeft echter 
geen sterke invloed op gewichtstoename over de daaropvolgende periode van 14 jaar. 
Desalniettemin vonden wij enkele bescheiden indicaties dat sommige subtypes van vlees 
een verschillend effect op de verandering in BMI hebben.  
Personen die een vegetarisch of veganistisch dieet volgen hebben mogelijk een grotere 
kans op het ontwikkelen van voedingsdeficiënties zoals een vitamine B12 tekort. Deze 
vitamine is alleen aanwezig in voedsel van dierlijke oorsprong. In hoofdstuk 3 van dit 
proefschrift hebben we daarom gekeken of vegetariërs en veganisten een verhoogd risico 
hebben op een dergelijk tekort. We hebben daarvoor gebruik gemaakt van cross-sectionele 
data van het grote ‘European Prospective Investigation into Cancer and Nutrition (EPIC) 
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Oxford’ cohort. Daarin hebben we aangetoond dat serum vitamine B12 waardes het 
hoogste waren in vleeseters (n=226), gemiddelde waardes hadden in vegetariërs (n=231) 
en het laagste waren in veganisten (232). Bijna de helft van alle veganisten werd 
geclassificeerd als vitamine B12 deficiënt en heeft naar verwachting een groter risico op het 
ontwikkelen van klinische symptomen die gerelateerd zijn aan een vitamine B12 
deficiëntie. Wij vonden geen significante relatie tussen de leeftijd, duur van het 
vegetarische of veganistisch dieet en bloed waardes van vitamine B12. Gebaseerd op deze 
bevindingen zouden zowel vegetariërs en veganisten er voor moeten zorgen voldoende 
vitamine B12 uit verrijkte voeding en/of voedingssupplementen binnen te krijgen.  
Het beperkte aantal prospectieve cohort studies dat speciaal is opgezet om naar 
kankerincidentie in vegetariërs te kijken heeft tot dusver gemengde resultaten opgeleverd. 
Daarnaast heeft geen enkele studie gekeken wat de relatie is tussen een lage vlees 
consumptie (gedefinieerd als één dag per week vlees) en het risico op kanker. Om te 
onderzoeken hoe een vegetarische en een laag vlees dieet het risico op kanker beïnvloedt 
in vergelijking met een meer gebruikelijk hoog vlees dieet, hebben wij het NLCS-Meat 
Investigation Cohort (NLCS-MIC) geëxtraheerd uit het totale NLCS cohort. Het NLCS cohort 
is opgevolgd om nieuwe kanker patiënten over de tijd te kunnen identificeren. Bij de opzet 
van het onderzoek is getracht het aantal vegetariërs en mensen met een lage vleesinname 
te vergroten door deze doelgroep te benaderen via gezondheidsbladen en reformwinkels. 
Door de uitgebreide dataverzameling, waren wij in staat om vegetariërs zowel te 
classificeren op basis van zelfrapportage (één vraag) en op basis van meer gedetailleerde 
FFQ. NLCS-MIC is uiteindelijke gecreëerd door alle ‘FFQ-bevestigde’- vegetariërs (n=702), -
pescetariërs (oftewel viseters) (n=394), en 1 dag/week vleeseters (n=1396) uit het totale 
NLCS-cohort te combineren met een random sample van personen die 2-5 dagen/week en 
6-7 dagen/week vlees eten (respectievelijk n=2965 en 5648). Als direct gevolg hiervan 
konden wij niet alleen onderzoeken hoe een vegetarisch- en laag vlees dieet het risico op 
kanker beïnvloedt, maar ook hoe betrouwbaar de zelfrapportage van de vegetarische 
leefstijl is.  
In de lijn der verwachting toonde een baseline vergelijking van het NLCS-MIC cohort in 
hoofdstuk 4 aan dat vegetariërs, pescetariers, en personen die slechts 1 dag/week vlees 
eten een gunstiger profiel van kankerrisicofactoren hadden (bijvoorbeeld een hogere 
inname van groente en fruit, lagere prevalentie van roken) in vergelijking met personen die 
(bijna) dagelijks vlees aten. Daarnaast vonden wij dat 50% van de personen die zichzelf als 
vegetariër classificeert toch aangeeft vis en/of vlees te eten op de uitgebreide FFQ. De 
misclassificatie die optreedt in termen van baseline voedselinname en leefstijlfactoren 
wanneer men gebruik maakt van zelfrapportage is echter relatief klein. Daarnaast zagen wij 
dat de proportie personen die op de baseline vragenlijst rapporteerde een kanker te 
hebben (gehad) het grootste was onder de vegetariërs en pescerariërs. Deze proportie nam 
verder significant af naar mate men meer vlees rapporteert te eten. Dit suggereert dat in 
etiologisch onderzoek rekening dient te moeten worden gehouden met dergelijke 
onderliggende bias. 
Vervolgens onderzochten we in hoofdstuk 5 de associatie tussen deze vleesconsumptie 
groepen en het risico op colorectaal kanker in NLCS-MIC. Na 20.3 jaar follow-up, en exclusie 
van deelnemers die rapporteerde kanker te hebben (gehad) op de baseline vragenlijst, 
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bleven er 437 colorectaalkanker patiënten (307 colon, 92 rectaal) over voor de analyses. 
Zowel vegetariërs als laag vlees eters hadden een niet significant verlaagd risico op op 
colorectaal, voornamelijk rectaal, kanker in vergelijking met personen die veel vlees eten. 
Dit effect werd minder sterk wanneer er voor confounders werd gecorrigeerd. De meeste 
verschillen in risicoschattingen tussen de vleesconsumptie groepen kon worden verklaard 
door verschillen in voedselconsumptie anders dan vleesinname. Wij observeerde geen 
statistisch significante verschillen in colorectaalkanker risico tussen vegetariërs en niet-
vegetariërs. De inverse associaties waren echter wel sterker wanneer we voor de 
classificatie van vegetariërs gebruik maakten van de FFQ data in plaats van zelfrapportage.  
Hoofdstuk 6 beschrijft de relatie tussen vleesconsumptie groep en het risico op longkanker, 
borstkanker (alleen vrouwen), en gevorderd- en totaal prostaatkanker. Voor deze analyses 
werd wederom gebruik gemaakt van gegevens van het NLCS-MIC cohort na 20.3 jaar 
follow-up. In de univariate analyses hadden vegetariers een meer dan twee keer zo laag 
statistisch significant risico op longkanker in vergelijking met personen die 6-7 dagen per 
week vlees eten. Voor de groep pescetariërs was dit risico 3.5 keer zo laag. Wanneer we 
echter ook corrigeerde voor confounding (voornamelijk roken) attenueerde deze 
risicoschattingen en waren deze niet meer significant. Vegetariërs, pescetariërs en 1 
dag/week vlees eters hadden geen verlaagd risico op borstkanker en totaal prostaatkanker 
in vergelijking met personen die dagelijks vlees eten. Wij zijn de eerste die rapporteren 
over de relatie tussen vleesconsumptie groep en gevorderd prostaatkanker risico. De 
onverwachte observatie dat mannen die ≤1 dag/week vlees aten een verhoogd risico op 
gevorderd prostaatkanker hebben vraagt om verder onderzoek in andere studies.  
DEEL  B: Een mechanistische benadering 
Het tweede deel van dit proefschrift had als doel te onderzoeken via welke mechanismes 
vlees mogelijk het risico op kanker verhoogd. Hierbij hebben wij enkele specifieke 
vleescarcinogenen onderzocht in relatie tot het kanker eindpunt waar deze het meest 
waarschijnlijk mee is geassocieerd.  
Het is lang gesuggereerd dat voedingsvet, en voornamelijk verzadigd vet, verantwoordelijk 
zou zijn voor de relatie tussen vleesconsumptie en het risico op kanker. Epidemiologische 
studies hebben echter inconsistente resultaten opgeleverd en interventiestudies gericht op 
het verlagen van de vetinname hebben ook geen risicoverlagende effect aangetoond, 
behalve voor kanker aan de eierstokken. In hoofdstuk 7 beschrijven wij een case-cohort 
analyse in het totale NLCS-cohort waarbinnen wij geen bewijs hebben gevonden dat vet uit 
vers vlees en/of vleeswaren het risico op eierstokkanker na 16.3 jaar follow-up beinvloed. 
Wij vonden ook geen duidelijke dosis effect relatie voor dierlijk vet, verzadigd vet en totaal 
vet, welke allen in grote mate aanwezig kunnen zijn een een vleesrijk voedingspatroon. 
Vrouwen met de hoogste inname van transonverzadigde vetzuren hadden een 50% 
statistisch significant hoger risico op ovariumkanker dan vrouwen met de laagste inname 
na correctie voor confounders. Dit type vet is echter niet afkomstig uit vlees maar uit 
margarines en fastfood.  
Specifieke vleescarcinogenen, zoals de heterocyclische amines (HCAs), polyaromatische 
koolwaterstoffen (PAKs), en N-nitroso verbindingen (NOCs), zijn mogelijk betrokken in het 
ontstaan van darmkanker. De kankerverwekkende werking van deze componenten is 
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afhankelijk van hun activatie en detoxificatie door fase I en II xenobiotica-metaboliserende 
enzymen (XME). Hier is echter nog weinig onderzoek naar gedaan in grootschalige 
epidemiologische studies. Om deze reden wilden wij in hoofdstuk 8 onderzoeken wat de 
gecombineerde effecten van de bovengenoemde vleescarcinogenen en genetische 
varianten in 18 XME genen zijn in relatie tot het risico op poliepen in de dikke darm en 
dikke darmkanker. Hiertoe zijn twee geneste patiëntcontrole onderzoeken (één bij 
patiënten met poliepen en één bij patiënten met colorectaal kanker) uitgevoerd binnen de 
“Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial”. Voedingsinname 
van de vleescarcinogenen was bepaald doormiddel van een FFQ met een gedetailleerde 
vleesbereidingsmodule. Na correctie voor multiple testing vonden wij één interactie tussen 
de HCA 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) en een polymorfisme in 
het NAT1 gen in de poliepstudie. Ondanks dat dit de grootste en meest uitgebreide studie 
was die tot dusver was uitgevoerd, kon genetische variatie in XME genen slechts in 
beperpkte mate de associatie tussen vleescarcinogeen inname en colorectale neoplasie 
verklaren.  
Het is gesuggereerd dat het positieve verband tussen rood vlees consumptie en het risico 
op colorectaal kanker kan worden verklaard door de hoge concentratie heem ijzer in dit 
type vlees. Omdat experimenteel onderzoek heeft aangetoond dat blootstelling aan 
heemijzer specifieke mutaties in het DNA kan veroorzaken, hebben wij onderzocht of 
heemijzer inname geassocieerd was met specifieke mutaties in darmkankergenen. Voor 
deze studie, welke beschreven is in hoofdstuk 9, hebben wij gebruik gemaakt van gegevens 
van het totale NLCS cohort. Na 7.3 jaar follow-up is DNA geïsoleerd uit de tumor van bijna 
alle darmkankerpatiënten. In dit tumor DNA is zowel de mutatie status van het KRAS en 
APC gen, en de expressie van P53 bepaald. De resultaten van dit onderzoek bekrachtigen 
de hypothese dat heemijzer het risico op colorectaalkanker verhoogt. Heemijzer was 
geassocieerd met een verhoogd risico op colorectaalkanker gekenmerkt door G-naar-A 
mutaties in KRAS en APC en overexpressie van P53. Er werd geen verband gevonden tussen 
heemijzer en het risico op darmkanker met G-naar-T mutaties in KRAS en APC. Deze nieuwe 
bevindingen suggereren dat het kanker verhogende effect van heemijzer mogelijk wordt 
veroorzaakt door alkylatie en niet door andere mechanismes.  
Dit proefschrift eindigt met een samenvatting van de belangrijkste bevindingen, een 
discussie over de limitaties en implicaties voor toekomstig onderzoek (hoofdstuk 10). 
Vleesconsumptie is een complexe leefstijl welke vanuit verschillende invalshoeken dient te 
worden onderzocht wanneer men het risico tussen vlees en kanker wil bestuderen. Onze 
resultaten laten geen sterk verband zien tussen vleesconsumptie en het risico op de 
onderzochte kankers. Uit onze univariate analyses blijkt dat in vergelijking tot personen die 
dagelijks vlees eten, vegetariërs en laag vleeseters een lager risico hebben op 
respectievelijk long- en colorectaalkanker. Echter deze resultaten verzwakken en zijn niet 
langer statistisch significant wanneer we corrigeren voor confounders. In ons onderzoek 
hebben wij speciale aandacht besteed aan het begrip confounding omdat vegetariërs en 
laag vleeseters ook vaak een ander leefstijl en voedingspatroon hebben, buiten het (niet) 
eten van vlees als zodanig. Deze confounders kunnen op hen beurt ook het risico op kanker 
kan beinvloeden. Onze observatie dat heemijzer mogelijk het risico op colorectaalkanker 
vergroot door specifieke alkylerende mechanismen, verschaft belangrijk nieuwe 
mechanistisch bewijs dat rood vlees inderdaad een risicofactor is voor colorectaalkanker.  
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In addition to the scientific value of this thesis described in Chapters 2-10, the results of the 
research presented also has societal and economic value (either directly or following 
additional research). The challenge of bridging our research results with clinical care, public 
policy, and community action can best be met through knowledge transfer and exchange. 
This thesis applied a multi-dimensional approach to study the association between meat 
and cancer risk and hence included studies on different health outcomes and exposures.  
Because examples of value creation differ by discipline and type of research, the studies 
described in this thesis were grouped into three categories and the valorization possibilities 
for each section are described separately below.  
MEAT CONSUMPTION AND WEIGHT CHANGE 
Overweight and obesity have reached pandemic proportions resulting in a growing global 
burden of obesity related chronic disease [1]. At a population level, even moderate 
elevations in BMI and body weight over a long period of time have been shown to increase 
disease risk [2-4]. It is thus of great importance to determine effective and safe 
mechanisms for maintaining a healthy body weight; this can reduce the enormous health 
care costs associated with obesity related chronic disease and will greatly increase the 
quality of life of the individual.  
Because several hypotheses suggested a role for meat consumption in weight management 
we set out to study if meat consumption was associated with weight gain in an elderly 
population (55-69 y) (Chapter 2). We observed only a small increase in BMI from baseline 
over a 14 y prospective follow-up. In line with these findings we did not find strong 
evidence for an association between (subtypes of) meat intake and prospective weight 
change. Other research indicates that men and women predominantly gain weight until 
middle age [5, 6].  We also conducted retrospective and cross-sectional analyses that 
indeed suggest that meat consumption is associated with weight change over the first 40 y 
of adult life. This offers a large window of opportunity for developing and implementing 
effective weight management strategies. Future studies may therefore focus on verifying 
and further deciphering these observations in observational and experimental settings.  
Such studies can provide important evidence for developing evidence-based dietary weight 
management guidelines that may be more effective than the existing recommendations.  
MEAT CONSUMPTION AND VITAMIN B12 DEFICIENCY 
The key message of the research described in Chapter 3 is that the vitamin B12 content of 
vegetarian (including vegan) diets is frequently below the reference limit. The vegetarian 
population, clinicians and policymakers are the principal target audience for this message 
and should be engaged to become active to take action. For example, more intense 
monitoring, fortification and supplementation of vitamin B12 will help to prevent negative 
vitamin B12 related health effects in persons adhering to these diets.  
First and foremost, changing awareness and educating the vegetarian population to take 
effective vitamin B12 supplements is key in preventing nutritional deficiencies in this group. 
Although there are many active online vegetarian communities to date, by far not all of 
them are preaching scientifically valid dietary recommendations and advice. It is therefore 
important to use effective platforms to actively communicate our research results to this 
target population. The results of the paper described in Chapter 3 have featured in the 
VALORISATION 
 
207 
September 2010 issue of the International Vegetarian Union newsletter and reached a wide 
target audience. This has prompted plenty of discussion on the importance of ensuring a 
reliable dietary source of vitamin B12 among the vegetarian community.  
Early detection and quick treatment of a vitamin B12 deficiency are essential to prevent 
development of irreversible neurologic damage [7]. Making an accurate and timely 
diagnosis, however, can be challenging. The list of related signs and symptoms is long, 
varied, and non-specific and vitamin B12 deficiency is often misdiagnosed for some other 
condition7. Increased awareness of this issue among clinicians may help to ensure a timely 
diagnosis (e.g. by inquiring after a person’s diet when patients present with assymtomatic 
complaints). 
The abovementioned valorization opportunities to prevent vitamin B12 deficiencies are 
hampered by the recommendation of the Health Council of the Netherlands to fortify 
bread and breakfasting cereals with folic acid [8]. Even though folic acid prevents neural 
type defects, high intakes can mask a vitamin B12 deficiency hampering early detection and 
treatment.  
MEAT CONSUMPTION AND CANCER RISK 
In the Netherlands, 1 out of 2.3 men will develop cancer at some point in his life, and the 
corresponding chance for women is 1 out of 2.6 [9]. The burden of cancer continues to 
increase in the future as a result of demographic changes and increasing adoption of 
cancer-causing lifestyle choices. This increase in number of cancer patients is expected to 
exert a substantial stressor on our health care system. It is thus important that we intensify 
our efforts for cancer prevention in order to decrease cancer incidence in the future.  
The outcomes of the studies presented in chapter 4-9 are of high importance from an 
economic perspective since effective cancer prevention strategies will reduce the 
enormous health care costs associated with cancer treatment. From a societal perspective 
it is important to prevent cancer occurrence or improve cancer prognosis because this will 
greatly increase the quality of life of the individual.  
Diet, including meat intake, is long hypothesized to be a modifiable risk factor for several 
cancers providing opportunities for cancer prevention. In the Netherlands, low(er) meat 
consumption is gaining popularity over the last years [10]. We set out to study if meat 
consumption was associated with cancer risk using a dietary pattern approach and a 
mechanistic approach.  
Dietary pattern approach 
Our descriptive analyses in Chapter 4 indicated that vegetarian and low meat consumers 
adhere to a lifestyle that is characterized by a more favorable distribution of dietary and 
lifestyle factors. This study provided a first unique and detailed insight into the 
characteristics and health status of an elderly population of vegetarians and low meat 
consumers in the Netherlands.  
We reported that self-definition is not a reliable indicator for estimating the prevalence of 
vegetarianism in a population. Many nutrition examination surveys, however, use this as a 
classification tool to estimate and the number of individuals adhering to a vegetarian 
VALORASATION 
 
208 
lifestyle. Since such data is used to direct and design health programs and services, it is 
important to use accurate classification tools.  
Although we found little evidence that the abstinence of meat per se reduces the risk of 
the major cancers under study, it does become evident that the total vegetarian and low 
meat lifestyle may promote health and wellbeing. This is supported by studies showing 
lower diabetes, cardiovascular disease, and mortality rates among individuals adhering to 
such lifestyles [11-13]. If careful attention is being paid to preventing nutritional 
deficiencies in vegetarians (e.g. vitamin B12 – see above), public health policy may consider 
promoting the adaption of a balanced vegetarian lifestyle.  
We also observed that a large percentage (>10%) of the vegetarians and pescetarians in the 
NLCS-MIC cohort switched to this lifestyle after a cancer diagnosis. This suggests that 
cancer survivors may be highly motivated to make dietary changes towards a more plant-
based diet after diagnosis with the intention to improve their health and well-being. While 
proper nutrition is important for cancer patients [14], it remains to be elucidated whether 
adopting a vegetarian lifestyle may influence the course of cancer prognosis and the risk of 
recurrence. Nutritional prognosis research is still in its infancy compared to etiologic 
research in cancer. With the aging of the population and rapid increase in the number of 
cancer patients and survivors, however, there is a great need for evidence based dietary 
recommendations for this specific target group. Some cohorts comprising a uniquely large 
number of cancer survivors have recently been initiated to investigate how diet and 
supplement use improve cancer survival and quality of life. This knowledge can eventually 
be used to develop protocols for nutritional care in cancer patients.   
Vegetarians choose to adopt a meat-free diet for a variety of reasons. While this thesis 
examines the health effects of these diets, there are also a number of recent societal and 
economic effects associated with adopting a vegetarian diet making this a timely topic.  
Some of the environmental effects that are claimed to be associated with meat production 
include pollution through fossil fuel usage, and water and land consumption.  In addition, 
the United Nations Sustainable Development Knowledge Platform recommends a 
substantial reduction of meat consumption and suggests that achieving such a sustainable 
meat production and consumption is essential in the transformation towards a more 
sustainable society. 
Mechanistic approach 
Our studies into specific mechanisms of meat-related carcinogenesis provided important 
biological insights that can potentially be used to develop (commercial) dietary prevention 
strategies.  Chapter 8 suggests that heme iron may increase the risk of colorectal cancer 
primarily through DNA-alkylating processes as a result heme-catalyzed endogenous 
formation of N-nitroso compounds (NOC). With this knowledge it may be possible to 
change or intervene on the production processes that lead to NOC formation. Several 
promising examples include adding calcium carbonate or vitamin C or E to the diet. If these 
interventions are fine-tuned and proven to be effective in an experimental setting, people 
may be able reduce their cancer risk associated with red meat consumption in the future.  
In Chapter 8 we studied gene-environment (G×E) interactions in relation to meat 
carcinogens and the risk of colorectal neoplasia. Such G×E studies may help to identify 
individuals at highest risk of cancer based on both their meat consumption patterns and 
genetic risk profiles. This knowledge may eventually be used to tailor interventions aimed 
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at cancer prevention on genotype status. Before this can be applied on a large scale some 
(large) hurdles should be taken, including ethical, scientific and commercial issues. Some 
promising initiatives, however, are currently exploring the possibilities of commercially 
offering a personalized dietary prevention service based on genotyping data. G×E studies as 
described in this thesis form the scientific basis of such enterprises. 
To conclude, this addendum illustrated how the research described in this thesis could 
results into social and economic knowledge translation. It is, however, important to point 
out that proper follow-up of our findings and recommendations are necessary before such 
knowledge transfer can be successful.  
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DANKWOORD 
Promoveren doe je niet alleen! De jaren van mijn promotieonderzoek heb ik ervaren als 
een bijzonder boeiende, uitdagende en meestal erg leuke en leerzame periode. Nu deze 
periode bijna is afgesloten kijk ik met trots terug op de dingen die ik doe en die ik de 
afgelopen jaren heb bereikt. Een groot woord van dank aan alle mensen die mij daarbij 
geholpen hebben en met wie ik mijn avonturen heb kunnen delen en beleven. 
(co)Promotoren: Allereerst natuurlijk Leo. Het is alweer zeven jaar geleden dat jij mij als 
stagiaire onder je hoede nam en de tijd is voorbij gevlogen. Wat heb ik veel van je geleerd 
de afgelopen jaren. Ik heb je persoonlijke betrokkenheid bij mijn promotieonderzoek 
buitengewoon gewaardeerd en ben je zeer dankbaar dat jij mij altijd hebt gestimuleerd 
mijn eigen weg te volgen. Zonder jouw hulp en enthousiasme waren mijn buitenlandse 
stages nooit zo eenvoudig tot stand gekomen. Matty, ik had de luxe om jou als tweede 
‘dagelijkse’ begeleider in mijn promotieteam te hebben. Dankzij jouw open en prettige 
manier van werken had ik altijd het gevoel dat ik voor alles bij je aan kon kloppen. Ik ken 
weinig mensen met zo’n enthousiasmerend vermogen en drive voor het onderzoek – 
bedankt voor al je hulp, Matty! Piet, ik wil je bedanken dat je mij de mogelijkheid hebt 
gegeven binnen de NLCS te promoveren. Je overzag het geheel en hield de hoofdlijnen van 
het project altijd goed in te gaten. Ook op onderwijsgebied heb ik altijd prettig met je 
samengewerkt. 
Co-auteurs: Aan de artikelen in dit proefschrift hebben veel co-auteurs een bijdrage 
geleverd. Ik wil iedereen dan ook hartelijk danken voor het kritisch becommentariëren van 
mijn stukken. Sandra, een speciaal woord van dank voor jou: jouw enthousiasme over en 
onuitputtelijke kennis van de voedingsepidemiologie is ongeëvenaard! Pieter, als ‘niet-
NLCS-er’ heb je een waardevolle bijdrage geleverd aan het vegetariër-project. Dank 
daarvoor! 
Collega’s Epidemiologie: Ik heb een fijne tijd gehad op de vakgroep Epidemiologie. 
Allemaal bedankt voor de gezellige sfeer en betrokkenheid op de afdeling. In het bijzonder 
wil ik Yvonne, Mariëlle, Petra, Jolanda, Sacha, Conny, Jos en Harry bedanken voor de 
geweldige ondersteuning. Jullie maken het leven van een promovenda een stuk 
makkelijker! Henny Brants wil ik bedanken voor de waardevolle input bij de classificatie van 
de vegetariërs. 
De club hippe aio’s en oud-aio’s van Deb1 en Uns40: Jullie laten zien dat epidemiologen 
echt geen geitenwollen sokken meer dragen! Door de jaren heen zijn we een hecht groepje 
geworden.  Mede door jullie kwam ik elke dag graag naar het werk. Ik denk met veel plezier 
terug aan de vele etentjes, borrels en natuurlijk de PhD tour.  Ik vind het dan ook fijn dat ik 
met veel van jullie nog steeds contact heb. Ivette en Nadine, onze hardlooprondjes, 
minivakantie naar Dublin en daarna de vele speeldates met Niels vormden de ideale 
gelegenheid om gezellig over van-alles-en-nog-wat te kletsen. Ik ben blij dat ik jullie tijdens 
onze gezamelijke epi-jaren heb leren kennen! 
Milan en Nadine: Zonder jullie als kamergenoten zou mijn promotieonderzoek een stuk 
minder gezellig zijn geweest. Wat hebben we de afgelopen vier jaar veel meegemaakt en 
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gelachen met zijn drieën. Het laatste jaar hebben we veel gesproken over onze 
toekomstplannen en ik ben blij dat we nu alle drie onze eigen dromen najagen. Ik mis jullie 
nu al!  
Martien van Dongen: Bedankt voor de meest briljante quote die ik tijdens mijn 
promotieonderzoek heb gehoord. Ik vind hem dan ook heel toepasselijk in deze epiloog van 
mijn proefschrift: 'Epi liegt niet, epi vertelt de waarheid'. Jij en Christel van Gool zijn het 
levende bewijs dat Brabantse krullenbollen prima epidemiologen zijn. Ik heb dan ook de 
stiekeme hoop dat de ‘golden triangle’ de komende jaren misschien ooit zal worden 
uitgebreid tot 'diamanten vierkant' – de tijd zal het leren.... 
Colleagues in Oxford: Francesca Crowe and Tim Key, your enthusiasm and passion for 
research have strengthened my conviction to pursue a career in science. I have truly 
enjoyed my time at the Cancer Epidemiology Unit during my Masters, and have great 
memories of my time in Oxford. It was wonderful to see everyone again during the PhD 
tour.  
Colleagues @ NCI: Rashmi Sinha, Amanda Cross, Liz Ruder, and Sonja Berndt. I learned so 
much during my five month work visit at the US National Cancer Institute. It was a great 
experience being part of such a coherent team. A big thank you to everyone from the 
Nutritional Epidemiology Branch for making my time at NCI so much fun! 
Lieke: Wat hebben we een hoop meegemaakt de afgelopen 20 jaar: van de atletiekbaan en 
de middelbare school in Helmond, via onze studententijd in Maastricht en ons avontuur in 
Finland naar het prachtige Deb1. Ik vind het dan ook heel bijzonder dat we nu één week na 
elkaar promoveren en jij op deze dag achter mij wilt staan. Kiitos!  
Familie: Pap en mam, hoe ver ik ook van jullie vandaan woon, de Kapelweg blijft altijd mijn 
thuis! Heel erg bedankt voor alle kansen die jullie mij hebben gegeven en jullie eindeloze 
vertrouwen, liefde, en geduld. Dit proefschrift is voor jullie! Guus, jij hebt de afgelopen 
jaren waarschijnlijk het vaakst van iedereen gevraagd wat ik nu precies voor onderzoek 
doe. Hopelijk ben je als je dit boekje leest dan ook net zo trots op mij als ik op jou! Mijn 
lieve schoonfamilie, Frank en Rita, Karin en Robert, en Ilze en Tom (en Teun!): het voelt 
goed om te weten dat jullie er altijd voor ons zijn. 
Tim en Niels: Jullie zijn mijn grootste geluk. Wat hebben wij het toch goed met zijn drietjes. 
Ik ben ontzettend trots op ons en verheug me op wat de toekomst ons zal brengen. 
 
                                          Hamilton, oktober 2014 
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